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ABSTRACT 
King cobra (Ophiophagus hannah) venom L-amino acid oxidase (OH-LAAO), a heat 
stable enzyme, has been shown to exhibit bactericidal activity against several strains of 
clinical isolates Gram-positive and Gram-negative bacteria. Its potency was compared 
with some common antibiotics such as cefotaxime, kanamycin, tetracycline, 
vancomycin and penicillin. King cobra venom LAAO was effective in inhibiting Gram-
positive bacteria tested, with minimum inhibitory concentration (MIC) of 0.78 μg/mL 
(0.006 μM) and 1.56 μg/mL (0.012 μM) against S. aureus and S. epidermidis, 
respectively. The MICs are comparable to the MICs of the antibiotics tested. However, 
the OH-LAAO was moderately effective against the Gram-negative bacteria tested (P. 
aeruginosa, K. pneumonia, and E. coli), with MIC ranges from 25 to 50 μg/mL (0.2 - 
0.4 μM). Catalase (1 mg/mL) significantly abolished the bactericidal activity of OH-
LAAO, indicating that the antibacterial effect of the enzyme involves generation of 
hydrogen peroxide. Binding studies indicated that OH-LAAO binds strongly to the 
Gram-positive S. aureus and S. epidermidis, but less strongly to the Gram-negative E. 
coli and P. aeruginosa, suggesting that specific binding to the bacteria is important for 
its potent antibacterial activity.  
The enzyme was also shown to exhibit very potent anti-proliferative activity against 
human tumourigenic breast (MCF-7), lung (A549), promyelocytic leukaemia (HL-60) 
and prostate (PC-3) cells, with IC50 of 0.04 - 0.07 μg/mL after 72 h incubation. In 
comparison, its cytotoxicity was about 3 to 4 times lower when tested against the non-
tumourigenic breast (184B5) and lung (NL 20) cells, suggesting selective anti-tumour 
activity. Furthermore, its potency in human tumourigenic cells was greater than the 
effects of doxorubicin, which has an IC50 of 0.1 - 0.63 μg/mL. The selective cytotoxic 
action of the OH-LAAO was confirmed by PE-annexin V/7-AAD apoptotic assay. The 
iv 
 
ability of OH-LAAO in inducing apoptosis in tumour cells was further demonstrated 
using caspase-3/7 and DNA fragmentation assays. Apoptosis induction activity of the 
enzyme is via both intrinsic and extrinsic pathways as indicated by increase in caspase-9 
and -8 activities as well as increased cytochrome c levels in both cytosolic and 
mitochondria fractions in the LAAO-treated cells. The generation of H2O2 plays a 
significant role in the cytotoxic action of the enzyme, as its cytotoxicity was 
significantly reduced in the presence of catalase (a H2O2 scavenger). It was postulated 
that the alterations of gene and protein expression in cells treated with OH-LAAO, as 
observed in microarray and proteomics studies, were largely caused by non-specific 
oxidative modifications of signalling molecules that eventually lead to apoptosis and 
cell death.  
Administration of 1 μg/g (i.p.) of OH-LAAO to PC-3 tumour-bearing NU/NU mice 
markedly inhibited the tumour growth. TUNEL staining analysis on the tumour sections 
showed a significantly increase of apoptotic cells in the LAAO-treated animals. The 
enzyme also did not cause any significant pathology changes on the vital organs as well 
as the body weight of the treated mice. In view of its heat stability, its selective and 
potent cytotoxic action on cancer cells, OH-LAAO can be potentially developed for 
treating solid tumours.  
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ABSTRAK 
L-asid amino oxidase dari bisa ular tedung selar (Ophiophagus hannah) (OH-LAAO) 
adalah enzim yang stabil terhadap haba. Kajian telah membuktikan bahawa ia 
mempunyai aktiviti anti-bakteria terhadap beberapa jenis bakteria klinkal Gram-negatif 
dan Gram-positif. Potensinya telah dibandingkan dengan beberapa jenis antibiotik yang 
lazim digunakan seperti cefotaxime, kanamycin, tetracycline, vancomycin, and penicillin. 
L-asid amino oxidase dari bisa ular tedung selar amat berkesan dalam mengawal 
pertumbuhan bakteria Gram-positif yang telah diuji, dengan kepekatan penghalang 
minimum sebanyak 0.78 μg/mL (0.006 μM) bagi S. aureus dan 1.56 μg/mL (0.012 μM ) 
bagi S. epidermidis. Keberkesanan OH-LAAO adalah setanding dengan antibiotik yang 
diuji. Walau bagaimanapun, kesan anti-bakteria OH-LAAO terhadap bakteria Gram-
negatif (P. aeruginosa, K. Pneumoniae, dan E. coli) yang diuji adalah sederhana sahaja, 
dengan julat kepekatan penghalang minimum antara 25 hingga 50 μg/mL (0.2 - 0.4 μM). 
Katalase (1 mg/mL) berupaya mengurangkan kesan anti-bakteria OH-LAAO. Ini 
menunjukkan bahawa kesan anti-bakteria enzim tersebut melibatkan pembebasan 
hidrogen peroksida. Hasil kajian juga menunjukkan bahawa darjah pengikatan OH-
LAAO adalah lebih kuat terhadap S. aureus dan S. epidermidis (bakteria Gram-positif) 
berbanding dengan E. coli dan P. aeruginosa (baketria Gram-negative). Ini 
membuktikan bahawa pengikatan khusus terhadap bakteria adalah penting bagi kesan 
anti-bakteria enzim tersebut. 
Enzim tersebut juga telah dibuktikan mempunyai aktiviti anti-proliferatif yang kuat 
terhadap sel karsinoma payudara (MCF-7), paru-paru (A549), leukemia (HL-60), dan 
prostat (PC-3) manusia dengan julat IC50nya sebanyak 0.04 - 0.07 μg/mL, selepas 72 
jam inkubasi. Kesan sitotoksik enzim tersebut adalah kira-kira 3 - 4 kali lebih rendah 
apabila diuji terhadap sel payudara (184B5), dan paru-paru (NL 20) normal manusia. Ini 
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mencadangkan bahawa enzim tersebut mempunyai activiti anti-tumor yang khusus. 
Selain itu, kesan anti-proliferatif OH-LAAO terhadap sel karsinoma manusia adalah 
jauh lebih berkesan berbanding dengan doxorubicin, iaitu agen klinikal kanser bagi 
rawatan kemoterapi yang sedia ada, dengan IC50nya dalam julat 0.1 - 0.63 µg/mL. 
Tindakan khusus OH-LAAO ini  juga telah dibuktikan dengan melalui PE-annexin V/7-
AAD assay. Kesan sitotoksik OH-LAAO telah dibuktikan melibatkan proses apoptosis 
kerana terdapat peningkatan aktiviti caspase-3/7 dan fragmentasi molekul DNA dalam 
sel-sel yang dirawat dengn OH-LAAO. Induksi aktiviti apoptosis enzim tersebut adalah 
melalui jalur intrinsik dan ekstrinsik seperti yang ditunjukkan dalam peningkatan 
aktiviti caspase-9 and -8 serta cytochrome c di bahagian sitosol dan mitokondria dalam 
sel-sel yang dirawat. Hidrogen peroksida memainkan peranan penting dalam tindakan 
sitotoksik OH-LAAO kerana panambahan katalase berjaya mengurangkan aktiviti 
sitotoksik enzim tersebut. Sebagaimana yang ditunjukkan melalui kajian microarray 
dan proteomik, perubahan gen dan protein dalam sel-sel yang dirawat dengan OH-
LAAO besar kemungkinan disebabkan oleh pengubahsuaian oksidatif yang tidak 
spesifik terhadap isyarat molekul yang akhirnya membawa kepada proses apoptosis lalu 
menyebabkan kematian sel-sel. 
Pertumbuhan tumor PC-3 dalam tikus NU/NU berjaya disekat dengan suntikan OH-
LAAO sebanyak 1 μg/g secara i.p. Analisis TUNEL bagi tisu-tisu tumor menunjukkan 
peningkatan proses apoptosis untuk sel-sel di dalam tikus yang dirawat dengan OH-
LAAO. Enzim tersebut tidak menyebabkan sebarang perubahan patologi terhadap 
organ-organ penting dan mahupun berat badan tikus. Disebabkan ciri-ciri istimewa OH-
LAAO yang merangkumi kestabilan haba yang tinggi, tindakan sitotoksik yang amat 
berkesan and khusus, OH-LAAO  mempunyai potensi yang baik dalam rawatan tumor. 
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1.1 Ophiophagus hannah (king cobra) 
 
Figure 1.1: Ophiophagus hannah (king cobra). Picture courtesy of N.H. Tan.  
Ophiophagus hannah (the king cobra) is the longest venomous snake in the world, with 
an average length of about 3.9 m (12.8 ft) although some can grow up to 5.5 m (18 ft). 
The adult king cobra is brown or olive above with scales dark-edged especially on tail 
and posterior body with traces of whitish crossbars (Tweedie, 1983; Das, 2006). The 
throat is orange-yellow or cream coloured with irregular blackish markings. A unique 
feature of this species is the presence of a pair of large occipital shields behind the 
parietals that come in contact with each other on midline, which allow recognition on 
smaller specimens (Lim et al., 2011). The king cobra is widely distributed in South and 
Southeast Asia, including Pakistan, Bhutan, Nepal, India, Bangladesh, Myanmar, 
southern China, Vietnam, Cambodia, Laos, Thailand, Peninsular Malaysia, Singapore, 
Borneo, Sumatra, Java, Bali, Sulawesi, and the Philippines (Iskandar and Colijn, 2001). 
It inhabits a wide range of habitats, in forest and in populated areas.  
Ophiophagus hannah is classified under the family Elapidae. It belongs to a unique 
genus Ophiophagus, while most others elapids are Naja (cobra) or Bungarus (krait). 
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Although all elapid snakes exhibit fixed front fangs that are situated in front of the 
upper jaw, however, king cobra can be distinguished from other cobras by the size and 
hood. King cobras are generally larger than other cobras, and the stripe on the neck is a 
chevron instead of a double or single eye shape that may be seen in most of the other 
Asian cobras. In addition, the hood of the king cobra is narrower and longer (Lim et al., 
2011). The generic name Ophiophagus derived from the Greek language and literally 
means "snake eater", ophio = snake and phagus = eater, in reference to its dietary habits. 
The picture of king cobra is shown in Figure 1.1. 
1.2 Biochemistry of snake venom L-amino acid oxidase (LAAO) 
1.2.1 General aspects 
L-amino acid oxidase (LAAO) (L-amino acid: O2 oxidoreductase, E.C. 1.4.3.2.) is a 
flavoenzyme that catalyses the oxidative deamination of an L-amino acid to produce the 
corresponding α-ketoacid, hydrogen peroxide and ammonia (Tan and Fung, 2009). The 
enzyme is widely distributed in venoms from most genera of snakes (Tan and 
Ponnudurai, 1992) and generally constitutes about 1 - 4% of the total venom proteins by 
dried weight (Tan, 1998). L-amino acid oxidase is highly specific for the oxidation of 
L-enantiomer of amino acids. Generally, the best substrates for the enzyme are 
hydrophobic amino acids; L-leucine, L-methionine, L- phenylalanine, L-tyrosine and L-
tryptophan (Tan and Fung, 2009). Ophiophagus hannah venom LAAO has been 
reported to oxidize L-lysine and L-ornithine in addition to the previously mentioned L-
amino acids (Tan and Saifuddin, 1991). Differences of the catalytic activities are mainly 
due to variations in side-chain binding sites for substrate specificity of the enzyme (Wei 
et al., 2009). 
Earlier, the studies of snake venom LAAO mainly focused on their enzymatic and 
physiochemical properties. Recently, its pharmacological activities such as anticancer, 
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antibacterial, leishmanicidal, anti-HIV, platelet aggregation as well as edema-inducing 
and haemorrhagic activities have been studied extensively. These studies indicated that 
king cobra venom LAAO has the potential to be developed as a therapeutic agent. 
1.2.2 Purification of snake venom L-amino acid oxidase 
Numerous LAAOs have been purified and characterized from various snake venoms 
(Izidoro et al., 2006; Samel et al., 2006; Toyama et al., 2006; Wei et al., 2003). The 
enzymes may exist in multiple isoforms in some snake venoms. Hayes and Wellner 
(1969) reported that there were at least 18 isoforms of Crotalus adamanteus venom 
LAAO, and the microheterogeneity of the enzyme is presumably due to the varying 
degree of glycosylation. However, high homogeneity of the oligosaccharide chain was 
found in many other snake venom LAAOs such as in Calloselasma rhodostoma 
(Pawelek et al., 2000) and Ophiophagus hannah (Tan and Fung, 2009). In general, 
snake venom LAAO can be easily purified to a high degree of molecular homogeneity 
using a single- or combination of two-step chromatography procedure (Ali et al., 2000; 
Ponnudurai et al., 1994; Souza et al., 1999; Stábeli et al., 2007; Toyama et al., 2006). 
1.2.3 L-amino acid oxidase assay 
Horseradish peroxidase coupled assay, a spectrophotometric method described by 
Bergmeyer (1983) is a commonly used LAAO assay method. In this assay, the 
oxidation rate is measured by the rate of formation of dye colour complex between the 
hydrogen peroxide and o-dianisidine (Bergmeyer, 1983). The colour complex was 
spectrophotometrically measured at 436 nm. 
Catalytic activity of LAAO can be devided into two stages: the α-hydrogen atom of the 
amino acid is first abstracted by the FAD prosthetic group, forming α-imino acid as the 
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intermediate product, which then reacts with water to form the α-keto acid in the later 
stage (Figure 1.2) (Tan and Fung, 2009). 
 
Figure 1.2: Mechanism of LAAO in catalysis oxidative deamination of L-amino acid. Figure 
taken from Tan and Fung 2009. 
 
1.2.4 Physical properties of L-amino acid oxidase 
Snake venom LAAO is a homodimeric flavoprotein containing two molecules of non-
covalently bound FAD (flavin adenine dinucleotide) or FMN (flavin mononucleotide). 
The flavin group is reponsible for the yellowish colour of the enzyme. Most of the 
snake venom LAAOs are FAD-binding proteins. 
The enzyme has a molecular weight of 112 - 140 kDa as determined by gel filtration 
chromatography, and a wide range of isoelectric point (pI), ranging from 4.4 to 8.12 
(Tan, 1998). Generally, most of the snake venom LAAOs are thermo-labile enzymes. 
They are stable at room temperature and usually store at 4 °C to avoid inactivation. 
However, many LAAOs are inactivated by freezing and unstable under alkaline 
conditions. For example, LAAOs isolated from Crotalus adamanteus and Vipera 
ammodytes (sand viper) venoms have been reported to undergo reversible pH or 
temperature-dependent inactivation (Coles et al., 1977; Kurth and Aurich, 1976). Curti 
et al. (1968) demonstrated that C. adamanteus LAAO was inactivated by storage at 
between -60 °C and -5 °C, the maximal inactivation was observed at -20 °C. The 
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inactivation was believed to be due to a limited conformational change of the enzyme 
structure, presumably in the vicinity of the flavin prosthetic group (Curti et al., 1968). 
Unlike other snake venom LAAOs, O. hannah venom LAAO exhibited unusual thermal 
stability. At pH 7.4, the enzyme retained 100% activity after incubation at 25 °C for 30 
days. The enzyme was also stable at alkaline condition and was not inactivated by 
freezing (Tan and Saifuddin, 1989). Because of these favourable stability properties, O. 
hannah venom LAAO has a greater potential to be developed as a therapeutic agent, 
when compared to other venom LAAOs. Therefore, it would be an interesting candidate 
for the investigation of the anti-cancer and antibacterial effects of LAAO.  
1.2.5 Chemical properties of L-amino acid oxidase 
Snake venom LAAO is a glycoprotein, containing 3 - 4% of carbohydrate. The sugar 
compositions of oligosaccharide moiety of C. adamanteus LAAO was first identified as 
fucose, mannose, galactose(N-acetyl)glucosamine and sialic acid (deKok and Rawitch, 
1969). Glycosylation may improve crystallization of the enzyme as suggested by Geyer 
et al. (2001). The glycan moiety has been shown to mediate the pharmacological actions 
of LAAO by binding to the cell surface leading to the production of highly localize 
concentrations of H2O2 in or near to the binding interface. This in turn leads to oxidative 
damage to the cells (Suhr and Kim, 1996; 1999).    
The N-terminal amino acid sequences of most snake venom LAAOs are highly 
homologous, except for O. hannah LAAO. The presence of a highly conserved 
glutamine rich motif may play an important role in substrate binding and therefore the 
potency of pharmacological activities of snake venom LAAOs (Tan and Fung, 2009; 
Guo et al., 2012).  
Snake venom LAAOs from Crotalus adamanteus, Crotalus atrox, Calloselasma 
rhodostoma, Agkistrodon halys blomhoffii, Trimeresurus stejneggeri and Bothrops 
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moojeni showed sequence homogeneity of approximately 80% (Rodrigues et al., 2009). 
Ophiophagus hannah venom LAAO, however, has been shown to posses only 50% 
protein sequence homology with other known snake venom LAAOs. Phylogenetic 
analysis indicated that O. hannah venom LAAO is evolutionary distant to other snake 
venom LAAOs with its unique amino acid sequence (Jin et al., 2007). 
1.2.6 Antibacterial activity of snake venom L-amino acid oxidase 
The emergence of multidrug-resistant bacteria has drawn major attention among 
healthcare and medical practitioners ever since the introduction of penicillin in the late 
1920s (Zainol et al., 2013). Although multidrug-resistant Pseudomonas aeruginosa, 
acinetobacter sp., Staphylococcus aureus and E. faecium are the best known therapeutic 
challenges among the gram-negative and gram-positive bacteria, resistance to the most 
potent antibiotics has been extended to members of the Enterobacteriaceae family of 
gram-negative bacteria, such as Klebsiella sp., Escherichia coli, and enterobacter sp. 
(Arias and Murray, 2009). In Malaysia, P. aeruginosa, S. aureus, K. pneumoniae, and E. 
coli were the most common healthcare-associated pathogens isolated from patients with 
nosocomial infection (Hughes et al., 2005; Rozaidi et al., 2001). 
The used of currently available antimicrobial agents in the treatment of bacteria 
infectious diseases is becoming more challenging due to emergence of several 
antibiotic-resistance microbial. Therefore, it is important to search for a new potent 
antibacterial agent in order to supplement the currently increasingly ineffective 
antibiotics. Snake venom LAAO may be a promising alternative anti-microbial agent. It 
has been shown to exhibit potent antibacterial activity against both gram-negative and 
gram-positive bacteria.  
Skarnes (1970) was the first to report that a LAAO isolated from Crotalus adamanteus 
venom possessed bactericidal activity. Subsequently, snake venom LAAOs isolated 
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from Bothrops jararaca (Ciscotto et al., 2009), Bothrops marajoensis (Torres et al., 
2010), Bothrops atrox (Alves et al., 2011), Bothrops pirajai (Izidoro et al., 2006), 
Trimeresurus jerdonii (Lu et al., 2002), Naja naja oxiana (Samel et al., 2008), Bothrops 
alternatus (Stábeli et al., 2004), Vipera lebetina (Tõnismägi et al., 2006), Crotalus 
durissus cascavella (Toyama et al., 2006), Trimeresurus mucrosquamatus (Wei et al., 
2003), Agkistrodon blomhoffii ussurensis (Sun et al., 2010), and Bothrops pauloensis 
(Rodrigues et al., 2009) have been shown to exhibit antibacterial activity. 
It is well established that the bactericidal activity of LAAO is due to the H2O2 liberated 
during the enzymatic reaction, as addition of catalase significantly diminished the 
antibacterial activity. Toyama et al. (2006), for example, using electron microscopic 
method demonstrated that the H2O2 generated during the enzymatic reaction induced 
bacterial membrane rupture, promoting the release of cytoplasmatic content and 
subsequently cell death. Although the H2O2 generated certainly plays an important role 
in bactericidal activity of the enzyme, the binding of the enzyme to bacterial membrane 
is essential for the potency of its bactericidal action. Such binding activity was observed 
in LAAO isolated from Agkistrodon halys using fluorescence labelling method (Zhang 
et al., 2004). Binding to bacteria is important for the antibacterial action of the enzyme 
as it enables production of highly localized concentration of H2O2 and this account for 
the high antibacterial potency of the enzyme (Ehara et al., 2002). Investigation of 
binding activity of LAAOs isolated from other organisms were also carried out by other 
authors, such as LAAO isolated from rockfish Sebastes schlegelii (Kitani et al., 2008), 
and giant snail Achatina fulica (Ehara et al., 2002), and these enzymes were also potent 
anti-bacterial agent.  
Compare to the pathogens, human host cells or normal flora are less sensitive to 
oxidative damage caused by H2O2 or other ROS, which implies that snake venom 
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LAAOs may selectively kill bacterial strains without causing significant damage to the 
host (Guo et al., 2012). Therefore, this enzyme has potential to be developed as an 
antibacterial agent. 
1.2.7 Apoptosis-inducing activity of snake venom L-amino acid oxidase 
Snake venom LAAOs have been reported to induce apoptosis in various cell lines; 
including mouse lymphocytic leukaemia (Suhr and Kim, 1996), human umbilical vein 
endothelial, human promyelocytic leukaemia (HL-60), human ovarian carcinoma 
(A2789), mouse endothelial (KN-3) (Torii et al., 1997), human lung carcinoma (A549) 
(Wei et al., 2009), Hela cervical cancer (Zhang and Wei, 2007), rat glioma (C6), human 
malignant glioma (RBR17T, and U251) (Sun et al., 2003), human leukaemia (HL-60), 
Jurkat, rat pheochromocytoma (PC-12), murine melanoma (B16F10) (Alves et al., 
2008), human gastric carcinoma (MKN-45), human colon carcinoma (RKO), human 
fibroblasts (LL-24), and human adenocarcinoma HUTU (Naumann et al., 2011). 
The apoptosis-inducing activity of the enzyme was reduced or abolished in the presence 
of catalase or other H2O2 scavengers, indicating that the H2O2 generated by the 
enzymatic reaction plays an important role in snake venom LAAO-induced apoptosis 
cell death. However, the morphological changes of cells induced by snake venom 
LAAO were different from that generated by the exogenous H2O2 (Guo et al., 2012), 
suggesting that snake venom LAAO-induced apoptosis is not entirely due to the H2O2 
liberated into the medium. Takatsuka et al. (2001) demonstrated that snake venom 
LAAOs were able to bind directly to cell surface thereby increasing the local peroxide 
concentration, and suggested that the binding activity played an important role in the 
apoptosis-inducing effect. Sun et al. (2003) suggested that the apoptotic effect of 
Trimeresurus flavoviridis LAAO on malignant glioma cells is mediated by the 
production of intracellular reactive oxygen species (ROS). Zhang and Wu (2008) 
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demonstrated that Agkistrodon acutus LAAO increased accumulation of sub-G1 phase 
cells, and subsequently apoptosis cell death. Zhang and Wei (2007) suggested that 
mitochondrial apoptosis pathway played a role in ACTX-8-induced cell apoptosis. Thus, 
these reports clearly demonstrated that snake venom LAAO is an apoptosis-inducing 
enzyme; and that its cytotoxic activities on cancer cell lines were presumably due to the 
production of high local concentration of H2O2, which depends on the molecular 
interaction of its glycan moiety with the cell surface.  
1.3 Overview of cancers 
Cancer is a class of diseases in which a group of cells display uncontrolled growth 
(division beyond the normal limits), invasion (intrusion on and destruction of adjacent 
tissues), and sometimes metastasis (spread to other locations in the body via lymph or 
blood) (Smart, 2010).  
Cancer is the leading cause of death globally and accounted for 7.6 million deaths, 
which is around 13% of all deaths in 2008. The deaths are caused mainly by lung (1.37 
million deaths), stomach (736 000 deaths), liver (695 000 deaths), colorectal (608 000 
deaths), breast (458 000 deaths), and cervical (275 000 deaths) cancers. Deaths from 
cancer worldwide are projected to continue rising, with an estimated 13.1 million deaths 
in 2030 (WHO, 2013). In Malaysia, a total of 18,219 new cancer cases were diagnosed 
in 2007 and registered with National Cancer Registry (NCR). It comprises of 8,123 
males and 10,096 females. The most common cancers among Malaysian during that 
period were breast, colorectal, lung, nasopharynx, cervical, lymphoma, leukaemia, 
ovary, stomach and liver (NCR, 2007). 
Lung cancer was the top leading cause to overall cancer mortality of estimated 1.37 
million deaths reported in 2008 worldwide (WHO, 2013). In Malaysia, it was the most 
common cancer among males and third most common cancer in the general population 
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with a total of 1,865 cases registered with NCR in 2007 (NCR, 2007). Breast cancer 
was the forth leading cause to overall cancer death and accounted for 458,000 deaths 
(WHO, 2013). In Malaysia, it was the most common cancer in females and also the 
most common cancer among Malaysian. A total of 3,242 cases were diagnosed in 2007 
and reported to NCR. Leukaemia was the seventh most common cancer among 
Malaysian with a total of 741 cases registered with NCR in 2007. Prostate cancer was 
the fourth most common cancer in Malaysian males with a total of 502 cases diagnosed 
and reported to NCR in 2007 (NCR, 2007).  
Chemotherapy, one of the most common modes of treatment, is also known for its 
potential to cause toxicity to normal cells, accompanied by a range of side effects such 
as vomiting, nausea and other severe complications. As such, there is always a need to 
search for new, potent and natural-based therapeutic agents that hopefully exhibit potent 
cytotoxicity against cancer cells over the normal cells, thus minimizing the undesirable 
side effects of chemotherapy. 
1.4 Apoptosis: a cell suicide mechanism 
Apoptosis, or programmed cell death, is a cell-intrinsic mechanism for suicide regulated 
by a variety of cellular signalling pathways (Edinger and Thompson, 2004). Apoptosis 
plays a crucial role in various processes during development and aging and as a 
homeostatic mechanism to maintain cell populations in tissues (Elmore, 2007). 
Dysregulation of apoptosis is implicated in various pathological states. Excessive 
apoptosis is associated with neurodegenerative disorders, immunodeficiency and 
infertility, whereas deficient apoptosis is associated with cancer, autoimmunity, and 
viral infections (Danial and Korsmeyer, 2004).  
Apoptosis is characterized by a series morphological and biochemical changes such as 
shrinkage of cell, loss of plasma membrane asymmetry and attachment, plasma 
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membrane blebbing, chromatin condensation (pyknosis), chromosomal DNA 
fragmentation as well as formation of apoptotic bodies (Edinger and Thompson, 2004). 
Apoptotic bodies are subsequently recognized and removed by macrophages, 
parenchymal cells, or neoplastic cells and degraded within phagolysosomes, without 
causing any inflammatory response (Elmore, 2007).  
Apoptosis is mediated by two inter-related signalling pathways: the intrinsic 
(mitochondria-mediated apoptosis) and extrinsic (death receptor-mediated apoptosis) 
pathways. The intrinsic pathway is associated with loss of mitochondrial membrane 
potential, and the release of pro-apoptotic factors into the cytosol in response to various 
stimuli, whereas the extrinsic pathway is mediated by the binding of ligand to cell 
surface death receptors and catalytically activate the caspase-8 (Bjelakovic et al., 2005; 
Beere, 2005). Regardless of which pathway is initiated, both pathways will eventually 
converge to a final apoptosis execution phase resulting in DNA fragmentation, 
degradation of cytoskeletal and nuclear proteins, and eventually the formation of 
apoptotic bodies (Elmore, 2007).  
1.4.1 Extrinsic pathway: death receptor-mediated apoptosis 
The extrinsic signalling pathway is mediated by death receptors that belong to the 
members of the tumour necrosis factor (TNF) receptor gene superfamily (Locksley et 
al., 2001). The well-known ligands and their corresponding death receptors are TNF-
α/TNF-R1, FasL/FasR, Apo3L/DR-3, Apo2L/DR-4 and Apo2L/DR-5 (Elmore, 2007).  
Using TNF-α/TNF-R1 as an example, binding of TNF ligand to TNF-R1 receptor 
enables the binding of multifunctional adaptor protein, TNF-R1 associated death 
domain (TRADD) to Fas-associated protein with death domain (FADD), with 
recruitment of receptor-interacting protein (RIP) (Hsu et al., 1995). This in turn initiates 
the formation of a death-inducing signalling complex (DISC), leading to caspase-8 
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activation and subsequently cleavage of effector caspases and leads to apoptosis 
(Kischkel et al., 1995). Table 1.1 lists the major extrinsic pathway proteins and its 
common abbreviations. 
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Table 1.1: Extrinsic pathway proteins and its abbreviations 
Abbreviation Protein name 
Apo2L Apo2 ligand 
Apo3L Apo3 ligand 
Caspase-8 Cysteinyl aspartic acid-protease 8 
DISC Death-inducing signalling complex 
DR-3 Death receptor 3 
DR-4 Death receptor 4 
DR-5 Death receptor 5 
FADD Fas-associated death domain 
FasL Fatty acid synthetase ligand 
FasR Fatty acid synthetase receptor 
TRADD TNF receptor-associated death domain 
TNF-α Tumour necrosis factor alpha 
TNF-R1 Tumour necrosis factor receptor 1 
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1.4.2 Intrinsic pathway: mitochondria-mediated apoptosis 
The mitochondria-mediated apoptosis pathway is activated by a variety of extracellular 
and intracellular death signals such as radiation, physical stress, oxidative stress, DNA 
damage, and protein misfolding (Crow et al., 2004). This pathway is associated with 
mitochondria dysfunction, release of apoptogenic proteins into the cytosol, and 
accompanied by the activation of caspase proteases which are responsible for cell 
disassembly (Vande et al., 2000).  
Integrity of the mitochondrial membrane is regulated by Bcl-2 family member proteins 
(Borner, 2003). This protein family can be divided into three groups: the anti-apoptotic 
members (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and Bfl-1/A1), the BH3-only protein (Bad, Bik, 
Bid, Bim, Bmf, Noxa, PUMA), and the pro-apoptotic members (Bax, Bak, and Bok). 
The BH3-only proteins act as activators for the pro-apoptotic Bcl-2 family member 
proteins (Sprick and Walczak, 2004).  
Activated Bax and/or Bak (Bcl-2 homologous antagonist/killer) results in an opening of 
the mitochondrial permeability transition (MPT) pore, and release of the cytochrome c, 
Smac/DIABLO, serine protease HtrA2/Omi, apoptosis-inducing factor (AIF), 
endonuclease G, and caspase-activated DNAse (CAD) from the mitochondrial 
intermembrane space (Elmore, 2007). Association of cytochrome c, dATP, Apaf-1, and 
procaspase-9 forming a functional apoptosome, leading to procaspase-9 activation and 
subsequently triggers the execution-phase of cell apoptosis through the activation of 
effector procaspase-3 (Arya et al., 2007). Smac/DIABLO and serine protease 
HtrA2/Omi promote apoptosis by inhibiting IAP (inhibitors of apoptosis proteins) 
activity (Schimmer, 2004; Loo et al., 2002). Apoptosis-inducing factor (AIF), 
endonuclease G, and CAD are involved in nuclear DNA fragmentation (Enari et al., 
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1998; Joza et al., 2001; Li et al., 2001). Table 1.2 lists the major intrinsic pathway 
proteins and its common abbreviations. 
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Table 1.2: Intrinsic pathway proteins and its abbreviations 
Abbreviation Protein name 
AIF Apoptosis inducing factor 
Apaf-1 Apoptotic protease activating factor 
Bad Bcl-2 antagonist of cell death 
Bak Bcl-2 antagonist killer 1 
Bax Bcl-2 associated X protein 
Bcl-2 B-cell lymphoma protein 2 
Bcl-w Bcl-2 like 2 protein 
Bcl-xL Bcl-2 related protein, long isoform 
Bfl-1/A1 Bcl-2-related protein A1 isoform 2 
Bid BH3 interacting domain death agonist 
Bik Bcl-2 interacting killer 
Bim Bcl-2 interacting protein BIM 
Bmf Bcl-2-modifying factor   
Bok Bcl-2 related ovarian killer 
CAD Caspase-activated DNAse 
Caspase-9 Cysteinyl aspartic acid-protease-9 
HtrA2/Omi High temperature requirement protein A2/ Omi stress-
regulated endoprotease 
Mcl-1 Myeloid cell leukaemia sequence 1 
Noxa Phorbol-12-myristate-13-acetate-induced protein 1 
PUMA Bcl-2 binding component 3 
Smac/DIABLO Second mitochondrial activator of caspases/direct IAP 
binding protein with low PI 
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1.4.3 Cross-talk between extrinsic and intrinsic pathways 
Cross-talk between extrinsic and intrinsic pathways occurs through truncated Bid (tBid), 
which is generated upon the proteolysis of BH3-interacting domain death agonist (Bid) 
by the activated caspase-8 (derived from the extrinsic pathway), The translocation of 
tBid to mitochondria promotes outer membrane permeabilization, release of 
apoptogenic factors, and thereby activating the intrinsic pathway (Khosravi and Esposti, 
2004). Schematic relations between intrinsic, extrinsic, and the cross-talk of the two 
apoptosis pathways is illustrated in Figure 1.3. 
Evidence has shown that both extrinsic and intrinsic apoptosis pathways can activate 
each other. Activation of caspase-3 by caspase-9 triggers the activation of caspase-8 in a 
feedback amplification loop. It is also speculated that activated caspase-3 might activate 
caspase-9 in a similar retrograde manner (Hotchkiss and Nicholson, 2006). 
Both extrinsic and intrinsic parthways converge at the execution phase. At this point, 
caspase-3, caspase-6, and caspase-7 function as effector or “executioner” caspases 
activate cytoplasmic endonuclease that ultimately cause the morphological and 
biochemical changes seen in apoptotic cells (Elmore, 2007). 
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Figure 1.3: Schematic relations between intrinsic, extrinsic, and the cross-talk of the two 
apoptosis pathways. Apoptosis is mediated by two signalling pathways: A) intrinsic 
(mitochondria) and B) extrinsic (death receptor) pathways. The intrinsic pathway is associated 
with loss of mitochondrial membrane potential, release of cytochrome c into the cytosol, and 
accompanied by activation of caspase-9. The extrinsic pathway is mediated by the binding of 
ligand to cell surface death receptors and catalytically activate the caspase-8. C) The two 
pathways are interconnected by truncated Bid (tBid) that is formed when Bid is cleaved by 
active caspase-8. 
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1.5 Oxidative stress and apoptosis 
Mitochondria is the main site of generation of oxygen radicals, such as, superoxide 
anions (O2
−
), hydroxyl radicals (OH·), singlet oxygen (
1
O2) and hydrogen peroxide 
(H2O2) within the cell (Kannan and Jain, 2000). Imbalance between the reactive oxygen 
species (ROS) generation and elimination could disrupt cellular redox homeostasis, 
leading to an overall increase of intracellular ROS levels, or oxidative stress 
(Trachootham et al., 2008). It has been suggested that the global shutdown of 
mitochondrial function under oxidative stress conditions could contribute to apoptosis 
due to dramatically decrease in cellular energy supply (Morel and Barouki, 1999).   
Reactive oxygen species are known to serve as second messengers for various 
signalling pathways as well as a potent mediator of signal transduction via oxidative 
modification of signalling proteins (Trachootham et al., 2008; Verzola et al., 2004). 
Activation of Jun N-terminal kinase (JNK) has been shown to induce mitochondria-
mediated apoptosis, in response to oxidative stress. Induction of apoptosis by activated 
JNK involves direct activation of BH3-only proteins (Bim, Bmf, and Bad), and 
inhibition of anti-apoptotic proteins (Bcl-2, Bcl-xL, and Mcl-1). This in turn promotes 
translocation and activation of Bax/Bak, leading to mitochondria-mediated apoptosis 
(Weston and Davis, 2002). Furthermore, activation of JNK was shown to promote its 
dissociation from p53, leading to stabilization of p53 which ultimately leads to 
apoptosis (Trachootham et al., 2008).  
Recent studies also raised the possibility that Akt (v-Akt murine thymoma viral 
Oncogene)/PKB (protein kinase-B), a serine/threonine kinase pathway may be activated 
by Fas ligand under oxidative stress condition and that this signalling pathway may be 
involved in Fas-mediated cell death (extrinsic pathway) (Lu et al., 2006). Activation of 
21 
 
this pathway is mainly through oxidative modification of Cys-dependent phosphatases 
(CDPs) and protein kinases in a redox-sensitive manner (Trachootham et al., 2008).  
1.6 Cytotoxic and apoptosis detection assays 
1.6.1 The MTT assay 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay, a 
method developed by Mosmann (1983) is most commonly employed for the detection 
of cytotoxicity or cell viability following exposure to the treatment compound in vitro.  
The principle of this assay is based on the cleavage of the tetrazolium salt MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) into an insoluble purple 
formazan by the mitochondria enzyme succinate dehydrogenase (Fotakis and Timbrell, 
2006). The reduction activity takes place only in living cells and the amount of the 
formazan product is proportional to the number of viable cells that present in the culture 
(Denizot and Lang, 1986).  
The MTT assay has been tested for its validity and reproducibility in various cell lines 
(Mosmann, 1983). Subsequently, Denizot and Lang (1986) and Hansen et al. (1989) 
developed improved versions of the assay.  
1.6.2 DNA fragmentation assay  
Apoptosis is often accompanied by the cleavage of chromosomal DNA into 
internucleosomal fragments of about 180 - 200 base pairs (bp) (Collins et al., 1997). 
Caspase-activated DNase (CAD) was identified as a DNase that is responsible for the 
process of DNA fragmentation in 1998 (Nagata et al., 2003). Caspase-activated DNase 
is produced as a complex with inhibitor of caspase-activated DNase (ICAD). 
Recombinant ICAD specifically inhibits CAD-induced degradation of nuclear DNA and 
its DNase activity. During apoptosis, activated caspases cleave ICAD, allowing CAD to 
enter to the nucleus and degrade chromosomal DNA into internucleosomal fragments 
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by cleaving the DNA at the linker sites between nucleosomes (Enari et al., 1998). 
Fragmented DNA was often analysed using agarose gel electrophoresis to demonstrate a 
“ladder” pattern at ~200 bp intervals (Collins et al., 1997). 
1.6.3 Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) 
assay 
Another method for examining apoptosis via detection of fragmented DNA is by the 
terminal deoxynucleotidyl transferase-dUTP nick end labelling (TUNEL) assay that was 
originally introduced by Gavrieli et al. (1992). TUNEL assay has become a widely used 
staining method in detection of apoptotic cells in tissue sections (Labat-Moleur et al., 
1998). 
TUNEL is based on the ability of the enzyme terminal deoxynucleotidyl transferase 
(TdT) to incorporate labelled dUTP into free 3′-hydroxyl termini ends of the fragmented 
DNA (Gavrieli et al., 1992). After proteolytic treatment of tissue sections, TdT 
incorporates X-dUTP (X = biotin, digoxigenin, or fluorescein) at sites of DNA strand 
breaks (Blankenberg, 2008). Terminally modified nucleotides are then allowed to bind 
with the antibody that is conjugated to a peroxidase reporter molecule. The bound 
peroxidase antibody conjugate enzymatically generates a permanent, intense, localized 
signal from chromogenic substrates, providing sensitive detection using light or 
fluorescent microscopy, flow cytometry, or via immunohistochemistry. 
1.6.4 Annexin-V binding assay 
Annexin-V binding assay is a rapid and reliable method for detecting early stages of 
apoptosis. This assay is based on the relocation of phosphatidylserine (PS) from the 
inner leaflets of the plasma membrane to the cell surface, soon after the apoptosis is 
initiated (Zhang et al., 1997). Viable cells maintain an asymmetric distribution of 
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different phospholipids between the inner and outer leaflets of the plasma membrane; 
phosphatidylcholine and sphingomyelin are exposed on the external leaflet of the lipid 
bilayer, while PS is located on the inner surface. During apoptosis, asymmetry of the 
cell membrane is disrupted and membrane PS is translocated from the inner to the outer 
leaflet of the plasma membrane while maintaining their intact plasma membrane 
integrity (Van Engeland et al., 1996). Annexin V is a 35 - 36 kDa Ca
2+
-dependent 
phospholipid-binding protein with high affinity for PS, and binds to exposed apoptotic 
cell surface PS (Van Engeland et al., 1996; Vermes et al., 1995). Annexin V can be 
conjugated to fluorochromes such as phycoerythrin (PE) or fluorescein isothiocyanate 
(FITC) to serve as a sensitive probe for detection using flow cytometry while retaining 
its high affinity for PS. 
Staining with Annexin V is typically used in conjunction with a vital dye such as 
propidium iodide (PI) or 7-amino-actinomycin (7-AAD) to allow differentiation of 
apoptotic cells. Viable cells with intact membranes exclude vital dye, whereas the 
membranes of dead and damaged cells are permeable to the viable dye. Therefore, 
apoptotic populations can be distinguished from dead or damage cells using double 
staining method (Hingorani et al., 2011). For example, using Annexin V/7-AAD 
staining, three populations of cells are distinguishable in two colour flow cytometry: 
Viable cells: Annexin-V negative and 7-AAD negative; 
Early apoptotic cells: Annexin-V positive and 7-AAD negative; 
Necrotic cells or late apoptotic cells: Annexin-V positive and 7-AAD positive. 
 
1.7 An overview of immunodeficient nude mouse model 
A nude mouse is a genetic mutant that has a deteriorated or removed thymus gland, 
resulting in immunodeficient due to a greatly reduced number of T cells (Belizário, 
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2009). They are characterized by lack of body hair (hairless) due to abnormal 
keratinization of hair follicles, reduced body growth rate, decreased fertility and usually 
die within 3 to 14 weeks of age (Flanagan, 1966). The genetic basis of the nude mouse 
mutation is a disruption of the Foxn1 gene or the HNF-3/forkhead homolog 11 gene 
(Nehls et al., 1994).  
The immune system of nude mouse is characterized by a reduced number of T cells, 
antibody response confined to IgM class, low T-dependent response to antigens and an 
increased natural killer cell response. Consequently the rudimentary thymus produces 
small population of mature T cells, with the result that nude mouse do not reject 
allografts or xenografts as they mount no rejection response (Belizário, 2009). Nude 
mouse are commonly employed for studies of imaging testing as well as 
pharmacological treatment of human tumour xenografts (Vidal and Richert, 2012).  
1.8 The study of gene expression 
Gene expression is a process by which the information encoded in the gene is 
transformed into a functional gene product. The gene products are often proteins, but 
some are functional RNAs. Study of gene expression will assist in the understanding of 
the functions of genes and the gene products, as well as the cellular regulatory networks 
that are involved in response to various stimuli by looking at the alteration of gene 
transcription profiles. Gene expression study becomes a powerful tool in various 
research fields after the introduction of microarray technology, which enables the study 
of the gene expression alteration profile of thousands of genes simultaneously.  
Analysis of gene expression patterns using microarray-based technology have been 
adopted in cancer research (Cooper, 2001; Grant et al., 2004; Kumar et al., 2012), as 
well as in studying the expression pattern of inflammatory diseases (Heller et al., 1997; 
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Torri et al., 2010). This approach has become a crucial tool in disease therapy, drug 
discovery, diagnostic applications, and finally to improve the treatment outcome.  
Global gene expression study using microarray technology enables simultaneous 
measurement of the expression of thousands of genes in a high-throughput fashion and 
allows characterization of gene transcription profiles which reflect the changes in the 
biological processes within the cells. However, much of the regulation of physiological 
processes occurs post-transcriptionally. Thus, measurement of mRNA levels alone is 
insufficient to give a complete picture of cellular activity and some other approaches 
such as proteomic study may be necessary in coupling with gene expression analysis. 
1.8.1 Microarrays 
Microarrays consist of hundreds to thousands of discrete DNA fragments or synthetic 
oligonucleotides that are immobilized on the glass or silicone surfaces using a variety of 
technologies such as photolithography, mechanical microspotting, and ink-jet printing 
(Schena et al., 1998). This technology has been applied to a wide range of studies, 
including gene expression analysis (Braxton and Bedilion, 1998; Schulze and 
Downward, 2001), genomic analysis (Meltzer, 2001; Sapolsky et al., 1999), and drug 
discovery process (Lockhart and Winzeler, 2000).  
Microarrays can be divided into two major groups based on the arrayed material. 
Oligonucleotide microarrays which can either be produced by spotting pre-synthesised 
short oligonucleotides onto the glass or synthesised in situ on the silicone wafer surface 
by photolithography. DNA microarrays consist of longer DNA fragments that are 
typically generated using the polymerase chain reaction (PCR) or inserted from cDNA 
libraries. The DNA fragments are printed on the glass slides or nylon (Schulze and 
Downward, 2000).  
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Oligonucleotide-based microarrays are becoming increasingly useful for the analysis of 
gene expression and single nucleotide polymorphisms because of its certain advantages 
over cDNA microarrays. In addtion to its capacity to screen whole genomic regions for 
gene function discovery study (Shoemaker et al., 2001), oligonucleotide microarrays 
has unique oligomer probes designed that specifically represent the cognate gene and 
minimizing cross-hybridization between similar sequences (Harrington et al.,  2000), 
which makes it particularly useful for the analysis of single nucleotide polymorphisms 
(LaForge et al., 2000) or mutational analysis (Drobyshev et al., 1997). Since biological 
samples or cDNA collections are not required to generate oligonucleotide array 
elements, the handling and tracking of oligonucleotide microarrays are generally easier 
compared to cDNA microarrays (Relogio et al., 2002).  
The principle of microarray technology involves manufacturing of microarrays, target 
preparation and array hybridization, and image acquisition and data analysis. It is based 
on the fact that the complementary nucleic acid sequences (target) hybridize with the 
oligonucleotide probes, which are immobilized on the solid support.  
1.8.1.1 Manufacturing of microarrays 
Microarray fabrication involves the printing and attachment of probes on the array. The 
key considerations in selecting a fabrication technology include microarray density and 
design, biochemical composition and versatility, reproducibility, throughput, quality, 
cost and ease of prototyping. The most widely used printing technologies are 
photolithography, mechanical microspotting, and ink-jet printing (Schena et al., 1998). 
In general, there are two types of microarray-fabricating technologies: synthesis and 
delivery (Schena et al., 1998). Synthesis approach is based on photolithographic 
synthesis of oligonucleotides in situ. In this approach, ultraviolet light is used to direct 
the adding of nucleotides to the growing nucleotide chains until the desired length is 
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achieved (Henriksen and Kotelevtsev, 2002; Schena et al., 1998). In contrast, delivery 
approach involves robotic deposition of cDNA clones amplified by PCR fragments onto 
known regions of the arrays (Schena et al., 1995).  
1.8.1.2 Target labelling and hybridization 
Several methods for target-producing are currently available for microarray 
hybridization and can be broadly classified into three categories: direct, indirect, and 
DNA dendrimer labelling. In direct labelling approach, the target sequence used in 
hybridization is prepared by reverse transcription in the presence of fluorescently 
labelled deoxynucleotides to produce fluorescently labelled cDNA, which will 
competitively hybridize to cDNA or oligonucleotides on the array (Hegde et al., 2000). 
This method however, results in lower nucleic acid target yields and significant fluor-
dependent dye bias due to steric hindrance of the large fluorescent moieties that were 
attached to the labelled nucleotides (Ouellet et al., 2009).  
In indirect labelling approach, modified (amino-allyl) nucleotides are introduced into 
the target samples during reverse transcription, and fluorescent dyes which can emit 
fluorescent light when excited with a laser are conjugated to these group in a subsequent 
reaction (Manduchi et al., 2002). Although indirect labelling method is able to improve 
dye incorporation and minimize dye bias, this method however, increased the amount of 
the starting material used and sample preparation time (Ouellet et al., 2009). 
Dendrimer labelling method was developed mainly aimed to increase specific 
fluorescence of the labelled product and decreasing the use of the starting material 
(Ouellet et al., 2009). In this technique, the initial reverse transcriptase reaction is 
primed with an oligonucleotide containing specific capture sequences that can bind with 
cyanine dye-tagged dendrimers. The cDNAs containing the “capture” sequences are 
first hybridized to the microarrays, and the bound cDNAs on the microarrays are 
28 
 
detected by incubating the arrays with the fluorescent dye-tagged dendrimers 
(Manduchi et al., 2002).  
Microarray hybridization is based on the association of a single stranded nucleic acid 
molecule labelled with a fluorescent tag with its complementary strand molecule that 
are immobilized on a solid support. Hybridization and washing steps are performed 
under highly stringent conditions to minimize the likelihood of cross-hybridization 
between similar genes and to remove the non-specific target binding (Macgregor and 
Squire, 2002; Tarca et al., 2006).  
1.8.1.3 Data-mining 
The complexity and vast amount of data generated by a single microarray experiment 
typically require a dedicated data analysis tools to process the data set prior to the 
analysis and interpretation of the results. Several data analysis tools have been 
developed to facilitate the analysis of microarray data. The methods used for data 
mining and data interpretation are varied, ranging from straightforward lists of increased 
and decreased genes expressed, based on user-defined thresholds to the integration of 
sophisticated clustering and visualization programs, such as hierarchical clustering, self-
organizing maps and k-means clustering (Harrington et al., 2000). Pre-processing step 
is necessary in order to extract or enhance the meaningful data characteristics and to 
prepare the data set for the application of data analysis methods (Tarca et al., 2006).  
Basically, there are three steps required for efficient and effective data analysis: data 
normalization, data filtering, and pattern identification. Data normalization is necessary 
to correct for any bias arises from variation in labelling and detection efficiencies for the 
fluorescent intensity (Hegde et al., 2000). Following data normalization, data filtering 
can be done to exclude genes that are expressed below the defined threshold level. By 
using this method, quantity of the dataset can be reduced. The last step is to identify the 
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expression patterns and to classify the data to assign biological meanings/significance to 
the expression profiles (Harrington et al., 2000).  
Integrating data analysis tool with a comprehensive database such as GenBank, Entrez, 
BLAST, and PubMed, provided by National Centre for Biotechnology Information 
(NCBI, http://www.ncbi.nlm.nih.gov/) would allow identification of common properties 
and biological functions of the differentially regulated genes and hence, more valuable 
information can be obtained from the microarray data (Harrington et al., 2000). 
Although the use of normalization approach during microarray data analysis can 
minimize the introduction of systematic bias when working with large numbers of the 
variables, nevertheless variable errors may be introduced at any points between the 
production of microarrays and the analysis of hybridization signals. The two critical 
steps that may strongly affect the microarray results are the isolation of RNA and 
labelling of target samples. Therefore, important results obtained from microarrays must 
be confirmed with other technique, such as real-time polymerase chain reaction (RT-
PCR) (Lucchini et al., 2001). 
1.8.2 Real-time polymerase chain reaction (RT-PCR) 
The real-time, fluorescence-based reverse transcription followed by polymerase chain 
reaction (PCR) has become an extensively applied technique in molecular biology study, 
medicine, and diagnostics fileds. It enables analysis of expression pattern of messenger 
RNA (mRNA) and to compare the relative levels of mRNA within distinct biological 
samples. Most importantly, this technique has become a method of choice for validation 
of microarray results (Jozefczuk and Adjaye, 2011). 
Several factors have contributed to the transformation of this technology into a 
mainstream research tool: (i) as a homogenous assay it avoids the need for post-PCR 
processing; (ii) a wide (> 10
7
-fold) dynamic range allows straightforward comparison 
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between RNAs that differ widely in their abundance; and (iii) the assay realizes the 
inherent quantitative potential of the PCR, making it a quantitative as well as a 
qualitative assay (Ginzinger, 2002).  
Real-time PCR uses fluorescent reporter molecules to monitor the amplification 
products during each cycle of the PCR reaction (Bustin et al., 2005). Because the 
amount of product is detected as a reaction progresses in "real time", real-time PCR has 
advantages in providing a wide linear quantification dynamic range, demonstrating high 
sensitivity, and good reproducibility (Bustin, 2000; Lockey et al., 1998; Orlando et al.,  
1998). However, errors will be introduced due to minor differences in the starting 
amount of RNA, quality of RNA or differences in efficiency of cDNA synthesis and 
PCR amplification. In order to minimize these errors and correct for sample-to-sample 
variations, an endogenous control gene is usually introduced to normalize the PCRs for 
the amount of RNA added to the reverse transcription reactions (Arya et al., 2005; 
Livak and Schmittgen, 2001). The most common housekeeping genes used for 
normalization include β-actin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
β2-microglobulin, and ribosomal RNA (rRNA) (Livak and Schmittgen, 2001). It is 
essential that the housekeeping gene is minimally regulated and exhibit a constant and 
cell cycle-independent basal level of transcription (Selvey et al., 2001). However, none 
of the housekeeping genes are ideal for each specific experiment. The selection of the 
housekeeping gene is depending on the cells type and the experimental condition 
1.8.2.1 Detection methods 
Two common methods for quantitative detection of real-time PCR products have been 
established: non-specific double-stranded DNA (dsDNA)-intercalating agents (DNA-
binding dyes), and sequence-specific fluorescent probes (Arya et al., 2005). The formar 
includes SYBR
® 
Green 1 or ethidium bromide. SYBR
® 
Green 1 binds to dsDNA and 
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exhibits enhancement of fluorescent signal. An increase in PCR products during reverse 
transcription reactions therefore leads to an increase in fluorescence intensity that was 
measured at the end of each PCR cycle, thus allowing amount of the PCR products to be 
quantified. This detection method is relatively inexpensive and can be used to monitor 
the amplification of any dsDNA sequence. As the presence of any dsDNA generates 
fluorescent, specificity and accuracy of this method is greatly decreased due to 
amplification of non-specific PCR products and primer-dimer (Ririe et al., 1997). 
The sequence-specific TaqMan
®
 hydrolysis probes are mainly dependent on 5’-3’ 
exonuclease activity of Taq polymerase to quantitate the target amplicons in the samples 
(Holland et al., 1991). TaqMan
®
 probes are oligonucleotides labelled with a fluorescent 
reporter dye at 5' end and a quencher moeity at the other 3' end, designed to hybridize 
specifically to an internal region of a PCR products. In the unhybridized state, the 
proximity of the reporter and quencher dyes prevent fluorescent emission to occur. 
During PCR amplification, the probe anneals to the target and cleaved by 5’-nuclease 
activity of Taq polymerase, resulting in emission of fluorescent signals from the 
reporter dye. The increased in fluorescent intensity is directly proportional to the 
amount of probe cleavage (Arya et al., 2005; Tsai et al., 2012). The advantages of 
TaqMan
®
 chemistry is that the fluorescent signal is generated only when there is 
specific hybridization of the probe to the target sequence, because the probes can be 
labelled with spectrally distinct reporter dyes, it allows the amplification of multiple 
target sequences within a single tube (multiplex real-time PCR). The primary 
disadvantage of TaqMan
®
 hydrolysis probes is that the synthesis of different probes is 
required for different target sequence, which renders the method less cost effective. 
Other detection methods using target-specific hybridization to sdDNA (single-stranded 
DNA) have been introduced, including molecular beacons, scorpions, an expanded 
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genetic information system (AEGIS), labelled primers, and light-up probes (Rickert et 
al., 2004). 
1.8.2.2 Quantitation of results 
The basic principle of real-time PCR is straightforward: the initial amount of template 
DNA used is inversely proportional to the threshold cycle (Ct). Threshold cycle is 
defined by amplification cycles that are required for the fluorescent signal to reach the 
threshold level of detection (Bustin et al., 2005). The Ct value will be employed to 
quantify the results obtained by real-time PCR. Generally, the levels of expressed genes 
can be measured by absolute or relative quantitative methods. 
In absolute or standard-curve quantitation, a standard curve (log of concentration of 
known standards versus Ct) is first constructed. The standard curve is then used as a 
reference standard to determine the amount of the target in the unknown sample by 
comparing to the Ct value. The most common source of the standards is plasmid of the 
gene of interest or synthetic single-stranded oligonucleotide for the amplicon (Arya et 
al., 2005). By using standard-curve quantitation method, it is possible to calculate the 
number of nucleic acid targets present in the sample in relation to a specific unit, this 
allow data comparison between different assays and laboratories (Mackay, 2004). 
However, this method is time consuming to quantify and validate an independent 
reliable standard for each gene that is subjected to analysis (Bolha et al., 2012).   
Relative quantitation involves the use of mathematical equation to calculate the 
expression levels of the target gene in relative to a reference control gene (calibrator) 
(Pfaffl, 2001). This approach is relatively easier to perform because a calibration curve 
is not necessary and is useful for most purposes for investigation of the physiological 
changes in gene expression levels (Bolha et al., 2012). Since relative quantitation is 
widely applied in real-time PCR analysis, several mathematical models for calculating 
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relative expression ratio have been established. The most commonly used model is 
comparative threshold (2
-ΔΔCt
) method. In this method, the amount of target, which is 
normalized to an endogenous reference and relative to a calibrator, is given by 2
-ΔΔCt 
, 
where ΔΔCt = ΔCt (sample) – ΔCt (control), and ΔCt for both the sample and control of 
the target gene are normalized to an appropriate endogenous housekeeping gene. In 
order for ΔΔCt calculation to be valid, amplification efficiencies of the target and 
reference must be approximately equal (Livak and Schmittgen, 2001).  
1.9 Proteomics 
Proteomics is a study of structure, function and expression of proteins in a complex 
biological sample. Study of protein expression is important in coupling with gene 
expression analysis due to the reasons that: protein expression and its activity levels can 
differ significantly from RNA levels, and the regulation of gene activity occurs at the 
translational level (Michaud and Snyder, 2002). 
In combination with large-scale protein separation and mass spectrometry (MS) 
analyses, proteomics has become a popular approach for the study of proteome profiling, 
comparative protein expression analysis, localization and identification of protein post-
translational modifications, and protein-protein interactions (Chandramouli and Qian, 
2009). Protein expression analysis could provide useful information on cellular 
processes that occur during development, response of cells to the treatment conditions, 
as well as differential proteomic profiling between normal and disease state tissues 
(Michaud and Snyder, 2002).  
1.9.1 Two-dimensional polyacrylamide gel electrophoresis  
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) is routinely applied 
for quantitative and qualitative expression profiling of complex protein mixtures in the 
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whole cell or tissue lysates (Gorg et al., 2004). This approach involves the separation of 
complex protein mixtures by molecular charge in the first dimension and followed by 
molecular weight in the second dimension (Chandramouli and Qian, 2009). In the first 
dimension, proteins are isoelectrically focused in a pH gradient, allowing for separation 
based on the isoelectric point (pI). In the second dimension, an electric field is applied 
to separate the proteins based on their mass or mobility through a polyacrylamide gel 
matrix (Michaud and Snyder, 2002; McDonald and Yates, 2000).  
The 2D-PAGE allows separation and comparison of thousands of proteins on a single 
gel and information such as the protein pI, the apparent molecular weight, and the 
abundance of each protein can be obtained (Chandramouli and Qian, 2009). A numbers 
of dedicated 2D-PAGE image databases have been constructed to provide proteomic 
profile for different cells and tissues (Hoogland et al., 1999). This approach has been 
widely adopted in cancer research (Chen et al., 2002; Chuthapisith et al., 2007; Hathout 
et al., 2002). 
1.9.2 Mass spectrometry (MS) 
Mass spectrometry (MS) is a fundamental tool for protein identification in proteomics 
research. It can precisely measure the mass and determine the amino acid sequence of a 
peptide (Michaud and Snyder, 2002). A mass spectrometer consists of three components: 
ion source, mass analyser, and detector. Analysis of proteins by MS occurs in three 
major steps (a) protein ionization and generation of gas-phase ions, (b) separation of 
ions according to their mass-to-charge ratio (m/z), and (c) detection of ions (Mann et al., 
2001).  
For protein analysis, the two most common types of ionization sources are matrix-
assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) 
(McDonald and Yates, 2000). Matrix-assisted laser desorption ionization utilizes a laser 
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ion source to excite a crystalline mixture of analyte molecules and release the ions into 
the gas phase. This type of ionization source measures the mass of peptides derived 
from a digested protein and generates the “mass fingerprints” (Karas and Hillenkamp, 
1988; Medzihradszky et al., 2000). This is a pulsed ionization technique because 
separate ionization event occurs when mixture is irradiated with the laser (McDonald 
and Yates, 2000). Using ESI, analyte is transferred from the solution into the gas phase 
by generating a fine spray from a high voltage needle, which results in the ionization of 
the analyte and generation of multiple consecutive ions (Chandramouli and Qian, 2009). 
A constant ionization event can be achieved but this ionization source is more sensitive 
to salts, buffers, and detergents contamination compare to MALDI (McDonald and 
Yates, 2000).  
Time-of-flight (TOF) mass analyser is a single stage mass spectrometer that has the 
widest application in proteomics research. The TOF analyser measures the mass-to-
charge ratio of an ion by the time it takes to progress through the analyser and strike to 
the detector (Kicman et al., 2007). Its high accuracy and ability to desorb a wide range 
of molecular mass (1 - 300 kDa), render it as a useful tool for protein mass 
determination in combination with MALDI ioniser (Kicman et al., 2007; Marvin et al., 
2003). Protein identification by MALDI-TOF mass spectrometry is carried out by 
peptide mass mapping or peptide mass fingerprinting technique, in which the specific 
peptide masses determined by MALDI-TOF mass spectrometry is searched against the 
databases of known protein sequences (Marvin et al., 2003).  
The use of tandem mass spectrometry (MS/MS) has become a popular method of choice 
for protein identification due to its ability to determine the amino acid sequence 
(Aebersold and Goodlett, 2001; Chandramouli and Qian, 2009). Tandem mass 
spectrometry analysis involves separation of a peptide mixture in the first stage of 
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analysis; individual peptides are isolated and fragmented at their peptide bonds, and the 
selected fragments are further separated in the second stage of analysis. This allows 
direct protein identification by comparing the peptide sequence obtained with those 
predicted in the database (Michaud and Snyder, 2002).  
1.10 Objectives of the study 
The objectives of this study are: 
1) To investigate the antibacterial activity of king cobra venom L-amino acid 
oxidase and compare its potency with some commonly used antibiotics. 
2) To investigate the cytotoxic effect of king cobra venom L-amino acid oxidase on 
human tumourigenic and non-tumourigenic cell lines, and compare its potency 
with doxorubicin (a common anti-cancer drug). 
3) To elucidate the possible mechanism(s) of cell death induced by king cobra 
venom L-amino acid oxidase using oligonucleotide microarray and proteomics 
approaches. 
4) To examine the antitumour effect of king cobra venom L-amino acid oxidase in 
a PC-3 tumour xenograft mouse model implanted in immunodeficient NU/NU 
mice, and evaluate its toxicity on vital organs. 
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MATERIALS 
2.1 King cobra (Ophiophagus hannah) venom 
King cobra (Ophiophagus hannah) venom was milked from several adult Malaysian 
king cobras from Snake Valley (Seremban, Malaysia).  
2.2 Bacteria strains 
The bacteria Escherichia coli ATCC 25922 was purchased from American Type Cell 
Culture (ATCC), USA. Clinical isolates of Staphylococcus aureus, Staphylococcus 
epidermidis, Pseudomonas aeruginosa, Klebsiella pneumonia and Escherichia coli 
were obtained from Department of Medical Microbiology, University of Malaya, Kuala 
Lumpur, Malaysia.  
2.3 Animals 
2.3.1 ICR mice 
Male ICR mice (20-30 g) were obtained from Animal Experimental Unit (AEU), 
University of Malaya, Malaysia. Mice were maintained in individually ventilated cage 
(IVC) system (4 mice per cage). Mice were fed with standard pellets and water ad 
libitum. 
2.3.2 Nude (NU/NU) mice 
Four-weeks-old, male NU/NU mice (18-25 g) were purchased from BioLASCO, 
Taiwan (certificate no: VP302S10023105). Mice were housed under specific pathogen 
free (SPF) conditions (3 mice per cage). Mice were fed with sterilized pellets and water 
ad libitum.  
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2.3.3 Animal handling 
Mice were housed for a week prior experiment to facilitate adaption to the new 
environment. All animal handling and procedures were performed according to the 
Council for International Organization of Medical Sciences (CIOMS) guidelines 
(Howard-Jones, 1985). The use of animals in this study was approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Malaya 
(Ethical clearance letter No. 2013-06-07/MOL/R/FSY). Animal ethical clearance is 
attached in Appendix I. 
2.3.4 Anaesthesia 
Mice were anaesthetized with an intraperitoneal (i.p.) injection of a combination of 
ketamine and xylazine at the dosage of 100 mg/kg and 10 mg/kg body weight, 
respectively. The degree of anaesthesia was monitored until the required depth was 
attained.  
2.4 Human cell line 
Human breast adenocarcinoma (MCF-7), human lung adenocarcinoma (A549), human 
promyelocytic leukaemia (HL-60), human prostate adenocarcinoma (PC-3), human non-
tumourigenic breast (184B5) and human non-tumourigenic lung (NL 20) cell lines were 
purchased from American Type Culture Collection (ATCC), USA. 
2.5 Chemicals and general consumables 
Resource
®
 Q ion exchange column, 2-D quant kit, 2-D clean-up kit, urea, thiourea, 
immobilized pH gradient (IPG) buffer (pH 3-10), linear immobilized pH gradient (IPG) 
strip (13 cm, pH 3-10), 3-[(3 cholamidopropyl) dimethylammonio]-1-propanesulfonate 
(CHAPS), dithiothreitol (DTT), iodoacetamide (IAA), protease inhibitor mix, and dry 
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strip cover fluid were purchased from GE Healthcare, Amersham Biosciences AB, 
Sweden.  
Spectra™ broad range protein ladder, PageRuler™ prestained protein ladder, 
GeneRuler™ 1 kb DNA ladder, Pierce® silver stain for mass spectrometry kit, 20X Tris 
buffer saline with Tween
®
 20, 1-Step 3,3',5,5'-tetramethylbenzidine (TMB)-blotting, 
and goat anti-mouse IgG secondary antibody HRP conjugate were purchased from 
Thermo Scientific, Waltham, USA.  
Cell culture medium; MEGM™ mammary epithelial cell growth medium (MEGM 
bullet kit) and Ham's F12 medium were purchased from LONZA, Basel, Switzerland.  
Iscove’s Modified Dulbecco’s Medium (IMDM) was purchased from American Type 
Culture Collection (ATCC), USA.  
Foetal bovine serum, RPMI-1640 and 0.25% trypsin-EDTA were purchased from 
Biowest, Nuaillé, France.  
Dehydrated bacteria culture media (Mueller-Hinton broth, nutrient agar and nutrient 
broth) were purchased from Oxoid Ltd, Cambridge, UK.  
Cefotaxime, kanamycin, tetracycline, vancomycin and penicillin antibiotics were 
purchased from Duchefa Biochemie B.V, Haarlem, Netherlands. 
Bovine serum albumin (BSA), L-leucine, L-glutamine, trypan blue dye, o-dianisidine, 
horseradish peroxidase, catalase, acrylamide, N-N’-methylene bisacrylamide, Trizma® 
base (Tris-HCl), sodium dodecyl sulphate (SDS), dimethyl sulfoxide (DMSO), 
ammonium persulphate, β-mercaptoethanol, coomassie brilliant blue G-250, coomassie 
brilliant blue R-250, magnesium chloride hexahydrate (MgCl2•6H2O), calcium chloride 
dehydrate (CaCl2•2H2O), orange G, glycerol, ammonium bicarbonate (NH4HCO3), 
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sodium thiosulphate, potassium ferricyanide, triton-X, ethylenediaminetetraacetic acid 
(EDTA), permount, RNase I, phenol:chloroform:isoamyl alcohol (25:24:1), sodium 
acetate, eosin Y disodium salt, methyl green, harris haematoxylin, 3-(N-
morpholino)propanesulfonic acid (MOPS) (free acid), formamide, and N,N,N',N'-
tetramethylethylenediamine (TEMED) were purchased from Sigma Aldrich Chemical 
Company, MO, USA.  
Trypsin gold (mass spectrometry grade), caspase-Glo
®
 3/7, caspase-Glo
®
 8, caspase-
Glo
®
 9, and P450-Glo™ CYP1A1 assay kits were purchased from Promega, Madison, 
USA. 
Cytochrome c (human) EIA kit was purchased from Enzo Life Sciences, Farmingdale, 
New York. 
Tween
® 
20, ortho-phosphoric acid, 3,(4,5-dimethythiazol-2-yl)-2,3-diphenyl tetrazolium 
bromide (MTT), doxorubicin, and iso-propanol were purchased from Merck, Darmstadt, 
Germany. 
Monoclonal anti-Hsc 70, monoclonal anti-Grp 75, and monoclonal anti-beta actin were 
purchased from Abcam
®
, Cambridge, UK.  
Matrigel™, and PE Annexin V Apoptosis Detection Kit I were purchased from BD 
Biosciences, California, USA.  
RNeasy
®
 mini kit was purchased from Qiagen, Hilden, Germany. 
Illumina
® 
TotalPrep RNA amplification kit was purchased from Ambion, California, US.  
HumanRef-8 v2 expression BeadChips was purchased from Illumina, San Diego, CA. 
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High capacity RNA-to-cDNA™ kit, TaqMan® gene expression master mix, TaqMan® 
gene expression assays, and beta actin were purchased from Applied Biosystems, CA, 
USA.  
OxiSelect™ intracellular ROS assay kit (green fluorescence) was purchased from Cell 
Biolabs, CA, USA. 
Agarose, TRIzol
® 
reagent, DNase I, and PVDF iBlot™ gel transfer stacks were 
purchased from Invitrogen™, Grand Island, USA.  
GelRed™ nucleic acid gel stain (10,000X in water) was purchased from Biotium, 
Hayward, CA.  
ApopTag
®
 plus peroxidase in situ apoptosis detection kit, proteinase K, and C18 
ZipTip
®
 were obtained from Millipore, MA, USA. 
Glycine, phosphate buffered saline (PBS) tablet, and bromophenol blue were purchased 
from MP Biomedicals, LLC, United States.  
Narketan
®
-10 (100 mg/mL) was purchased from Vetoquinol, UK.  
Ilium xylazil-20 (20 mg/mL) was purchased from Troy laboratories, Australia.  
N-butanol, acetic acid glacial, xylene, hydrogen peroxide, chloroform, 37% 
formaldehyde (12.3 M), acetonitrile, and formic acid were purchased from J.T. Baker 
Center Valley, PA, USA. 
 Sodium chloride, ethanol and methanol were purchased from J. Kollin Corporation, 
Germany. 
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GENERAL METHODS 
2.6 L-amino acid oxidase assay 
L-amino acid oxidase (LAAO) activity was determined according to Bergmeyer (1983). 
To 925 μL of substrate (containing 0.34 mM L-leucine and 81 μg of o-dianisidine in 
100 mM Tris-HCl buffer, pH 8.5), 50 μL of 0.0075% horseradish peroxidase and 25 μL 
of the sample were added to initialize the reaction. Increase in absorbance at 436 nm 
was recorded. One unit of enzyme activity was defined as the oxidation of 1 μmol of L-
leucine per min. Molar absorption coefficient of the reaction product was 8.31×10
−3
 M
−1
 
cm
−1
. 
2.7 Purification of king cobra venom L-amino acid oxidase 
King cobra venom L-amino acid oxidase (OH-LAAO) was purified using a method 
modified from Tan and Saifuddin (1989). Lyophilized king cobra venom (20 mg in 200 
μL) was fractionated by Resource® Q high performance liquid chromatography (HPLC) 
(Shimadzu, Japan) previously equilibrated with 20 mM Tris-HCl, pH 9.0. Elution was 
carried out using a linear gradient of NaCl in 20 mM Tris-HCl, at a flow rate of 1 
mL/min. The gradient program used was: 100% buffer A (20 mM Tris-HCl, pH 9.0) for 
5 min, followed by a linear 0 - 60% buffer B (20 mM Tris-HCl, pH 9.0, 0.5 M NaCl) 
for another 50 min and finally 100% buffer B for 5 min. The UV absorbance of the 
eluate was monitored at 280 nm. Fractions exhibiting LAAO activity were pooled and 
stored at 4 °C. 
2.8 Buffer exchange 
Buffer exchange was carried out using vivaspin
® 
15R (30,000 molecular weight cut-off) 
(Sartorius Stedim Biotech, Goettingen, Germany) according to the manufacturer’s 
protocol. In brief, purified OH-LAAO in the elution buffer (20 mM Tris-HCl, pH 9.0, 
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0.5 M NaCl) was first concentrated using vivaspin
®  
by centrifugation at 3,000 x g for 
30 min at 4 °C. The concentrated sample was then washed three cycles with PBS by 
centrifugation at 3,000 x g for 30 min. 
2.9 Protein concentration determination 
2.9.1 Protein concentration determination by Bradford method 
Protein concentration was determined by Bradford (1976) method. The calibration 
curve was constructed using bovine serum albumin (BSA) ranging from 0 to 60 µg. One 
hundred microlitres of the sample/BSA was added to 5 mL of the Bradford reagent 
[prepared as described in Appendix II (A)]. The absorbance was measured at 595 nm 
using 1.5 mL cuvette placed in the 1 cm light path spectrophotometer (Cary 50 Conc, 
Varian, Australia). Specific activity of the pure OH-LAAO was determined by the 
formula below: 
 
 
2.9.2 Protein concentration determination using 2-D quant kit 
Protein concentration was determined using 2-D quant kit according to the 
manufacturer’s protocol (GE Healthcare, Sweden) with slight modifications. Briefly, 
100 µL of the precipitant was mixed with the protein sample or BSA standard and 
incubated at room temperature for 3 min. Co-precipitant (100 µL) was then added into 
the mixture. After centrifugation at 10,000 x g for 5 min, the supernatant was discarded. 
Copper solution (20 µL) and milli-Q
®
 water (80 µL) were pipetted on top of the pellet 
and vortexed until it is fully dissolved. Subsequently, 200 µL of the working color 
reagent (mixture of 100 parts of color reagent A with 1 part of color reagent B) was 
added into each tube and incubated at room temperature for 20 min. Absorbance reading 
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of each sample was taken at 460 nm using Model 680 microplate reader (Bio-Rad, 
Hercules, CA). Standard curve was constructed by plotting the absorbance reading at 
460 nm versus amount of the BSA standard used (BSA ranging from 0 to 12 µg). 
Protein concentration for each sample was calculated using the constructed standard 
curve.  
2.10 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Formulations of solutions or reagents for Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) are shown in Table 2.1. The homogeneity of OH-LAAO 
was assessed by 12.5% (w/v) SDS-PAGE according to Laemmli (1970). Sodium 
dodecyl sulphate polyacrylamide gel electrophoresis was conducted using 4-gel Mini-
PROTEAN
®
 Tetra Cell (Bio-Rad, Hercules, CA). The molecular weight of the enzyme 
was determined by Spectra™ broad range protein ladder (Thermo Scientific, USA), as 
calibration standards (molecular mass 10 - 260 kDa). The log10 molecular weight of the 
standard proteins was plotted against their respective Rf to obtain a calibration curve.  
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Table 2.1: Formulations of solutions or reagents for sodium dodecyl sulphate 
polyacrylamide gel electrophoresis 
 
Solution/reagent Formulations 
Solution A 29.2% (w/v) acrylamide, 0.8% (w/v) N-N’-methylene 
bisacrylamide 
 
Solution B 1.5 M Tris-HCl, 0.4% sodium dodecyl sulphate (SDS) (w/v), pH 
was adjusted to 8.8 
  
Solution C 10% (w/v) ammonium persulphate (freshly prepared) 
 
Solution D 0.5 M Tris-HCl containing 0.4% sodium dodecyl sulphate (w/v), 
pH was adjusted to 6.8 
 
Sample incubation 
buffer 
62 mM Tris-HCl, 2.3% (w/v) sodium dodecyl sulphate, 10% 
(v/v) glycerol, 5% β-mercaptoethanol and 0.005% bromophenol 
blue, pH was adjusted to 6.8 
 
Electrophoresis 
buffer 
0.025 M Tris-HCl, 0.129 M glycine and 0.1% (w/v) sodium 
dodecyl sulphate 
 
Fixing solution 40% (v/v) methanol, 10% (v/v) acetic acid and 50% water 
 
Staining solution 0.2% (w/v) coomassie brilliant blue R-250 in the fixing solution 
 
Destaining solution 5% (v/v) methanol and 7% (v/v) acetic acid in water 
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2.10.1 Preparation of 12.5% resolving gel and 4% stacking gel 
Formulations of resolving gel and stacking gel are shown in Table 2.2. Solution 
mixtures for resolving gel were gently swirled and rapidly poured into the gel cassette 
until a level which sufficient for the comb to be inserted. Water was then overlaid on 
top of the gel solution. The gel was allowed to stand at room temperature for 20 - 30 
min for polymerization to occur.  
After polymerization of resolving gel, water was carefully removed. Solution mixtures 
for stacking gel were layered on top of the resolving gel and the comb was inserted 
immediately. Polymerization occurred within 10 - 15 min.  
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Table 2.2: Compositions of resolving and stacking gels 
Solution 
12.5% resolving gel 
(mL) 
4% stacking gel 
(mL) 
Milli-Q
®
 water
 
4.5 6.1 
Solution A 7.5 1.4 
Solution B 6 - 
Solution C - 2.5 
Ammonium persulphate 0.1 0.2 
TEMED 0.01 0.01 
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2.10.2 Preparation of protein sample under denaturing and reduce condition 
Protein samples (20 µg) were mixed with sample incubation buffer at an equal ratio for 
a maximum volume of 20 µL. Sample mixtures were boiled at 70 - 80 °C for 5 - 10 min 
and chilled on ice. 
2.10.3 Running condition 
Gel cassettes were assembled onto the electrophoresis tank according to the 
manufacturer’s instructions (Bio-Rad, Hercules, CA). Sample mixtures were loaded 
onto the wells of the stacking gel. Electrophoresis was carried out at a constant voltage 
of 90 V for approximately 2 h.  
2.10.4 Fixing, staining and destaining 
Electrophoresis was stopped when the front dye reached half centimetre to the bottom 
of the gel. To prevent diffusion of the protein bands, gels were treated with fixing 
solution for 10 min with mild shaking. After fixing, gels were transferred into the 
staining solution for another 10 - 15 min and finally destained in the destaining solution 
until the background is cleared. 
2.11 Formaldehyde agarose (FA) gel electrophoresis 
Formulations of buffers for formaldehyde agarose (FA) gel electrophoresis are shown in 
Table 2.3. Solution mixtures for 1.2% FA gel was heated using a microwave oven until 
the agarose is melted and cooled under the running tap water. Nine hundred microlitres 
of formaldehyde and two microlitres of GelRed™ (Biotium, CA) were then added into 
the mixtures and mixed. Solution mixtures were poured onto the gel tray and the comb 
was inserted immediately. When the gel has solidified, it was transferred to the gel tank 
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(ENDURO 7.10 Horizontal Gel Box, Labnet International Inc. Woodbridge, USA) and 
equilibrated in 1X FA gel running buffer prior to electrophoresis. 
The RNA samples were prepared by mixing one volume of 5X RNA loading buffer 
with four volumes of RNA samples. The mixtures were incubated at 65 °C for 5 min 
and immediately chilled on ice. Samples were loaded onto the wells of FA gel 
previously equilibrated with 1X FA gel running buffer. Electrophoresis was carried out 
at a constant voltage of 80 V for 20 - 30 min. Image acquisition was done using gel 
documentation system (Infinity-3026, Vilber Lourmat, France).  
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Table 2.3: Formulations of buffers for formaldehyde agarose gel electrophoresis 
Buffers Compositions 
10X FA gel buffer 
200 mM 3-(N-morpholino)propanesulfonic acid 
(MOPS), 50 mM sodium acetate, 10 mM EDTA. pH 
was adjusted to 7.0. 
 
1X FA gel running buffer 
100 mL of 10X FA gel buffer, 20 mL of 37% 
formaldehyde (12.3 M), 880 mL of RNase-free water. 
 
5X RNA loading buffer 
16 µL of saturated aqueous bromophenol blue solution, 
80 µL of 500 mM EDTA (pH 8.0), 720 μL of 37% 
formaldehyde (12.3 M), 2 mL of 100% glycerol, 3.084 
mL of formamide, 4 mL of 10X FA gel buffer. Top-up 
with RNase-free water to 10 mL and tored at 4°C. 
 
1.2% FA gel 
0.6 g agarose, 5 mL of 10X FA gel buffer and 45 mL of 
RNase-free water. 
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2.12 Cell culture 
2.12.1 The cell lines 
2.12.1.1 Human breast adenocarcinoma, MCF-7 (ATCC
®
 HTB-22
™
) 
The MCF-7, human breast adenocarcinoma cell line was isolated from a pleural 
effusion of a 69-year-old Caucasian female patient with metastatic breast cancer. The 
cell line was named after the Michigan Cancer Foundation-7, an institute in Detroit 
where the cell line was established by Soule and associates in 1973 (Soule et al., 1973). 
The adherent epithelial-like MCF-7 was grown in RPMI-1640 medium supplemented 
with L-glutamine and 10% (v/v) foetal bovine serum. The popularity of MCF-7 is 
largely due to its sensitivity to hormones through the expression of oestrogen receptor 
(ER), making it an ideal cell line for hormone response study (Levenson and Jordan, 
1997). 
2.12.1.2 Human lung adenocarcinoma, A549 (ATCC
®
 CCL-185
™
)  
Human lung adenocarcinoma, A549 was isolated through the explants culture of lung 
carcinomatous tissue from a 58-year-old Caucasian male (Giard et al., 1973). The A549 
cells grow as monolayer, adherent to the cell culture flask. The cells were grown in 
RPMI-1640 medium supplemented with L-glutamine and 10% (v/v) foetal bovine 
serum. 
2.12.1.3 Human non-tumourigenic breast, 184B5 (ATCC
®
 CRL-8799
™
) 
The 184B5 cell line was established from normal mammary epithelium tissue obtained 
from a normal reduction mammoplasty. Stampfer and Bartley (1985) established the 
transformed immortalized cell line by exposing the rapidly growing primary cells 
derived from mammary tissue to benzo(α)pyrene. The cell line grown as adherent, 
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monolayer in MEGM
™
 mammary epithelial cell growth medium (MEGM bullet kit) 
supplemented with 10% (v/v) foetal bovine serum. 
2.12.1.4 Human non-tumourigenic lung, NL 20 (ATCC
®
 CRL-2503
™
)  
An immortalized, human non-tumourigenic lung cell line (NL 20) was obtained from 
autopsy samples of normal bronchus tissue. The cell line was established by transfection 
with the origin of replication-defective SV40 large T plasmid, p129 (Schiller and 
Bittner, 1995). The cells were grown as adherent in Ham's F12 medium supplemented 
with 10% (v/v) foetal bovine serum.  
2.12.1.5 Human prostate adenocarcinoma, PC-3 (ATCC
®
 CRL-1435
™
)  
Human prostate adenocarcinoma, PC-3 cell line was derived from a bone metastasis of a 
grade IV prostatic adenocarcinoma from a 62-year-old Caucasian male. The cells do not 
respond to androgens, glucocorticoids, or epidermal or fibroblast growth factors 
(Kaighn et al., 1979). This cell line grown as adherent-epithelial like in complete 
RPMI-1640 medium supplemented with 10% (v/v) foetal bovine serum. 
2.12.1.6 Human promyelocytic leukaemia, HL-60 (ATCC
®
 CCL-240
™
)  
Human promyelocytic leukaemia cell line, HL-60 was derived from a 36-year-old 
Caucasian female with acute promyelocytic leukaemia by leukopheresis (Collins et al., 
1977). The HL-60 cells are predominantly a neutrophilic promyelocyte with prominent 
nuclear or cytoplasmic asynchrony (Gallagher et al., 1979). This cell line proliferates as 
a suspension culture in ATCC-formulated Iscove's Modified Dulbecco's Medium 
(IMDM) supplemented with 10% (v/v) foetal bovine serum.  
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2.12.2 Cell line maintenance 
Different cell lines were grown in their respective media: RPMI-1640 for MCF-7, A549, 
and PC-3 cells; MEGM
™
 mammary epithelial cell growth medium (MEGM bullet kit) 
for 184B5 cells, Iscove’s Modified Dulbecco’s Medium (IMDM) for HL-60 cells and 
Ham's F12 medium for NL 20 cells. The medium were supplemented with 10% (v/v) 
foetal bovine serum. Cells were cultured in a humidified atmosphere with 95% air and 
5% CO2 at 37 °C. Inverted microscope (CK2 Olympus, Japan) was used to check the 
confluency and any contamination of the cell cultures. 
2.12.3 Sub-culture 
2.12.3.1 Sub-culturing of adherent cells 
Sub-culture was performed when the cells reached the confluency of about 80 - 90%. 
Spent medium was removed and the cells were washed twice with phosphate buffered 
saline (PBS) prior for the trypsinization with an adequate volume of 0.25% trypsin-
EDTA. Cells were incubated at 37 °C for 5 - 10 min to allow detachment of the cells. 
Complete cell culture medium was added onto the trypsinized cells to inactivate the 
trypsin. Cells were then spun down at 1,500 rpm for 5 min at 25 °C and the pellet was 
resuspended with culture medium. Desired amount of cell suspension was seeded onto 
the cell culture flask containing fresh medium. 
2.12.3.2 Sub-culturing of suspension cells 
Suspension cells (HL-60) were collected and spun down at 2,000 rpm for 10 min at 
25 °C. Cell pellet was resuspended with fresh culture medium. Cells at desired density 
were seeded onto the cell culture flask. 
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2.12.4 Cryopreservation and thawing of cells 
For cryopreservation, cell pellet was collected by centrifugation at 1,500 rpm for 5 min 
at 25 °C and resuspended with complete growth medium containing 5% dimethyl 
sulfoxide (DMSO). One millilitre of the cell suspension was aliquoted into the 2 mL 
cryovials and stored overnight at -80 °C. For long term storage, the cryopreserved cells 
were stored in the vapour phase of the liquid nitrogen. 
Cryopreserved cells were thawed instantly in the pre-heated 37 °C water bath, spun 
down at 1,500 rpm for 5 min and resuspended with culture medium. Cell suspension 
was transferred into a cell culture flask containing complete growth medium and 
incubated in a humidified atmosphere with 95% air and 5% CO2 at 37 °C. 
2.12.5 Cell counting 
Cell counting was performed using Neubauer-improved haemocytometer (Marienfeld, 
Lauda-Königshofen). Cells were spun down at 1,500 rpm for 5 min and adequate 
volume of culture medium was added to resuspend the cells. Ten microlitres of the cell 
suspension was gently mixed with 90 µL of the trypan blue dye. Subsequently, the cell 
mixture (10 µL) was loaded into the counting chamber placed under the coverslip by 
capillary action. Haemocytometer were observed under inverted light microscope (CK2 
Olympus, Japan) at 200X magnifications and the 16 corner squares were focused. The 
viable cells (unstained by trypan blue) that fall within the 4 sets of the 16 corner squares 
and any position on the upper and left hand side boundary line were counted using hand 
tally counter. Cell concentration was calculated as follows: 
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CHAPTER 3 
ANTIBACTERIAL ACTION OF KING COBRA  
(Ophiophagus hannah) VENOM L-AMINO ACID OXIDASE (OH-LAAO) 
AGAINST SEVERAL STRAINS OF CLINICALLY ISOLATED BACTERIA 
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INTRODUCTION 
The emergence of multidrug-resistant bacteria has drawn major attention among 
healthcare and medical practitioners ever since the introduction of penicillin in the late 
1920s (Zainol et al., 2013). Although multidrug-resistant Pseudomonas aeruginosa, 
acinetobacter sp., Staphylococcus aureus and E. faecium are the best known therapeutic 
challenges among the gram-negative and gram-positive bacteria, resistance to the most 
potent antibiotics has been extended to members of the Enterobacteriaceae family of 
gram-negative bacteria, such as Klebsiella sp., Escherichia coli, and enterobacter sp. 
(Arias and Murray, 2009). In Malaysia, P. aeruginosa, S. aureus, K. pneumoniae, and E. 
coli were the most common healthcare-associated pathogens isolated from patients with 
nosocomial infection (Hughes et al., 2005; Rozaidi et al., 2001). 
The used of currently available antimicrobial agents in the treatment of bacteria 
infectious diseases is becoming more challenging due to emergence of several 
antibiotic-resistance microbial. Therefore, it is important to search for a new potent 
antibacterial agent in order to supplement the currently increasingly ineffective 
antibiotics. Snake venom LAAO has been shown to exhibit potent antibacterial activity 
against both gram-negative and gram-positive bacteria. Compare to the pathogens, 
human host cells or normal flora are less sensitive to oxidative damage caused by H2O2 
or other ROS, which implies that snake venom LAAOs may selectively kill bacterial 
strains without causing significant damage to the host (Guo et al., 2012). Therefore, this 
enzyme may be a promising alternative anti-microbial agent in treating bacterial 
infection diseases. In this chapter, the antibacterial activity of king cobra venom LAAO 
(OH-LAAO) was examined against several strains of clinical isolates Gram-positive 
and Gram-negative bacteria using broth microdilution assay. Its antibacterial potency 
was compared with some common antibiotics such as cefotaxime, kanamycin, 
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tetracycline, vancomycin and penicillin. Binding activity of OH-LAAO on bacteria cells 
was also carried out in order to study the mode of antibacterial action of the enzyme. 
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METHODS 
3.1 Bacteria growth and preparation of inoculums suspensions 
Bacteria from frozen suspensions were grown on the nutrient agar plates [prepared as 
described in Appendix II (B)] and passaged twice prior to susceptibility testing. Isolated 
colonies were selected from an agar plate culture and transferred with a wire loop into a 
tube containing 5 mL of the nutrient broth medium [prepared as described in Appendix 
II (C)]. Broth cultures were incubated at 37 °C until it achieved the turbidity of 0.5 
McFarland (1 to 2 x 10
8
 CFU/mL). The turbidity of the cultures was measured at 625 
nm using 1 cm light path spectrophotometer (Cary 50 Conc, Varian, Australia). The 
absorbance reading of 0.08 - 0.1 at 625 nm was corresponding to 0.5 McFarland 
(National Committee for Clinical Laboratory Standards, NCCLS, 2000). 
3.2 Broth microdilution assay and effect of catalase 
Broth microdilution assay was carried out according to the protocol described by 
National Committee for Clinical Laboratory Standards, NCCLS (2000). In brief, 
inoculums suspensions were diluted with 2X Mueller-Hinton broths [prepared as 
described in Appendix II (D)] to a final concentration of 1 × 10
6 
CFU/mL. Bacterial 
suspensions (50 μL) were incubated in 96-well plate in the presence of 50 μL of 
different concentrations of sterilized OH-LAAO ranging from 0.049 to 100 μg/mL or 
antibiotics ranging from 0.031 to 64 μg/mL using 2-fold serial dilutions to yield the 
appropriate bacterial density of 5 × 10
5
 CFU/mL. The plates were incubated at 37 °C. 
After 24 h incubation, MIC (minimum inhibitory concentration) end points were 
determined by visual inspection. The end point was reached when the cultures were 
completely transparent. Susceptibility of E. coli ATCC 25922 to tetracycline was 
chosen as quality control and its acceptable quality control limit is MIC of 0.5 - 2 
μg/mL (National Committee for Clinical Laboratory Standards, NCCLS, 2000). 
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Minimum inhibitory concentration was taken as the lowest concentration of 
antimicrobial agent that inhibited visible growth of the bacteria (n = 3). To evaluate the 
effect of catalase on the antibacterial action of the enzyme, the same assay was carried 
out in the presence of 1 mg/mL catalase. 
3.3 Bacteria-binding activity of king cobra venom L-amino acid oxidase 
Bacteria-binding activity of OH-LAAO was examined according to Kitani et al. (2008) 
with slight modifications. Two Gram-positive bacteria (S. aureus and S. epidermidis) 
and two Gram-negative bacteria (E. coli and P. aeruginosa) were chosen for this study. 
Bacteria were grown in nutrient broth at 37 °C. Cells were collected by centrifugation at 
2,000 × g for 15 min, washed twice with PBS, and adjusted to 1 × 10
9
 CFU/mL using 
2X Mueller-Hinton broth. Bacterial suspensions (500 μL) were incubated with 500 μL 
of OH-LAAO (1 μg/mL) at 37 °C for 1, 3, 5 and 24 h. After the incubation time, 
mixture was filtered using 0.20 μm syringe filter and the enzyme activity of the filtrate 
was measured.  The binding potency of the enzyme is inversely proportional to the 
enzyme activity of the filtrate. Relative LAAO activity in percentage was calculated 
using the formula below: 
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RESULTS 
3.4 Purification of king cobra venom L-amino acid oxidase 
Figure 3.1 shows the chromatogram of the purification of OH-LAAO using single step 
Resource
®
 Q ion exchange high performance liquid chromatography. Fractions 
constituting peak-7 which exhibited LAAO activity were pooled and designated as pure 
OH-LAAO. The purified enzyme was homogeneous as judged by SDS-PAGE, with a 
molecular mass of approximately 65 kDa, which is in agreement with the previous 
report (Tan and Saifuddin, 1989). Specific activity of the purified OH-LAAO was 437.7 
μmol/min/mg. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
Figure 3.1: Purification of king cobra venom L-amino acid oxidase by Resource
®
 Q ion 
exchange chromatography. King cobra (Ophiophagus hannah) venom (20 mg in 200 μL) was 
injected into the Resource
®
 Q anion exchange column pre-equilibrated with 20 mM Tris-HCl, 
pH 9.0. Elution was carried out with a linear gradient of 0 - 0.3 M NaCl. Seven major protein 
peaks were obtained. Peak-7 was the pure OH-LAAO. Insert: SDS-PAGE of molecular weight 
markers (left, Spectra™ broad molecular weight protein ladder, Molecular mass 10 - 260 kDa) 
and fraction of peak-7 (right). 
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3.5 Antibacterial action of king cobra venom L-amino acid oxidase 
Table 3.1 shows the minimum inhibitory concentration (MIC) of OH-LAAO against 
clinically isolated Gram-positive bacteria (S. aureus and S. epidermidis) and Gram-
negative bacteria (K. pneumonia, P. aeruginosa, and E. coli), as well as E. coli ATCC 
25922. For comparison, the MICs of some common antibiotics against both Gram-
negative bacteria (cefotaxime, kanamycin and tetracycline) and Gram-positive bacteria 
(cefotaxime, vancomycin and penicillin) were also determined. The MIC of tetracycline 
against the standard E. coli ATCC 25922 was 2 μg/mL, which is within the acceptable 
quality control limit of 0.5 - 2 μg/mL. For comparison, the MIC values were also 
expressed in μM. 
Results show that OH-LAAO is a potent antibacterial agent, effectively inhibiting both 
the growth of Gram-positive and Gram-negative bacteria examined. Its MICs against 
the Gram-positive bacteria S. aureus and S. epidermidis were 0.78 and 1.56 μg/mL, 
respectively. Its MICs against the Gram-negative bacteria K. pneumonia, P. aeruginosa 
and E. coli, ranged from 25 to 100 μg/mL. On a molar basis, MICs of OH-LAAO 
ranged from 0.006 μM to 0.800 μM, against both the Gram-positive and Gram-negative 
bacteria. The antibacterial action of OH-LAAO against all bacteria tested was abolished 
in the presence of 1 mg/mL of catalase (MIC > 100 µg/mL). 
Under the same experimental conditions, MICs of the antibiotics (cefotaxime, 
kanamycin and tetracycline) against the three Gram-negative bacteria ranged from 0.06 
μg/mL to > 64.00 μg/mL, whereas the MICs of the antibiotics (cefotaxime, vancomycin 
and penicillin) against the two Gram-positive bacteria ranged from < 0.031 μg/mL to 
2.0 μg/mL. 
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Table 3.1: Antibacterial activities of king cobra venom L-amino acid oxidase in 
comparison to antibiotics 
 
Bacteria Antibiotic/LAAO MIC (µg/mL) MIC (µM) 
Gram-negative  
  
Klebsiella pneumonia Cefotaxime 0.060 0.130 
Kanamycin 4.000 6.900 
Tetracyclin 4.000 9.000 
LAAO  50.000 0.400 
 LAAO+catalase >100.000 >0.800 
Pseudomonas aeruginosa Cefotaxime 16.000 35.100 
Kanamycin 64.000 109.800 
Tetracyclin 64.000 144.000 
LAAO  25.000 0.200 
 LAAO+catalase >100.000 >0.800 
Escherichia coli Cefotaxime >64.000 >140.500 
Kanamycin 16.000 27.500 
Tetracyclin 4.000 9.000 
LAAO  50.000 0.400 
 LAAO+catalase >100.000 >0.800 
Escherichia coli ATCC 25922 
 
Cefotaxime 0.060 0.130 
Kanamycin 8.000 13.700 
Tetracyclin 2.000 4.500 
 LAAO 100.000 0.800 
 LAAO+catalase >100.000 >0.800 
Gram-positive  
  
Staphylococcus aureus Cefotaxime 1.000 2.000 
Vancomycin 0.500 0.340 
Penicillin <0.030 <0.090 
LAAO  0.780 0.006 
 LAAO+catalase >100.000 >0.800 
Staphylococcus epidermidis  Cefotaxime 2.000 4.400 
Vancomycin 0.500 0.340 
Penicillin 0.060 0.180 
LAAO  1.560 0.012 
 LAAO+catalase >100.000 >0.800 
 
Minimum inhibitory concentration (MIC) of OH-LAAO and common antibiotics 
against several clinically isolated Gram-negative and Gram-positive bacteria were 
examined using broth microdilution assay. The end points were determined by visual 
inspection after 24 h incubation. The MICs values were expressed in µg/mL and μM 
from 3 independent experiments.  
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3.6 Bacteria-binding activity of king cobra venom L-amino acid oxidase 
Table 3.2 shows the binding activity of OH-LAAO to bacteria cells. At a bacteria 
concentration of 5 × 10
8
 cells/mL and OH-LAAO concentration of 0.5 μg/mL (3.8 × 
10
−12
 mol/mL, molecular weight of OH-LAAO = 130 kDa), the enzyme binds 
effectively to all 4 bacteria tested. The binding activity was time-dependent and reached 
a plateau after 5 h incubation. At 24 h, approximately 40% of the OH-LAAO in the 
incubation mixture was bound to the two Gram-positive bacteria, S. aureus and S. 
epidermidis, and 25% was bound to the two Gram-negative bacteria, E. coli and P. 
aeruginosa. 
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Table 3.2:  Bacterial cell binding activity of king cobra venom L-amino acid oxidase 
Time (h) Relative LAAO activity (%) of the filtrate of bacterial suspension 
treated with OH-LAAO for 0 to 24 h. 
S.aureus S. epidermidis E.coli P.aeruginosa 
0 88.8 ± 3.5% 93.9 ± 3.7% 94.6 ± 2.4% 93.2 ± 4.0% 
1 75.5 ± 4.0% 84.2 ± 3.8% 88.5 ± 4.7% 85.0 ± 5.1% 
3 64.2 ± 3.6% 73.1 ± 3.1% 76.6 ± 5.8% 82.3 ± 3.0% 
5 62.3 ± 3.3% 61.3 ± 4.4% 75.9 ± 5.2% 76.6  ± 4.8% 
24 60.5 ± 2.3% 62.7 ± 3.7% 75.2 ± 4.8% 77.3 ± 4.1% 
 
The incubation mixture consists of bacterial cell suspension (5 × 10
8
 cells) and 0.5 μg/mL OH-
LAAO in 2X Mueller-Hinton broth, incubated at 37 °C. The incubation mixture was filtered 
using 0.20 μm syringe filter; LAAO activity of the filtrate was measured. The results (mean ± 
S.D, n = 3) were expressed as the ratio of LAAO activity in the filtrate to that of the control 
(LAAO in incubation mixture without the bacteria), in percentage. Statistical analysis was 
performed using one-way analysis of variance (one-way ANOVA), followed by Tukey’s post 
hoc multiple comparison test. Relative LAAO activities after 1 h incubation were all 
significantly different from control (P < 0.05). 
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DISCUSSION 
3.7 Comparison of the antibacterial activity of king cobra venom L-amino acid 
oxidase with common antibiotics 
Skarnes (1970) was the first to report the bactericidal activity of LAAO isolated from C. 
adamanteus venom. Subsequently, bactericidal activities of LAAO from various snake 
venoms have been reported (Ciscotto et al., 2009; Alves et al., 2011; Tõnismägi et al., 
2006; Vargas et al., 2013; Zhong et al., 2009). Stiles et al. (1991) reported that in vitro 
antibacterial effects of LAAOs isolated from Australian elapid, Pseudoechis australis 
were 17.5 to 70.0 times more potent than tetracycline (on a molar basis). Therapeutic 
potential of the antibacterial agent is important to be evaluated by comparing its potency 
to that of common antibiotics. Hence, the antibacterial activity of king cobra venom 
LAAO (OH-LAAO) was carried out using the standardized broth microdilution assay 
according to the protocol described by National Committee for Clinical Laboratory 
Standards, NCCLS (2000). Its therapeutic potential was evaluated by comparing to the 
potency of five common antibiotics.  
The present study demonstrated that OH-LAAO is indeed a potent antibacterial agent 
when compared to the common antibiotics. On a molar basis, the antibacterial activity 
of OH-LAAO against all bacteria tested is far more potent than most of the antibiotics 
examined. For example, the MIC of OH-LAAO against Gram-positive S. epidermidis 
was 0.012 µM which is far more potent than cefotaxime (MIC = 4.400 µM), 
vancomycin (MIC = 0.340 µM) and penicillin (MIC = 0.180 µM). Against the Gram-
negative P. aeruginosa, the enzyme has a MIC of 0.2 µM, whereas the MICs for the 
antibiotics cefotaxime, kanamycin and tetracyclin against the same bacterium were 35.1 
µM, 109.8 µM and 144.0 µM, respectively (Table 3.1). On a weight basis, the MICs of 
OH-LAAO against the two Gram-positive bacteria were comparable to the antibiotics 
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tested, except for penicillin, which was far more potent than the OH-LAAO. On the 
same (weight) basis, however, the MICs of the OH-LAAO against Gram-negative 
bacteria were generally higher than the antibiotics tested, except against the clinically 
isolated of P. aeruginosa, where the enzyme has a MIC (25 μg/mL), comparable to the 
three antibiotics tested (16 - 64 μg/mL) (Table 3.1). 
Antibacterial activities of many different snake venom LAAOs have been reported 
(Table 3.3). Unfortunately, it is difficult to quantitatively compare the antibacterial 
potency of these LAAOs with the OH-LAAO, mainly because different methods of 
antibacterial assay were used. Of these, only three reported MICs of the enzyme using 
the standard broth microdilution assay according to NCCLS. Torres et al. (2010) 
reported that LAAO isolated from B. marajoensis has a MIC of 50 μg/mL against S. 
aureus. However, the enzyme was ineffective against Candida albicans (MIC > 200 
µg/mL) and P. aeruginosa (MIC > 200 µg/mL). Zhong et al. (2009) reported that the 
MICs of D. russellii siamensis LAAO for S. aureus, P. aeruginosa and E. coli were 9 
μg/mL, 144 μg/mL and 288 μg/mL, respectively. Vargas et al. (2013) demonstrated that 
the LAAO isolated from Crotalus durissus cumanensis effectively inhibiting the growth 
of Gram-positive S. aureus and Gram-negative A. baumannii and the MICs were 8 
µg/mL and 16 µg/mL, respectively. In comparison, OH-LAAO is more potent against 
these same organisms. The antibacterial action of OH-LAAO is diminished by the 
catalase (1 mg/mL); suggesting that the antibacterial action of the enzyme is mainly due 
to the H2O2 generated during the oxidative deamination process. This is in agreement 
with previous reports (Rodrigues et al., 2009; Stábeli et al., 2007; Stiles et al., 1991; 
Tõnismägi et al., 2006; Toyama et al., 2006; Vargas et al., 2013). 
The present results show that OH-LAAO was more potent against the Gram-positive 
bacteria than the Gram-negative bacteria tested. This is in agreement with the selectivity 
of antibacterial action of LAAOs of B. marojoensis, D. russellii siamensis, C. durissus 
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cascavella, B. atrox, C. durissus cumanensis and T. mucrosquamatus. On the other hand, 
LAAOs from B. pauloensis, B. alternates, V. lebetina, N. oxiana and P. australis were 
more active against Gram-negative than the Gram-positive bacteria, whereas LAAOs 
from A. halys and B. moojeni inhibited Gram-positive and Gram-negative bacteria 
almost equally (Table 3.3). These differences in the selectivity of the antibacterial action 
of these LAAOs are probably due to the differences in bacteria binding activity of the 
enzymes. 
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Table 3.3: The antibacterial actions of some snake venom L-amino acid oxidases      
    
Venom source of 
LAAO 
Antibacterial actions Reference 
Crotalus adamanteus  Almost equally active against Gram-
negative P. aeruginosa and E. coli 
(Skarnes, 1970) 
   
Crotalus durissus 
cascavella  
More active against Gram-positive  
Staphylococcus mutans than Gram-
negative Xanthomonas axonopodis 
pv passiflorae  
(Toyama et al., 
2006) 
   
Agkistrodon halys  Almost equally active against Gram-
negative E. coli and Gram-positive 
Bacillus subtilis  
(Zhang et al., 2004) 
   
Bothrops alternatus Slightly active against Gram-
negative E.coli than Gram-positive 
B. subtilis 
(Stábeli et al., 2004) 
   
Bothrops marajoensis Most active against Gram-positive S. 
aureus (MIC = 50 µg/ml) than C. 
albicans (MIC > 200 µg/mL) and P. 
aeruginosa (MIC > 200 µg/mL)   
(Torres et al., 2010) 
   
Bothrops moojeni  Almost equally active against Gram-
negative E. coli, Salmonella 
typhimurium, P. aeruginosa and 
Gram-positive S. aureus  
(Stábeli et al., 2007) 
   
Bothrops pauloensis More active against Gram-negative 
E. coli than Gram-positive S. aureus 
(Rodrigues et al., 
2009) 
   
Bothrops pirajai Almost equally active against Gram-
negative E. coli and P. aeruginosa 
(Izidoro et al., 2006) 
   
Trimeresurus jerdonii 
(now known as 
Protobothrops jerdonii) 
Active against Gram-positive 
Bacillus megaterilum and S. aureus 
and Gram-negative E. coli and P. 
aeruginosa 
(Lu et al., 2002) 
   
Trimeresurus 
mucrosquamatus (now 
known as 
Protobothrops 
mucrosquamatus) 
Most active against Gram-positivie 
S. aureus. Also active against Gram-
negative E. coli and Bacillus 
dysenteriae 
(Wei et al., 2003) 
   
Vipera lebetina  More active against Gram-negative 
E. coli than Gram-positive B. subtilis 
(Tõnismägi et al., 
2006) 
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Table 3.3, continued   
   
Venom source of 
LAAO 
Antibacterial actions Reference 
Daboia russellii 
siamensis 
 
 
 
Most active against Gram-positive S. 
aureus (MIC = 9 µg/mL) than Gram-
negative P. aeruginosa (MIC = 144 
µg/mL) and E. coli (MIC = 288 
µg/mL) 
(Zhong et al., 2009) 
   
Naja naja oxiana (now 
Naja oxiana) 
Slightly more active against Gram-
positive B. subtilis than Gram-
negative E. coli 
(Samel et al., 2008) 
   
Pseudechis australis Most active against Gram-negative 
A. hydrophila than Gram-positive B. 
subtilis and S. aureus 
(Stiles et al., 1991) 
 
   
Crotalus durissus 
cumanensis 
Active against Gram-positive S. 
aureus (MIC = 8 µg/mL) than Gram-
negative A. baumannii (MIC = 16 
µg/mL) 
(Vargas et al., 2013) 
   
Agkistrodon blomhoffii 
ussurensis 
Active against S. aureus (Sun et al., 2010) 
   
Bothrops atrox Slightly more active against Gram-
positive S. aureus than Gram-
negative E. coli 
(Alves et al., 2011) 
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3.8 Bacteria-binding activity of king cobra venom L-amino acid oxidase 
Although H2O2 has been demonstrated to play an important role in the bactericidal 
activity of OH-LAAO, it should be noted that the amount of H2O2 generated by a very 
small amount of the enzyme is insufficient to inhibit the growth of the bacteria tested. 
For example, the MIC of OH-LAAO against S. aureus and S. epidermidis were as low 
as 0.78 µg/mL and 1.56 µg/mL, respectively. Thus, a unique mechanism must have 
taken place in order for the OH-LAAO to elicit its potent antibacterial activity.  
The present study showed that the OH-LAAO binds effectively to bacteria, and its 
binding is a time-dependent process: it reached saturation only after approximately 5 h 
of incubation at 37 °C. The results also demonstrated that the binding affinity of the 
enzyme was higher against the Gram-positive S. aureus and S. epidermidis than the 
Gram-negative E. coli and P. aeruginosa. The binding affinity of the enzyme against S. 
aureus was approximately the same as the other Gram-positive bacteria, S. epidermidis 
and that the binding affinity of the enzyme against the two Gram-negative bacteria, E. 
coli and P. aeruginosa was also comparable. The higher bacteria binding affinity of 
OH-LAAO to the Gram-positive bacteria than to the Gram-negative bacteria are 
consistent with the observed differences in the MICs reported in the present study, 
suggesting that bacterial binding affinity of the enzyme plays an important role in its 
antibacterial activity.  
This finding is in agreement with the bacteria binding study of LAAO isolated from 
venom of Agkistrodon halys, as reported by Zhang et al. (2004). Using fluorescence 
detection method, they reported that AHP-LAAO could bind to the surfaces of E. coli 
and B. subtilis and that binding of AHP-LAAO to the bacteria enables production of 
highly localized concentration of H2O2 near to the binding sites that would be 
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sufficiently potent to kill the bacteria. Therefore, a very small amount of AHP-LAAO is 
able to elicit antibacterial activity.  
Similar studies and conclusions have also been reported with LAAO isolated from other 
organisms. Ehara et al. (2002), for example, showed that Achacin (LAAO isolated from 
the giant snail, Achatina fulica ferussac) binds stronger to S. aureus than E. coli, 
consistent with the observed differences in MICs between the two bacteria. Kitani et al. 
(2008) also suggested that bacterial-binding plays an important role in the antibacterial 
activity of SSAP (LAAO isolated from the skin mucus of Rockfish S. schlegelii). Using 
Western blotting and bacterial-binding studies, they demonstrated that the differences in 
the MICs of SSAP against various bacteria could be correlated to the differences in 
affinity of the enzyme towards the bacteria.  
Toyama et al. (2006), on the other hand, showed that the antibacterial activity of LAAO 
isolated from C. durissus cascavella snake venom induced bacterial membrane rupture 
and subsequently promote the releasing of its plasmatic content. As the estimated 
amount of H2O2 generated was sufficient to inhibit the bacterial growth, they suggested 
that the binding activity does not play an important role in inhibition of bacterial growth 
(Toyama et al., 2006). Vargas et al. (2013) using scanning electron microscopy method 
further demonstrated that treatment of S. aureus and A. baumannii with Cdc LAAO for 
24 h induced morphological alterations which are correlated with membrane damage 
and deposition of debris on the bacteria cell surface. They suggested that the enzyme 
generated high level of H2O2 in the medium to cause the membrane damages (Vargas et 
al., 2013). 
The discrepancy in the role of bacterial binding affinity of LAAOs in their antibacterial 
activity is presumably due to the differences of their antibacterial potency as well as the 
amount of the enzyme used in the study. For LAAOs with weaker antibacterial activity 
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(these are usually LAAO that could not bind effectively to the bacteria), large amount of 
the enzyme was used in the studies, and the enzyme was likely to exert its antibacterial 
effect by generating sufficiently high level of H2O2 in the medium to cause direct 
cytotoxic effect, whereas for LAAOs with very potent antibacterial activity, the enzyme 
could bind effectively to bacteria, and therefore even a very small amount of the 
enzyme that binds to the bacteria could generate highly localized H2O2 that could elicit 
effective antibacterial effect.  
It is important to note that while the results demonstrated that the OH-LAAO is a very 
potent antibacterial agent, therapeutic application of the enzyme as an antibacterial 
agent will always have its limitations due to its relatively high production cost (either 
purified from venom or via cloning). However, understanding of the mode of 
antibacterial action of LAAO (as an efficient H2O2 generator) may lead to the design of 
new antibacterial drugs or new therapeutic approaches. 
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CHAPTER 4 
ANTICANCER EFFECTS OF KING COBRA (Ophiophagus hannah)  
 VENOM L-AMINO ACID OXIDASE (OH-LAAO) 
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INTRODUCTION 
Cancer is a class of diseases in which a group of cells display uncontrolled growth 
(division beyond the normal limits), invasion (intrusion on and destruction of adjacent 
tissues), and sometimes metastasis (spread to other locations in the body via lymph or 
blood) (Smart, 2010). Cancer is the leading cause of death globally and accounted for 
7.6 million deaths, which is around 13% of all deaths in 2008. The deaths are caused 
mainly by lung, stomach, liver, colorectal, breast, and cervical cancers. Deaths from 
cancer worldwide are projected to continue rising, with an estimated 13.1 million deaths 
in 2030 (WHO, 2013). 
The high mortality rate of cancer was due to ineffectiveness of currently available 
cancer treatments and their potential to cause toxicity to normal cells, accompanied by a 
range of side effects such as vomiting, nausea and alopecia. Thus, there is a continuous 
need to search for potential natural-based therapeutic agents that exhibit potent 
cytotoxicity against cancer cells over the normal cells. 
Snake venom LAAOs have been reported to exhibit cytotoxicity against various cancer 
cell lines and its cytotoxic action was believed to be via apoptosis-induction. Unlike 
other venom LAAOs, king cobra (Ophiophagus hannah) venom LAAO, has an unusual 
thermal stability and is not inactivated by freezing (Tan and Saifuddin, 1989). Due to 
these favourable properties, king cobra venom LAAO (OH-LAAO) has a greater 
potential, when compared to other venom LAAOs, to be developed as a cancer 
therapeutic agent. In this study, the cytotoxic actions of OH-LAAO against human 
tumourigenic cell lines were investigated, and its cytotoxicity and apoptosis induction 
activities were compared with the respective non-tumourigenic cell lines. Its potency as 
a cytotoxic agent was also compared with doxorubicin, a standard anticancer drug. In 
addition, the enzyme’s anti-tumour effect in a PC-3 tumour xenograft mouse model 
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implanted in immunodeficient NU/NU mice and its toxicity on the vital organs were 
also investigated. 
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METHODS 
4.1 Cytotoxicity assay 
The cytotoxic effect of king cobra venom LAAO (OH-LAAO) and doxorubicin was 
determined by 3,(4,5-dimethythiazol-2-yl)-2,3-diphenyl tetrazolium bromide (MTT) 
method according to Ahn et al. (1997) with modifications. Briefly, 100 µL of the cells 
at their optimal density were seeded onto a 96-well microtitre plate (Table 4.1).  After 
overnight incubation, serially diluted doxorubicin or purified OH-LAAO was added into 
each well. Following 24 or 72 h treatment, 20 µL of the MTT stock solution of 5 
mg/mL in PBS was added. Cells were then incubated for a further 4 h in the dark. 
Seventy-five percent of the medium was aspirated out and an equal volume of dimethyl 
sulfoxide (DMSO) was added to solubilize the formazan crystals. The absorbance was 
measured with a Model 680 microplate reader (Bio-Rad, Hercules, CA) at 570 nm. Cell 
viability was calculated as follows: 
 
 
The half-maximal inhibitory concentration (IC50) value was determined from the dose-
response curve. 
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Table 4.1: Seeding density of cell lines in 96-well microtitre plate for 24 and 72 h 
treatment period 
 
Cell line 24 h (cells/well) 72 h (cells/well) 
MCF-7  10,000 1,000 
A549 15,000 3,000 
PC-3 12,000 5,000 
HL-60 100,000 28,000 
184B5  20,000 5,000 
NL 20 20,000 5,000 
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4.2 Apoptosis analysis 
Apoptosis effect of OH-LAAO was first screened on the human tumourigenic (MCF-7, 
A549, PC-3 and HL-60) and non-tumourigenic (184B5 and NL 20) cell lines using 
caspase-3/7, DNA fragmentation, and Phycoerythrin-Annexin V/7-Amino-Actinomycin 
D (PE-Annexin V/7-AAD) assays. 
4.2.1 Caspase-3/7 assay 
Caspase-3/7 activity was measured using Caspase-Glo
®
 3/7 assay kit (Promega, USA) 
according to the manufacturer’s protocol. Briefly, cells at their optimal density (Table 
4.1) were seeded onto white-walled 96-well microtitre plate. After overnight incubation, 
cells were treated with OH-LAAO at their respective IC50. Following 72 h treatment, 
100 μL of Caspase-Glo® 3/7 reagent containing DEVD sequence luminogenic substrate 
selective for caspase-3 and -7 was added into each well. The content of the wells was 
gently mixed with shaking for 2 min. The plate was then incubated in the dark for 1 h at 
room temperature. The luminescence of each sample was measured using Glomax-
Multi Detection System (Promega, USA). 
4.2.2 DNA fragmentation assay 
DNA fragmentation assay was carried out as described by Lin et al. (2003) with some 
modifications. Briefly, human tumourigenic (MCF-7, A549, PC-3 and HL-60) and non-
tumourigenic (184B5 and NL 20) cells were treated with OH-LAAO at their respective 
IC50 for 72 h. Controls were treated with PBS (vehicle). After treatment, cells were 
harvested using trypsin-EDTA, washed with PBS and spun down at 2,000 rpm for 5 
min. Cell pellet was resuspended with 500 μL of PBS. This was followed by adding 
with 50 µL of lysis buffer [1 M Tris-HCI (pH 8.0), 0.5 M EDTA and 5% (v/v) TritonX-
100] and incubated on ice for 30 min. After centrifugation at 10,000 x g for 30 min at 
81 
 
4 °C, cell lysate was collected from the supernatant. An equal volume of 
phenol/chloroform/iso-amyl alcohol (25:24:1) was then added and gently mixed for 5 
min. After centrifugation, the top layer was collected and precipitated with an equal 
volume of iced-cold iso-propanol and 1/10 volume of 3 M sodium acetate (pH 5.2). 
Following 30 min incubation at -20 °C, the mixture was subjected to centrifugation at 
10,000 x g for 30 min at 4 °C. The supernatant was discarded and the DNA pellet was 
allowed to air-dry for 10 min. DNA pellet was dissolved in an adequate volume of 
RNase I solution (10 mg/mL RNase I) and incubated at 37 °C for 30 min. DNA was 
subjected to 1.2% agarose gel (containing GelRed
™
) electrophoresis at a constant 
voltage of 90 V for 1 h. Image acquisition was performed using gel documentation 
system (Infinity-3026, Vilber Lourmat, France).  
4.2.3 Phycoerythrin-Annexin V/7-Amino-Actinomycin D (PE-Annexin V/7-AAD) 
assay 
PE-Annexin V/7-AAD assay was performed using PE annexin V apoptosis detection kit 
I (BD Biosciences, USA) according to the manufacturer’s instructions. In brief, human 
tumourigenic (MCF-7, A549, PC-3 and HL-60) cells were treated with OH-LAAO at 
their respective IC50 values. The corresponding non-tumourigenic breast (184B5) and 
lung (NL 20) were treated with 0.04 μg/mL and 0.05 μg/mL of OH-LAAO, respectively 
(IC50 of MCF-7 and A549 respectively). After 72 h treatment, cells were trypsinized and 
washed twice with PBS. The number of cells (1 x 10
5
 cells) was adjusted with 1X 
binding buffer to a final volume of 100 µL. Cells were stained with 5 µL of Annexin V 
conjugated to phycoerythrin (PE) and followed by 5 µL of 7-Amino-Actinomycin D (7-
AAD). After incubation in the dark for 15 min at room temperature, 400 µL of 1X 
binding buffer was added into the mixture. Cells (10,000 events) were analysed using a 
FACSCanto™ II, and FACSDiva software version 6.1.3 (BD Biosciences, USA). Data 
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analyses were performed using FCS express 4 flow software (De Novo™ software, CA). 
Results were expressed in density plots and plotted as 7-AAD versus PE-Annexin V. 
Data was obtained from an average of two independent experiments from two separate 
measurements. 
4.3 Apoptotic pathways induced by king cobra venom LAAO 
The apoptotic cell death induced by OH-LAAO was studied in more detailed by 
examine the components of the apoptotic cascade that involved in the apoptosis. For 
this purpose, MCF-7 was used as a representative cell line in measuring the enzymatic 
activities of caspase-8 and caspase-9 as well as the expression level of cytochrome c in 
the cells treated with OH-LAAO. 
4.3.1 Caspase-8 and caspase-9 assays 
Caspase-8 and caspase-9 activities were determined using Caspase-Glo
®
 8 and Caspase-
Glo
®
 9 assay kits, respectively according to the protocols described by the manufacturer 
(Promega, USA). Briefly, MCF-7 cells at 1,000 cells/well were seeded onto white-
walled 96-well cell culture plate. After overnight incubation, cells were treated with 
0.04 µg/mL of OH-LAAO (IC50 of OH-LAAO). Following 72 h treatment, 100 μL of 
the reconstituted Caspase-Glo
®
 8 or Caspase-Glo
®
 9 reagent was added into each well. 
The contents of the wells were gently mixed and incubated at room temperature for 1 h. 
The luminescence of each sample was measured with a Glomax-multi Detection System 
(Promega, USA).  
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4.3.2 Measurement the expression level of cytochrome c  
4.3.2.1 Protein samples preparation 
Cytochrome c levels in MCF-7 cells treated with OH-LAAO or PBS (vehicle) were 
measured using Cytochrome c (human) EIA kit according to the manufacturer’s 
guideline (Enzo Life Sciences, New York). Cells were treated with 0.04 µg/mL of OH-
LAAO for 72 h, harvested by trypsin-EDTA and washed twice with PBS. Cell pellet 
was then resuspended with digitonin cell permeabilization buffer, vortexed briefly and 
incubated on ice for 5 min. Subsequently, cell lysate was centrifuged at 1,000 x g for 5 
min at 4 °C and the supernatant was collected as a cytosolic fraction. The remaining cell 
pellet was further lysed with radioimmunoprecipitation assay (RIPA) cell lysis buffer, 
vortexed, incubated on ice for another 5 min and spun down at 10,000 x g for 10 min at 
4 °C. The supernatant was then collected as a subcellular or mitochondria fraction. 
Protein concentrations of the cytosolic and mitochondria fractions were determined 
using 2-D quant kit (GE Healthcare, Sweden), as described in general methods (Chapter 
2, Section 2.9.2). 
4.3.2.2 Determination of cytochrome c levels  
One hundred microlitres of cytochrome c standards (ranging from 0 to 450 pg/mL) or 
protein samples (100 µg of cytosolic fraction protein or 30 µg of mitochondria fraction 
protein) were pipetted onto the 96-well ELISA plate provided by the manufacturer, and 
incubated at room temperature for 1 h with shaking. The wells were emptied and 
washed four times with 400 µL of washing solution. After washing, 100 µL of the 
yellow antibody was introduced into the wells and incubated for another 1 h with 
agitation. The contents of the wells were then discarded and washed again with the 
washing solution. Blue conjugate (100 µL) was added and incubated for 30 min. After 
washing for four times with washing solution, 100 µL of substrate solution was added 
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into the wells and incubated for another 45 min. Reaction was stopped by adding with 
25 µL of the stop solution. The optical density of each sample was measured using a 
Model 680 microplate reader (Bio-Rad, Hercules, CA) at 415 nm with the reference 
wavelength of 570 nm.  
4.4 Prostate adenocarcinoma (PC-3) tumour xenograft mouse model 
Prostate adenocarcinoma cells (PC-3) were grown to 80-90% confluency and harvested 
using trypsin-EDTA. Cells were washed twice with PBS and followed by centrifugation 
at 2,000 rpm for 5 min. Cell pellet was resuspended in PBS and the number of viable 
cells was determined using trypan blue exclusion method and counted with a 
haemocytometer. Subsequently, cell suspension was mixed with an equal volume of 
Matrigel
TM
. Under anaesthesia condition, each mouse was inoculated subcutaneously 
(s.c.) with 200 μL of the cells-Matrigel™ mixture which contained approximately 0.6 x 
10
7
 cells. Mice were examined daily for tumour growth at the injection site. Tumour 
volumes (mm
3
) were measured weekly using a digital calliper (Mitutoyo, Japan) and 
were calculated as (length x width x height x π/6) to approximate the volume of a 
spheroid. When the tumour volume reached about 100-200 mm
3
 (usually 1 - 2 weeks 
after inoculation of the PC-3 cells), mice were randomly assigned into control (n = 6) 
and treated (n = 6) groups. Mice were treated intraperitonealy (i.p.) daily with either 
PBS (control group) or OH-LAAO (treated group) at a dose of 1 μg/g/day/200 μL for 8 
weeks. Tumour volume (mm
3
) and body weight of individual animals were monitored 
and recorded weekly over the 8-week treatment period. 
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4.5 Toxicity study of king cobra venom L-amino acid oxidase in tumour-bearing 
mice 
4.5.1 Organs/tissues fixation 
Mice from both OH-LAAO and vehicle-treated groups were sacrificed at the end of the 
8 weeks study by cervical dislocation after anaesthetize with i.p. injection of a 
combination of ketamine and xylazine. Vital organs (lung, liver, heart, spleen, kidneys) 
and solid tumour tissues were harvested and fixed in 10% buffered formalin for 48 h.  
4.5.2 Tissue processing 
4.5.2.1 Dehydration and clearing 
Tissues were placed into the tissue cassettes and dehydrated by submerging in an 
increasing concentration of ethanol for 1 h in each concentration, starting with 60% and 
progressing through 70%, 80%, 95%, and finally in two volume changes of absolute 
ethanol. After dehydration, tissues were rinsed with benzene. 
4.5.2.2 Infiltration and embedding 
Tissues were transferred into a mixture containing equal volume of benzene and melted 
paraffin wax and incubated at 60 °C for 1 h. The mixture of benzene and paraffin wax 
was discarded and the tissues were allowed to equilibrate in melted paraffin for another 
45 min at 60 °C. This step was repeated with freshly melted paraffin. Tissue cassettes 
were then transferred into an embedding mold and filled with melted paraffin. Paraffin 
was allowed to solidify at room temperature.  
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4.5.2.3 Tissue sectioning and mounting on microscope slides 
Paraffin-embedded tissues were sectioned at 5 µm thick using a microtome. Tissue 
sections were floated on a pre-heated 45 °C water bath until the sections are flattened. 
Tissue sections were then mounted on a clean silanized microscope slides. Excessive 
water or adhesive solution around the section area was drained with a paper towel. 
Subsequently, slides were placed on a pre-heated 40 °C platform until the sections are 
firmly fixed on the slides.  
4.5.2.4 Clearing and rehydration of tissue sections 
Tissue sections were dewaxed in two volume changes of xylene for 5 min each in a 
coplin jar. Tissue sections were then rehydrated by submerging in a decreasing 
concentration of ethanol for 2 min in each concentration, starting with 100% ethanol, 
followed by 85% and 70% and finally washed with milli-Q™ water for 1 min.  
4.5.2.5 Haematoxylin and eosin staining 
Rehydrated tissue sections were stained with Harris haematoxylin for 5 min, washed in 
two volume changes of milli-Q™ water for 30 sec in each wash and differentiated in 
acidic ethanol (70% ethanol containing a few drops of HCl). Tissue sections were then 
washed with milli-Q™ water and finally counter stained with Eosin Y, 0.5% aqueous 
for 5 min. Subsequently, tissue sections were dehydrated in 95% ethanol for 20 sec, 
followed by absolute ethanol for 30 sec and xylene for 1 min. Slides were removed 
from the coplin jars and tapped gently on the edge to remove the excess solvent. Cover-
slip was mounted on top of the tissue section by a mounting medium (permount). 
Images were capture using light microscope equipped with camera (BX 51 Olympus, 
Japan).  
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4.6 TdT-mediated dUTP nicked-end labelling (TUNEL) immunohistochemical 
staining of tumour tissue 
TdT-mediated dUTP nicked-end labelling (TUNEL) assay for the detection of apoptotic 
cells was performed using ApopTag
®
 plus peroxidase in situ apoptosis detection kit   
according to the manufacturer’s protocol (Millipore, USA). Briefly, tumour tissues were 
processed, sectioned at 5 µm thick, and mounted on the silanized slides (as described in 
Section 4.5.2). Tumour sections were treated with proteinase K (20 mg/mL) for 15 min, 
and followed by quench in 3% H2O2 (diluted with PBS) for 5 min. An adequate volume 
of the equilibration buffer was pipetted onto the tissue sections and incubated for 10 sec. 
Subsequently, tissue sections were incubated with terminal deoxynucleotidyl transferase 
(TdT) enzyme at 37 °C for 1 h in a humidified chamber. Tissue sections were then 
washed with the washing buffer and allowed to bind to anti-digoxigenin conjugate in a 
humidified chamber for another 30 min. Subsequently, slides were stained with 3, 3'-
diaminobenzidine (DAB) peroxidase substrate for 5 min, washed in 3 volume changes 
of milli-Q™ water, and counter stained with 0.5% methyl green for 10 min. Finally, 
cover-slip was mounted on top of the tumour section using a mounting medium 
(permount). Slides were examined under light microscope (BX 51 Olympus, Japan) and 
the pictures of 5 random fields of view per section at 200X magnifications were taken. 
The percentage of apoptotic cells were scored as an average of the ratio of TUNEL-
positive cells to the total number of cells present in each field. 
4.7 Statistical analysis 
Results for in vitro studies; cytotoxicity, PE-annexin V/7-AAD, caspase-3/7, caspase-8, 
and caspase-9 activities as well as cytochrome c expression level were expressed as 
mean ± S.D. The in vivo anti-tumour activities were expressed as mean ± S.E.M. The 
significance of the differences of the means was determined by one-way ANOVA, 
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followed by Tukey’s post hoc multiple comparison test. The statistical analysis was 
conducted using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). 
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RESULTS 
4.8 Cytotoxicity of king cobra venom L-amino acid oxidase  
Cytotoxicity of king cobra venom LAAO (OH-LAAO) and doxorubicin (the commonly 
used chemotherapeutic drug) were investigated by MTT assay. As shown in Figure 4.1 
and 4.2, the cytotoxic effects of both OH-LAAO and doxorubicin treatments in six cell 
lines examined were in dose- and time-dependent manner. Table 4.2 and Table 4.3 show 
the IC50 values of the OH-LAAO and doxorubicin in four human tumourigenic cell lines; 
MCF-7 (breast adenocarcinoma), A549 (lung adenocarcinoma), HL-60 (promyelocytic 
leukaemia) and PC-3 (prostate adenocarcinoma), as well as two human non-
tumourigenic cell lines; 184B5 (non-tumourigenic breast) and NL 20 (non-tumourigenic 
lung) after 24 h and 72 h incubation. 
The results showed that the enzyme was very potent against the four tumourigenic cell 
lines (MCF-7, A549, HL-60 and PC-3), with IC50 ranging from 0.05 to 0.15 μg/mL after 
24 h incubation. The cytotoxicity was increased when the treatment prolonged to 72 h 
(IC50 of 0.04 - 0.07 μg/mL). Surprisingly, such cytotoxicity was not observed in non-
tumourigenic breast (184B5) and lung (NL 20) cell lines, even after 72 h incubation; the 
IC50 was at least 3 to 4 times higher than that of their corresponding tumourigenic cell 
lines (P < 0.05). Treatment with 400 μg/mL of catalase (ROS scavenger) substantially 
reduced the cytotoxic effect of OH-LAAO (P < 0.05) (Table 4.2, Figure 4.1). The IC50 
values in all cell lines examined were ranged from 0.37 - 0.90 µg/mL and 0.33 - 1.13 
µg/mL after 24 h and 72 h incubation, respectively (Table 4.2). 
For comparison, the IC50 values of doxorubicin, a standard anti-cancer 
chemotherapeutic agent against the same cell lines were also determined under the same 
experimental conditions as OH-LAAO treatment. As shown in Table 4.2 and Table 4.3, 
OH-LAAO’s anti-proliferative effects were far more potent than that of doxorubicin, 
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with at least 9- to 92-folds lower IC50 (24 h treatment) when compared on the same 
tumourigenic cell lines. Doxorubicin has minimal selectivity against tumourigenic and 
non-tumourigenic cells: at 24 h incubation, it was essentially equally cytotoxic to both 
tumourigenic MCF-7 (IC50 of 0.70 µg/mL) and non-tumourigenic 184B5 (IC50 of 1.00 
µg/mL) breast cells, and in fact even more cytotoxic to non-tumourigenic NL 20 (IC50 
of 1.37 µg/mL) lung cells than the tumourigenic A549 (IC50 of 2.23 µg/mL) counterpart 
(Table 4.3).  
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Figure 4.1, continued 
  
  
Figure 4.1: Effect of king cobra venom LAAO on viability of various human tumourigenic and 
non-tumourigenic cell lines. The tumourigenic (MCF-7, A549, PC-3 and HL-60) and non-
tumourigenic (184B5 and NL 20) cells were treated with different concentrations of OH-LAAO 
(0.01 - 5.00 µg/mL) for 24 or 72 h, with or without catalase (400 µg/mL). The viability of the 
cells was measured by MTT assay. Results given are mean ± S.D (n = 3). Solid line —■—: 
without catalase; Broken line ---♦---: with catalase. 1A: MCF-7, 24 h treatment; 1B: MCF-7, 72 
h treatment; 2A: A549, 24 h treatment; 2B: A549, 72 h treatment; 3A: PC-3, 24 h treatment; 3B: 
PC-3, 72 h treatment; 4A: HL-60, 24 h treatment; 4B: HL-60, 72 h treatment; 5A: 184B5, 24 h 
treatment; 5B: 184B5, 72 h treatment; 6A: NL 20, 24 h treatment; 6B: NL 20, 72 h treatment. 
 
 
 
 
 
 
 
 
 
5A 5B 
6B 6A 
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Table 4.2: Cytotoxic effect [IC50 (µg/mL)] of king cobra venom L-amino acid oxidase 
against human tumourigenic and non-tumourigenic cell lines 
 IC50 (24 h Treatment) 
 
(24 h Treatment) 
IC50 (72 h Treatment) 
(72 h Treatment) 
(µg/mL±SD) without catalase with catalase without catalase 
 
with catalase 
     MCF-7 0.05 ± 0.00 0.37 ± 0.10 0.04 ± 0.00 1.08 ± 0.48 
A549 0.09 ± 0.01 0.48 ± 0.03 0.05 ± 0.00 0.33 ± 0.13 
PC-3 0.08 ± 0.02 0.65 ± 0.13 0.05 ± 0.01 0.95 ± 0.28 
HL-60 0.15 ± 0.05 0.80 ± 0.15 0.07 ± 0.02 1.13 ± 0.38 
184B5 0.25 ± 0.05 0.90 ± 0.30 0.15 ± 0.05 1.05 ± 0.51 
NL 20 0.22 ± 0.08 0.73 ± 0.28 0.18 ± 0.06 0.62 ± 0.35 
     
Human tumourigenic cells (MCF-7, A549, PC-3 and HL-60) and non-tumourigenic cells 
(184B5 and NL 20) were treated with OH-LAAO for 24 h and 72 h, with or without catalase 
(400 µg/mL). Data are expressed as mean ± S.D (n = 3). 
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Figure 4.2: Effect of doxorubicin on viability of various human tumourigenic and non-
tumourigenic cell lines. Cells were treated with different concentrations of doxorubicin (0.02 - 
10.00 µg/mL for MCF-7, A549, PC-3, HL-60 and 184B5; 0.01 - 10.00 µg/mL for NL 20) for 24 
or 72 h. The viability of the cells was measured by MTT assay under the same experimental 
conditions as for OH-LAAO. Results given are mean ± S.D (n=3). Broken line ---♦---: 24 h 
treatment; Solid line —■—: 72 h treatment. A: MCF-7, B: A549, C: PC-3, D: HL-60, E: 184B5, 
F: NL 20. 
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Table 4.3: Cytotoxic effect [IC50 (µg/mL)] of doxorubicin against human tumourigenic 
and non-tumourigenic cell lines 
IC50 (µg/mL±SD) 24 h Treatment 72 h Treatment 
MCF-7 0.70 ± 0.05 0.18 ± 0.03 
A549 2.23 ± 0.57 0.63 ± 0.21 
PC-3 7.33 ± 0.58 
 
0.40 ± 0.00 
 
HL-60 1.35 ± 0.41 
 
0.10 ± 0.00 
 
184B5 1.00 ± 0.27 0.48 ± 0.20 
NL 20 1.37 ± 0.57 0.02 ± 0.00 
   Cells were treated with doxorubicin for 24 h and 72 h. Data are expressed as mean ± S.D (n = 3). 
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4.9 Apoptosis effect of king cobra venom L-amino acid oxidase 
To examine whether the OH-LAAO exerts its cytotoxicity via induction of apoptosis, 
caspase-3/7 activities, formation of DNA fragmentation, and surface externalization of 
membrane phospholipid phosphatidylserine (PS) in human tumourigenic and non-
tumourigenic cell lines following OH-LAAO treatment were examined. 
4.9.1 Effect of king cobra venom L-amino acid oxidase on caspase-3/7 activities 
Caspase-3/7 activities in both vehicle- and LAAO-treated tumourigenic (MCF-7, A549, 
PC-3 and HL-60) and non-tumourigenic (184B5 and NL 20) cells at their respective 
IC50 value were measured after 72 h treatment. As shown in Figure 4.3, caspase-3/7 
activities were significantly increased in LAAO-treated cells, with at least 1.8-fold 
greater than in vehicle-treated (control) cells. The highest caspases activation (3.8-fold) 
was observed in PC-3 cells. Low levels of caspase-3/7 activities were also detected in 
the control cells, which was probably due to small numbers of cells undergoing normal 
apoptosis in the growing cell population.  
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Figure 4.3: Caspase-3/7 activities of OH-LAAO treated cells. The following cell lines were 
treated with OH-LAAO at their respective IC50 dosage for 72 h: MCF-7, A549, PC-3, HL-60, 
184B5 and NL 20 cells. Caspase-3/7 activities were determined using Caspase-Glo
®
 3/7 assay 
kit (n = 3). Fold change of the control is 1 and the error bars indicate S.D from three 
independent experiments. Statistical analysis was performed using one-way ANOVA, followed 
by Tukey’s post hoc multiple comparison test. * P < 0.05 in the LAAO-treated versus control 
cells. 
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4.9.2 Effect of king cobra venom L-amino acid oxidase on nuclear fragmentation 
The formation of DNA ladders in tumourigenic and non-tumourigenic cells were 
examined following OH-LAAO treatment at their respective IC50 value for 72 h. Figure 
4.4 shows the presence of DNA fragments in MCF-7, A549, PC-3, HL-60, 184B5 and 
NL 20 cells as a result of OH-LAAO treatment. No DNA fragmentations were observed 
in the respective vehicle-treated (control) cells. Both increase in caspase-3/7 activities 
and the formation of DNA fragments indicated that OH-LAAO induced cell death via 
apoptosis. 
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Figure 4.4: King cobra venom L-amino acid oxidase induced DNA fragmentations in 
tumourigenic and non-tumourigenic cells. Tumourigenic and non-tumourigenic cells were 
treated with OH-LAAO at their respective IC50 for 72 h. M: 1 kb DNA ladder, Lane 1: Treated 
MCF-7, Lane 2: MCF-7 control, Lane 3: Treated A549, Lane 4: A549 control, Lane 5: Treated 
PC-3, Lane 6: PC-3 control, Lane 7: Treated HL-60, Lane 8: HL-60 control, Lane 9: Treated 
184B5, Lane 10: 184B5 control, Lane 11: Treated NL 20, Lane 12: NL 20 control. Red 
coloured lines indicate the estimated size of the DNA fragments.  
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4.10 The selectivity of cytotoxic and apoptosis effects of king cobra venom L-amino 
acid oxidase  
The selectivity of cytotoxic action of OH-LAAO was demonstrated by PE-annexin V/7-
AAD assay. The MCF-7 and 184B5 cells were treated with 0.04 μg/mL of OH-LAAO 
(IC50 value of MCF-7), A549 and NL 20 cells were treated with 0.05 μg/mL of OH-
LAAO (IC50 of A549), whereas PC-3 and HL-60 cells were treated with 0.05 µg/mL 
and 0.07 µg/mL of OH-LAAO, respectively (their respective IC50),  for 72 h. Cells 
stained with PE-annexin V and 7-AAD were analysed using flow cytometry.  
In tumourigenic MCF-7 cells, OH-LAAO treatment resulted in 35.9% cell death, 
compared to 16.9% in the non-tumourigenic counterpart (184B5) (Figure 4.5). Selective 
cytotoxic action of OH-LAAO was evident as the vehicle-treated cells only showed 
4.5% and 11.4% of cell death, respectively, in MCF-7 and 184B5 cells. Similarly, a 
greater percentage cell death occurred in LAAO-treated A549 cells (34.6%) than in its 
non-tumorigenic counterpart, NL 20 cells (6.4%). In comparison, vehicle treated cells 
only showed 7.6% and 4.9%, of cell death respectively, for A549 and NL 20 cells 
(Figure 4.5) (data obtained from an average of 2- independent experiments).  
Besides the selectivity, PE-annexin V/7-AAD data also suggest that LAAO-induced cell 
death in tumourigenic cells (MCF-7, A549, PC-3 and HL-60) is via induction of 
apoptosis, as a significant increased of early and late apoptotic cells of 30.8%, 21.0%, 
24.7% and 34.2% were observed in the LAAO-treated MCF-7, A549, PC-3 and HL-60, 
respectively (Figure 4.5A and B minus the control). 
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Figure 4.5, continued 
 
Figure 4.5: PE-Annexin V/7-AAD analysis of the effects of OH-LAAO treatment on 
tumourigenic and non-tumourigenic cell lines. (A) Flow cytometry analysis of PE Annexin V/7-
AAD dual staining. The MCF-7 and 184B5 cells were treated with 0.04 μg/mL of OH-LAAO, 
A549 and NL 20 cells were treated with 0.05 μg/mL of OH-LAAO, whereas PC-3 and HL-60 
cells were treated with 0.05 µg/mL and 0.07 µg/mL of OH-LAAO respectively, for 72 h. Cells 
(10,000 events) were analysed by fluorescent-activated cell scanner. The lower left quadrant 
contains the viable cells (Annexin V -; 7-AAD -), the upper left quadrant contains the damage 
population (Annexin V -; 7-AAD +), the upper right quadrant contains the late apoptotic cells 
(Annexin V +; 7-AAD +) and the lower right quadrant contains the early apoptotic cells 
(Annexin V +; 7-AAD -). X-axis indicates the number of PE-Annexin V stained cells. Y-axis 
indicates the number of 7-AAD stained cells. Total apoptotic cells (%) are shown in each figure. 
(B) Quantitative data of PE-Annexin V/7-AAD dual staining. Data is expressed in % of 
apoptotic cells (in lower right and upper right quadrants). All figures represent the mean ± S.D 
of duplicate analysis from 2-independent experiments. * P < 0.05 in the LAAO-treated versus 
control cells. 
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4.11 Apoptotic pathways induced by king cobra venom L-amino acid oxidase 
To examine the components of the apoptotic cascade involved in king cobra venom 
LAAO-induced apoptotic cell death in MCF-7 cells, enzymatic activities of caspase-8 
and caspase-9 as well as the expression level of cytochrome c were measured following 
72 h OH-LAAO treatment at its IC50 value. 
4.11.1 Effect of king cobra venom L-amino acid oxidase on caspase-8 and caspase-
9 activities  
Caspase-8 and caspase-9 activities in the control and LAAO-treated MCF-7 cells were 
measured using caspase-Glo
®
 8 and caspase-Glo
®
 9 assay kit, respectively. As shown in 
Figure 4.6, caspase-8 and caspase-9 activities in the treated cells were 3.3- and 4.7-fold, 
respectively greater than that in their corresponding control cells (P < 0.05).  
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Figure 4.6: Caspase-8 and caspase-9 activities in LAAO-treated MCF-7 cells. The cells were 
treated with 0.04 µg/mL of OH-LAAO. The caspase activities were determined after 72 h 
incubation. Fold-change of the control is 1 and the error bars indicate the S.D from three 
independent experiments. Statistical analysis was performed using one-way ANOVA, followed 
by Tukey’s post hoc multiple comparison test. * P < 0.05 in the LAAO-treated versus control 
cells. 
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4.11.2 Effect of king cobra venom L-amino acid oxidase on cytochrome c levels  
Expression levels of cytochrome c in the vehicle- and LAAO-treated MCF-7 cells were 
determined using cytochrome c (human) EIA kit. After 72 h treatment with 0.04 µg/mL 
(IC50) of OH-LAAO, proteins from both cytosolic and mitochondria fractions were 
extracted. The concentrations of the cytochrome c were determined. When compared to 
the controls, expression levels of cytochrome c in LAAO-treated cells were 1.6- and 
3.3-fold higher in the cytosolic and mitochondria fraction, respectively (P < 0.05) 
(Figure 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
 
Figure 4.7: Expression levels of cytochrome c in MCF-7 cells in response to OH-LAAO 
treatment. MCF-7 cells were treated with 0.04 µg/mL of OH-LAAO for 72h. The expression 
levels of cytochrome c in both cytosolic and mitochondria fractions were determined and 
expressed as fold-change. The error bars indicate the S.D from three independent experiments. * 
P < 0.05 in the LAAO-treated versus control cells. 
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4.12 In vivo anti-tumour studies 
4.12.1 In vivo anti-tumour effects of king cobra venom L-amino acid oxidase in PC-
3 tumour xenograft mouse model 
As shown in Figure 4.8, LAAO-treated tumours grew markedly slower than those 
treated with vehicle only. A significant difference in mean tumour size was seen 
between vehicle-treated and LAAO-treated group (P < 0.01), as early as 7 days post-
treatment. By the 8
th
 week, tumours in control mice had grown to greater than 700% of 
the original size (size of the tumour at the start of treatment assigned as 100%), whereas 
for the OH-LAAO treated mice, the average tumour size was 300% of their original size 
(P < 0.01, between treated and control). All tumours were harvested at the end of the 
study (week 8) (Figure 4.9). One of the tumours achieved complete regression with no 
sign of tissue left for harvest (picture not shown). 
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Figure 4.8: In vivo anti-tumour effect of OH-LAAO on solid PC-3 prostrate tumour in nude 
mice. Tumour-bearing nude mice were treated i.p. daily with either vehicle (control, broken 
line---♦---, n = 6) or OH-LAAO (1 μg/g/day/200 µL, solid line —■—, n = 6). Tumour volume 
was measured weekly. The percentage change of tumour volume was calculated after compare 
with those at week 0. Data was expressed as mean ± standard error of the mean. Statistical 
analysis was performed using one-way ANOVA, followed by Tukey’s post hoc multiple 
comparison test (P < 0.05 for data points marked with *, P < 0.01 for data points marked with 
#). 
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Figure 4.9: Suppression of tumour size in PC-3 tumour-bearing nude mice treated with OH-LAAO. Images showing tumours harvested at the end of 8
th
 week 
treatment: control group (1A-F) and OH-LAAO treated group (2A-E). One of the tumours from the LAAO-treated group achieved complete regression, as no 
evidence of tumour tissue could be detected at the end of treatment period (picture not shown). 
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4.13 Toxicity study of king cobra venom L-amino acid oxidase in tumour-bearing 
mice 
Histological examinations of the major organs harvested (heart, kidney, liver, lung and 
spleen) at the end of 8
th
 week show that the OH-LAAO treatment did not cause any 
abnormal pathological changes when compared to those in vehicle-treated (Figure 4.10). 
Also, the body weight of the LAAO-treated group did not differ (P > 0.05) from the 
vehicle-treated mice throughout the treatment period (Figure 4.11). 
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Figure 4.10: Histological sections of major organs of control and LAAO-treated mice. Haematoxylin and Eosin (H&E) stained sections (100X magnifications) of 
heart, kidney, liver, lung and spleen tissues of (A) vehicle-treated mice and (B) LAAO-treated mice. Intraperitoneal (i.p.) administration of 1 μg/g/200 µL of OH-
LAAO daily for 8 weeks did not cause significant pathological changes in heart, kidney, liver, lung and spleen of the mice when compared to those in the vehicle-
treated mice. 
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Figure 4.11: Changes in the body weight of mice in the control and LAAO-treated groups. Body 
weight of the mice in both control and LAAO-treated groups were determined weekly. There 
were no significant differences in the average body weight of the two groups over the 8-weeks 
treatment period (P > 0.05). Solid line —■—: LAAO-treated mice; Broken line ---♦---: Control 
mice. Data was expressed as mean ± standard error of the mean. 
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4.14 In vivo apoptosis effect of king cobra venom L-amino acid oxidase 
To determine whether decreased in tumour volume is associated with apoptotic cell 
death induced by the enzyme, the extent of DNA fragmentation in the tumour cells were 
examined by TUNEL method. Representative tumour sections stained with TUNEL are 
shown in Figure 4.12 (A). Figure 4.12 (B) shows the average percentage of TUNEL-
positive cells in the control and LAAO-treated tumour. The amount of apoptotic cells in 
the tumour section harvested from LAAO-treated mice was 26.7%. In contrast, tumour 
section from the control mice showed that the tumour predominantly consists of viable 
cells, with only few individual scattered cells (2.5%) stained positively with TUNEL 
[Figure 4.12 (A) and (B)].  
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Figure 4.12: Apoptotic effect of L-amino acid oxidase in PC-3 solid tumour. (A) Representative 
TUNEL stained of tumour sections harvested from tumour-bearing nude mice treated with 
vehicle (PBS) and OH-LAAO (200X magnifications). Apoptotic cells were stained in dark 
brown (indicated by red arrows). (B) Average percentage of TUNEL-positive cells in tumour 
sections from the vehicle- and LAAO-treated mice. Data was expressed as mean ± standard 
error of the mean. * P < 0.05 in the LAAO-treated versus control group. Results showed that 
higher numbers of tumour cells underwent apoptosis in LAAO-treated mice compared to the 
vehicle-treated mice. 
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DISCUSSION 
4.15 The in vitro cytotoxic action of king cobra venom L-amino acid oxidase 
Results in the present study showed that the L-amino acid oxidase purified from 
Malaysian king cobra venom (OH-LAAO) is an extremely potent anti-proliferative 
agent against cancer cells, when compared with LAAO purified from other snake 
venoms including king cobra venom of unknown geographical origin reported by Ahn 
et al. (1997). The IC50 of OH-LAAO against MCF-7, A549, HL-60 and PC-3 cells (0.05 
- 0.15 μg/mL) after 24 h incubation, were 28 to 1000 times more potent than those 
reported non-king cobra snake venom LAAOs (IC50 of 1.4 - 50 μg/mL), and were 3 to 
12 times more potent than that of king cobra venom LAAO reported by Ahn et al. (1997) 
(Table 4.4). This may be due to intra-species variation as king cobras from different 
geographical regions may contain different forms of LAAO. 
Interestingly, OH-LAAO exerts lower cytotoxicity in human non-tumourigenic cell 
lines (184B5 breast and NL 20 lung cells) when compared to their corresponding 
tumourigenic (MCF-7 and A549) cell lines, suggesting a selective cytotoxic property of 
the OH-LAAO against tumourigenic cells. The selectivity of the enzyme’s cytotoxic 
action was demonstrated by the greater extent of cell death in tumourigenic MCF-7 
(31.4%) and A549 (27%) cells than in the corresponding non-tumourigenic 184B5 
(5.5%) and NL 20 (1.5%) cells, respectively as shown by PE-annexin V/7-AAD assay. 
The differential cytotoxicity could be due to the differences in the metabolism of the 
cells as well as the selective binding activity of the enzyme to tumourigenic versus non-
tumourigenic cells. Such selectivity was not seen in standard anti-cancer drugs such as 
doxorubicin. Doxorubicin exerts stronger cytotoxicity against non-tumourigenic lung 
(NL 20) cells than its corresponding tumourigenic (A549) cells, though it was slightly 
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selective against the tumourigenic MCF-7 cells than the corresponding non-
tumourigenic 184B5 cells.  
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Table 4.4: Anti-proliferative activities of some snake venom L-amino acid oxidases 
Venom source 
of LAAO 
Cell line and IC50 (µg/mL, incubation time) Reference 
Ophiophagus 
hannah 
(Malaysia) 
Human breast adenocarcinoma (0.05 µg/mL, 24 h) 
Human lung  adenocarcinoma (0.09 µg/mL, 24 h) 
Human prostate adenocarcinoma (0.08 µg/mL, 24 h) 
Human promyelocytic leukaemia (0.15 µg/mL, 24 h) 
This work 
Ophiophagus 
hannah 
(Unknown 
geographical 
origin) 
Murine melanoma B16/F10     (0.17 µg/mL, 24 h) 
Human fibrosarcoma HT-1080  (0.60 µg/mL, 24 h) 
Chinese hamster ovary cells       (0.30 µg/mL, 24 h) 
Murine epithelial cells Balb/3T3 (0.45 µg/mL, 24 h) 
(Ahn et al., 
1997) 
Bungarus 
fasciatus 
Human lung cancer A549    (24.00 µg/mL, 12 h) (Wei et al., 
2009) 
Agkistrodon 
acutus 
Human lung cancer A549   (10.00 µg/mL, 24 h) (Zhang and 
Cui, 2007) 
Agkistrodon 
acutus  
(ACTX-8) 
Human cervical Hela     (10.00 µg/mL, 48 h) (Zhang and 
Wei, 2007) 
Trimeresurus 
flavoviridis 
Rat glioma C6    (1.90 µg/mL, 48 h) 
Human malignant glioma RBR 17T  (2.48 µg/mL, 48 
h) 
Human malignant glioma U251   (2.10 µg/mL, 48 h) 
(Sun et al., 
2003) 
Bothrops atrox Human leukaemia HL60      (~50.00 μg/mL, 24 h) 
Jurkat     (~ 25.00 μg/mL, 24 h) 
Murine melanoma B16F10  (~25.00 μg/mL, 24 h) 
Rat pheochromocytoma PC12    (~25.00 μg/mL, 24 h) 
(Alves et al., 
2008) 
Bothrops 
leucurus 
Human gastric carcinoma MKN-45 (25.00 μg/mL or 
0.41µM, 24 h) 
Human colon carcinoma RKO (2.40 μg/mL or 0.04 
µM, 24 h) 
Human fibroblasts LL-24 (23.17 µg/mL or 0.38 µM, 
24 h) 
Human adenocarcinoma HUTU (9.15 µg/mL or 0.15 
µM, 24 h) 
(Naumann et 
al., 2011) 
Bothrops 
moojeni 
Ehrlich ascites tumour cells (5.00 µg/mL, 1 h) (Stábeli et 
al., 2007) 
Trimeresurus 
stejnegeri 
Human T cell leukaemia cells (C8166) (1.44 µg/mL or 
24 nM, 72 h) 
(Zhang et al., 
2003) 
Bothrops 
marajoensis 
Murine macrophages ( > 200.00 µg/mL, 24 h) (Torres et al., 
2010) 
Lachesis muta Human gastric adenocarcinoma AGS (22.70 µg/mL, 
24 h) 
Human breast adenocarcinoma MCF-7 (1.41 µg/mL, 
24 h) 
(Bregge-
Silva et al., 
2012) 
Agkistrodon 
acutus  
(ACTX-6) 
Human lung cancer A549 (20.00 µg/mL, 24h) (Zhang and 
Wu, 2008) 
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Snake venom LAAOs have been shown to induce apoptosis in cancer cells (Alves et al., 
2008; Ande et al., 2006; Braga et al., 2008; Alves et al., 2011; Sun et al., 2003; Zhang 
and Wei, 2007). Recent study demonstrated an increase in caspase-3/7 activities in OH-
LAAO treated cells, suggesting that the cytotoxic action of OH-LAAO is also due to the 
enzyme-induced apoptosis in the treated cells. The results showed clearly that for all 6 
cell lines tested, caspase-3/7 activities were significantly increased over the basal level 
of the control cells. The formation of typical DNA fragments of oligonucleosomal size 
of about 180 - 200 bp by cleavage of the inhibitor of the caspase-activated DNase 
(ICAD) is one of the biochemical hallmarks of apoptosis in many cells (Bortner et al., 
1995; Janicke, 2009). The formation of DNA fragments were also observed in the 
present study. Apparently, activation of caspase-3/7 leads to the typical DNA 
fragmentation pattern as observed on the agarose gel electrophoresis. The apoptotic 
mode of cell death was further demonstrated by surface externalization of membrane 
phospholipid phosphatidylserine (PS) using PE-Annexin V/7-AAD assay, in which 
increase of cells undergoing early and late apoptosis were detected. The increase in 
caspase-3/7 activities, surface externalization of membrane phospholipid 
phosphatidylserine (PS), and the formation of fragmented DNA in king cobra venom 
LAAO-treated cells all strongly supported that the enzyme exerts its cytotoxic action 
via induction of apoptosis. 
It is well established that snake venom LAAOs induced cytotoxicity by the H2O2 
liberated as a result of oxidative deamination reaction of the enzyme (Tan and Fung, 
2009). This is also confirmed in the case of OH-LAAO, as the presence of catalase (a 
H2O2 scavenger), effectively reduced the cytotoxicity of the enzyme. This finding is in 
agreement with the suggestions by several other authors (Alves et al., 2008; Alves et al., 
2011; Samel et al., 2006; Stábeli et al., 2007; Sun et al., 2003; Zhang and Wei, 2007; 
Zhang and Cui, 2007). 
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Apoptosis is initiated via two pathways: the extrinsic (death receptor-mediated) and 
intrinsic (mitochondria-mediated) apoptosis pathways. The extrinsic pathway is 
activated upon the binding of ligands to membrane death receptors, leading to activation 
of caspase-8 and the downstream procaspase-3, which eventually triggers cell execution 
(Crow et al., 2004). The intrinsic pathway involves loss of mitochondrial membrane 
potential, release of cytochrome c and other apoptogens into the cytosol and leading to 
procaspase-9 activation, which subsequently triggers the execution-phase of cell 
apoptosis by activating the effector procaspase-3 (Arya et al., 2007; Crow et al., 2004). 
Regardless of pathway initiated, both will eventually converge and activate the 
execution-phase of cell apoptosis (Lee et al., 2011). 
Zhang and Wei (2007) reported that the cytotoxic action of LAAO isolated from 
Agkistrodon acutus snake venom involved activation of caspase-3 and -9, and that the 
apoptosis was accompanied by the release of cytochrome c, indicating involvement of 
the intrinsic pathway. Similarly, Alves et al. (2008) reported the induction of caspase-9 
and caspase-3 in the cytotoxic action of B. atrox LAAO, again supporting the intrinsic 
pathway of apoptosis.  On the other hand, Zhang and Cui (2007) reported that ACTX-6, 
a LAAO isolated from Agkistrodon acutus snake venom, could increase the activities of 
caspases-3, -8 and -9 in ACTX-6 treated cells. They also reported that the enzyme could 
induce mitochondrial-dependent apoptosis via regulations of Fas and FasL expression at 
the transcriptional level, suggesting the involvement of both intrinsic and extrinsic 
pathways of apoptosis.  
In the same way, king cobra venom LAAO-induced apoptosis involve activation of 
caspase-8 and -9, supporting the involvement of both intrinsic and extrinsic apoptosis 
pathways. In addition, significantly increase expression levels of cytochrome c in both 
cytosolic and mitochondria fractions were also detected after 72 h treatment period. 
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This may due to the possibility that the initial leakage of cytochrome c itself acts as the 
feedback regulator that triggers the synthesis of this mitochondrial protein (Sanchez et 
al., 2001). Alternatively, it is possible that the synthesis and enrichment of the 
mitochondrial cytochrome c is the primary event that facilitates the release of 
cytochrome c into the cytosol (Sanchez et al., 2000; Sanchez et al., 2001). Nevertheless, 
these results are consistent with the involvement of both extrinsic and intrinsic 
pathways of apoptosis. 
The apoptosis induced by OH-LAAO may be related to its action in releasing high local 
levels of H2O2 in the cancer cells. Ali et al. (2000) suggested that LAAOs can bind 
directly to the cell surface and generate a high concentration of H2O2 locally. Suhr and 
Kim (1996) and Torii et al. (1997) using fluorescence microscopy method demonstrated 
that the enzyme accumulated or bind to the cell surface and generate a high local 
concentration of H2O2. Similar mechanism presumably also occurs in the cytotoxic 
action of OH-LAAO, in view of its very high cytotoxic potency, as the amount of H2O2 
generated by the minute amount of OH-LAAO would be too little to have any 
significant direct cytotoxic effect if the H2O2 is evenly distributed in the medium. 
Earlier, Ande et al. (2006) reported that the LAAO purified from Calloselasma 
rhodostoma venom induced cell death in Jurkat cells by necrosis caused by the 
generated H2O2 in the medium, and that apoptosis occurred only when the H2O2 
concentration was lowered in the presence of catalase.  
The apparent discrepancy regarding the cause of cell death induced by different LAAOs 
(whether apoptosis induced by local high concentration of H2O2 or necrosis by direct 
action of H2O2 in the medium) can be explained by comparing the cytotoxic potency 
(IC50 values) of the enzymes used. Calloselasma rhodostoma LAAO is a weak 
cytotoxic agent with IC50 of approximately 25 - 50 μg/mL against various cell lines 
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tested (Ande et al., 2006). Therefore, a very large amount of C. rhodostoma LAAO has 
to be used in the cytotoxicity experiments and resulting in a relatively large amount of 
H2O2 being generated in the medium. It was well established that large amounts of H2O2 
can cause cell death by necrosis (Kannan and Jain, 2000). On the other hand, the 
cytotoxic action of king cobra venom LAAO (and many other venom LAAOs) is 
probably more than 250 times stronger than that of C. rhodostoma LAAO and the 
minute amount of H2O2 produced by approximately 0.1 μg/mL of king cobra venom 
LAAO (the amount of the enzyme used in cytotoxicity studies) is very unlikely to be 
able to cause cell necrosis, and hence apoptosis is the sole mechanism of cell death here. 
4.16 In vivo anti-cancer effect of king cobra venom L-amino acid oxidase 
In vivo studies using PC-3 tumour xenograft in nude mice showed that 8 weeks of OH-
LAAO treatment at a dose of 1 μg/g (i.p.) markedly inhibited the growth of the solid 
tumour. The original rationale for choosing the dosage of 1 μg/g OH-LAAO for the in 
vivo anticancer was based on toxicity consideration. Tan and Saifuddin (1989) reported 
that the intravenous (i.v.) LD50 was 5 µg/g in mice. Indeed the 8-weeks treatment of 
OH-LAAO at the chosen dosage did not cause any significant pathological 
abnormalities in the major organs of the treated animals, nor did it cause any body 
weight reduction, compared to the vehicle-treatment mice throughout the treatment 
period. These observations, together with the high IC50 of OH-LAAO determined in 
non-tumourigenic breast and lung cells, strongly suggest that this enzyme is relatively 
non-toxic to normal tissues. These were in the agreement with the findings of Wei et al. 
(2009) and Bregge-Silva et al. (2012). Wei et al. (2009) reported that at dosage up to 50 
μg, Bungarus fasciatus LAAO did not induce significant organ damage including lung, 
heart, kidneys, liver and spleen. Bregge-Silva et al. (2012) reported that 100 μg of 
Lachesis muta LAAO did not cause morphological changes in the heart, lung and 
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kidney tissues. However, Wei et al. (2007) reported that 50 μg of Agkistrodon 
blomhoffii ussurensis LAAO caused severe lung lesions after 6 and 24 h injections. 
The dose of OH-LAAO chosen in the in vivo anti-tumour studies (1 μg/g body weight) 
was estimated to give a theoretical level of LAAO of about 5 μg/mL in the extracellular 
fluid (ECF) of the mice, assuming that ECF was 20% of body weight (Chapman et al., 
2010), if all the injected LAAO were absorbed and distributed throughout the entire 
ECF compartment instantaneously. This level would far exceed the IC50 dose of PC-3 
cells in vitro (0.08 μg/mL). However, it should be noted that absorption of injected 
LAAO is not likely to be instantaneous, and not all injected LAAO would be absorbed. 
Further, a certain quantity of LAAO may be degraded or excreted before it reaches the 
target cells. Also, the rate and ability of the LAAO to permeate the capillary wall and 
penetrate to the tumour cells are likely to be limited. Thus, the exact level of LAAO that 
the tumour cells in the treated mice are exposed to is likely to be much lower than 5 
μg/mL. Nevertheless, at this dose of treatment, the LAAO in the circulation was shown 
to be able to inhibit growth of the tumour effectively, with no visible deleterious effect 
on the major organs nor reducing the body weight of the animals. 
It is well established that many anti-cancer drugs cannot penetrate solid tumour tissue 
efficiently to reach the target cancer cells due to the tumour microenvironment 
(Minchinton and Tannock, 2006). This is particularly so for a large molecules such as 
snake venom LAAOs (with molecular weight of 130 kDa), which possess low diffusion 
coefficient. Present study demonstrated that despite the large molecular size, OH-LAAO 
could effectively inhibit solid tumour growth in vivo. Compared to the control, 
treatment with OH-LAAO caused 39% reduction on PC-3 tumour size in the nude mice 
(P < 0.01) after just one week of treatment. While substantial individual variation in 
anti-tumour effect was observed in the LAAO-treated mice during the 8-weeks 
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treatment, data also demonstrated that OH-LAAO could indeed effectively inhibit 
tumour growth in vivo. The ability of OH-LAAO to effectively inhibit the tumour 
growth is presumably due to its very high cytotoxicity as well as its ability to induce 
apoptotic cell death in the tumour cells as demonstrated by TUNEL staining on tumour 
sections. 
Zhang and Wu (2008) reported that 10 days treatment with 1.5 μg/g of Agkistrodon 
acutus venom LAAO inhibited tumour growth of Hepatoma 22, Sarcoma 180 and 
Ehrlich ascites carcinoma tumours (established in Kun Ming mice) by 21.6%, 12.9% 
and 14.2%, respectively. In contrast, immunocompromised (nude) mice were used in 
this study and the OH-LAAO yielded greater level of growth inhibition, including one 
complete regression after 8-weeks treatment. 
In conclusion, the selective cytotoxic action of OH-LAAO against tumourigenic, in 
contrast to non-tumourigenic cells and its capability to suppress solid PC-3 tumour 
growth in a tumour xenograft mouse model via apoptotic cell death without causing any 
significant toxic effect to the treated-mice suggest that the enzyme has the potential as 
an anti-cancer agent. However, its high molecular weight may hinder its penetration into 
the tumour cells; therefore further development in delivery system may be required. The 
enzyme is probably more effective against cancer cell suspensions such as leukaemias 
and ascites, than in solid tumours. Alternatively, the enzyme could be cloned and 
transfected to tumour cells to induce cell death in situ, an approach suggested by Sun et 
al. (2003). 
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CHAPTER 5 
ALTERATIONS OF GENE EXPRESSIONS LEADING TO CELL DEATH 
INDUCED BY KING COBRA (Ophiophagus hannah) VENOM L-AMINO ACID 
OXIDASE (OH-LAAO) 
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INTRODUCTION 
Gene expression is a process by which the information encoded in the gene is 
transformed into a functional gene product. The gene products are often proteins, but 
some are functional RNAs. Study of gene expression will assist in the understanding of 
cellular regulatory networks that are involved in response to various stimuli by looking 
at the alteration of gene transcription profiles. Analysis of gene expression patterns 
using microarray-based technology have been adopted in cancer research (Cooper, 2001; 
Grant et al., 2004; Kumar et al., 2012). Global gene expression study using microarray 
technology enables simultaneous measurement of the expression of thousands of genes 
in a high-throughput fashion and allows characterization of gene transcription profiles 
which reflect the changes in the biological processes within the cells. 
King cobra venom L-amino acid oxidase (OH-LAAO) has been shown to induce 
apoptosis in various cancer cell lines and the apoptosis induction activity of the enzyme 
is via both intrinsic and extrinsic pathways as demonstrated by increase in caspase-9 
and -8 activities, as well as increased cytochrome c levels in both cytosolic and 
mitochondria fractions in the LAAO-treated cells (Chapter 4). However, the molecular 
mechanism leading to cell death has not been investigated. This chapter describes the 
OH-LAAO induced alterations in gene expression in MCF-7 cells as examined by 
oligonucleotide microarray approach, to provide in-depth understanding of the 
molecular events leading to cell death induced by the enzyme. 
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METHODS 
5.1 RNA samples preparation 
5.1.1 Treatment of cells 
In order to study the relationship between alterations of gene expression and mechanism 
of cell death induced by OH-LAAO, it is necessary to choose a non-toxic treatment 
dose. In this case, IC20 (0.015 µg/mL) was chosen as the dose for the treatment of MCF-
7 cells. Human breast adenocarcinoma cells (MCF-7) were seeded onto 6-well plate and 
incubated overnight in 37 °C humidified incubator for the cells to attach. Cells were 
then treated with 0.015 µg/mL of OH-LAAO for 72 h. 
5.1.2 Total RNA isolation 
Total RNA was extracted using TRIzol
® 
reagent according to the methods of 
Chomczynski and Sacchi (1987) and Chomczynski (1993). In brief, cell culture media 
was removed and the cells were washed twice with PBS. Cells were lysed in one 
millilitre of TRIzol
® 
reagent by pipetting several times. The homogenized sample was 
incubated at room temperature for 5 min for complete dissociation of nucleoprotein 
complex. Chloroform (0.2 mL) was then added, incubated at room temperature for 3 
min and subsequently centrifuged at 12,000 x g for 15 min at 4 °C. After centrifugation, 
the upper aqueous phase was transferred into a new tube. Three units of DNase I were 
added, mixed and incubated at 37 °C for 20 min. Iso-propanol (0.5 mL) was then added 
into the mixture and kept at -20 °C for 30 min. The mixture was centrifuged at 12,000 x 
g for 10 min at 4 °C and the supernatant was decanted. The RNA pellet was washed 
with one millilitre of 75% ice-cold ethanol and centrifuged at 12,000 x g for 5 min. The 
pellet was dried at 37 °C for 10 min and dissolved in nuclease-free water.  
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5.1.3 RNA clean-up 
Isolated RNA was cleaned-up using RNeasy
®
 mini kit according to the methods 
described by the manufacturer (Qiagen, Germany). In brief, volume of RNA was 
adjusted to 100 µL with nuclease-free water prior to RNA clean-up. The RNA sample 
was added with 350 µL of RLT buffer, followed by 250 µL of absolute ethanol and 
mixed well. The sample mixture (700 µL) was transferred into an RNeasy mini spin 
column placed onto the collection tube and centrifuged at 10,000 x g for 15 sec at 25 °C 
and the flow-through was discarded. Washing was performed twice by adding 500 µL 
of RPE buffer and centrifuged at 10,000 x g for 15 sec. Spin column was then placed 
onto the new collection tube and centrifuged at full speed for 1 min to ensure no ethanol 
is carried over during RNA elution. Finally, RNA was eluted by adding 50 µL of 
nuclease-free water into the spin column and spun at 10,000 x g for 1 min.  
5.1.4 Quantitation of RNA 
RNA samples were quantified using Nanodrop, software ND-1000 V3.7.1 (Thermo 
scientific, MA). Two microlitres of nuclease-free water was used as blank and the same 
volume of RNA samples were used for RNA quantitation. RNA samples with OD ratio 
of A260/A280 and A260/A230 greater than 1.8 were considered as good quality RNA 
and further subjected to formaldehyde denaturing agarose gel electrophoresis. 
Formaldehyde denaturing agarose gel electrophoresis was carried out as described in 
general methods (Chapter 2, Section 2.11). 
5.2 Whole-genome gene expression direct hybridization assay 
Oligonucleotide microarray was carried out by direct hybridization assay using 
HumanRef-8 v3.0 Expression BeadChips
® 
(Illumina, San Diego, CA). Each gene chip 
contains more than 22,000 transcript probes. Sample labelling was performed using 
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Illumina
® 
TotalPrep RNA amplification kit (Ambion, US) and the gene chip was 
scanned by Illumina Beadarray reader (Illumina, San Diego, CA).  
5.2.1 First strand cDNA synthesis   
All procedures for cRNA synthesis were carried out according to the protocols 
described by the manufacturer. Reverse transcription master mix was prepared at room 
temperature as follows: 
 
T7 Oligo(dT) primer 1 µL 
10X First strand buffer 2 µL 
dNTP mix 4 µL 
RNase inhibitor 1 µL 
ArrayScript 1 µL 
Reverse transcription master mix (9 µL) was mixed with 11 µL of 350 ng RNA sample. 
Reactions were initiated by incubation at 42 °C for 2 h and hold at 4 °C using PTC-
100
TM
 programmable thermal controller (MJ Research™, Inc., USA). The tubes were 
then placed on ice until preparation for second strand cDNA synthesis is ready.  
5.2.2 Second strand cDNA synthesis   
Master mix for second strand cDNA synthesis was prepared on ice as follows: 
 
Nuclease-free water 63 µL 
10X Second strand buffer 10 µL 
dNTP mix 4 µL 
DNA polymerase 2 µL 
RNase H 1 µL 
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The master mix for second strand cDNA synthesis (80 µL) was mixed with 20 µL of the 
previously synthesized first strand cDNA. Mixtures were incubated in the thermal 
cycler programmed at 16 °C for 2 h and hold at 4 °C. 
5.2.3 Purification of cDNA 
The cDNA binding buffer (250 µL) was mixed with the synthesized cDNA sample. 
Mixtures were then transferred onto cDNA filter cartridge and centrifuging at 10,000 x 
g for 1 min at room temperature. Flow-through was discarded. Subsequently, cDNA 
filter cartridge was washed with 500 µL of the wash buffer by centrifuging at 10,000 x g 
for 1 min. The cDNA filter cartridge was then placed onto the cDNA elution tube and 
20 µL of pre-heated nuclease-free water (55 °C) was applied onto the centre of the 
cDNA filter cartridge. The cDNA filter cartridge was incubated at room temperature for 
5 min and followed by centrifugation at 10,000 x g for 1 min. A volume of approximate 
17.5 µL of double-stranded cDNA was collected. 
5.2.4 In vitro transcription to synthesize biotinylated cRNA 
In vitro transcription master mix was prepared at room temperature as follows: 
 
T7 10X reaction buffer 2.5 µL 
T7 enzyme mix 2.5 µL 
Biotin-NTP mix 2.5 µL 
 
In vitro transcription master mix (7.5 µL) was mixed with 17.5 µL of the purified 
cDNA and incubated in thermal cycler programmed at 37 °C for 14 h and followed by 
hold at 4 °C. The reaction was stopped by adding 75 µL of nuclease-free water. 
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5.2.5 Purification and quantitation of cRNA 
The cRNA binding buffer (350 µL) was mixed with 100 µL of the biotinylated cRNA 
sample. Two hundred fifty microlitres of 100% ethanol was then added into the mixture. 
The mixtures were transferred into the cRNA filter cartridge and centrifuged at 10,000 x 
g for 1 min. Subsequently, cRNA filter cartridge was washed with 650 µL of wash 
buffer by centrifugation at 10,000 x g for 1 min. The flow-through was discarded. One 
hundred microlitres of pre-heated nuclease-free water (55 °C) was applied onto the 
centre of the filter cartridge and the cartridge was incubated at room temperature for 2 
min. Finally, cRNA was collected by centrifugation at 10,000 x g for 2 min. The 
purified cRNA samples were quantified using Nanodrop as described in this chapter 
(Section 5.1.4). 
5.2.6 BeadChip hybridization   
Prior to hybridization, 5 µL of 750 ng cRNA sample was heated at 65 °C for 5 min and 
cooled to room temperature. Ten microlitres of hybridization buffer (HYB) was mixed 
with the pre-heated cRNA sample. Hybridization chamber gasket was assembled into 
the hybridization chamber and the humidifying buffer reservoirs were filled with 200 
µL of humidity control buffer. BeadChip was placed into a hybridization chamber insert 
and 15 µL of the cRNA sample mixtures were loaded onto the centre of the inlet port. 
The hybridization chamber insert containing sample-laden BeadChip was then placed 
into the hybridization chamber. BeadChip hybridization chamber was placed into the 
Illumina hybridization oven (Illumina, San Diego, CA) pre-equilibrated at 58 °C. The 
samples were allowed to hybridize for 18 h at 58 °C.  
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5.2.7 Washing and blocking  
After hybridization, BeadChip hybridization chamber was removed from the 
hybridization oven. BeadChip was submerged into the diluted E1BC wash buffer and 
the cover-seal was removed. BeadChip was then quickly transferred to the slide rack 
and submerged into 250 mL of the E1BC wash buffer. Subsequently, BeadChip was 
incubated for 10 min in 1X high-temperature wash buffer that was pre-heated at 55 °C 
on the previous day in hybex microarray incubation system (SciGene, USA). First room 
temperature wash was performed by submerging the BeadChip into the fresh E1BC 
wash buffer for 10 min with shaking. BeadChip was then washed with 100% ethanol for 
10 min followed by second room temperature wash with E1BC wash buffer for 2 min. 
BeadChip was then incubated in 4 mL of E1 block buffer for 10 min on the wash tray 
that was placed on a rocker mixer.  
5.2.8 Staining and signal detection 
BeadChip was stained with streptavidin-Cy3 (stock of 1 mg/mL) diluted in 2 mL of E1 
block buffer with a 1:1,000 dilution. After staining, third room temperature wash was 
performed by submerging the BeadChip into the E1BC wash buffer for 5 min with 
shaking. BeadChip was then dried by centrifugation at 1,400 rpm for 4 min at room 
temperature and scanned by Illumina BeadArray reader (Illumina, San Diego, CA) at a 
scan factor of 0.6. The primary data was saved as an “idat” file. 
5.2.9 Microarray data analysis 
The initial quality controls (housekeeping, sample labelling, array hybridization, signal 
generation and negative control) of the BeadChip were checked using 
GenomeStudioV2010.1 software (Illumina, San Diego, CA). The generated “txt” file 
was imported and further analysed using GeneSpring GX 11.0 software (Agilent 
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Technologies, Inc., Santa Clara, CA). Those genes that displaying fold-change greater 
than 1.5 and Anova P-value < 0.05 were considered as significantly deregulated genes. 
These genes were classified according to their biological functions as described by Liu 
et al. (2003), using PubMed database provided by National Centre for Biotechnology 
information (NCBI, http://www.ncbi.nlm.nih.gov/). 
5.3 Real-time polymerase chain reaction (RT-PCR) 
In order to validate the microarray results, genes from different biological function 
groups in particularly related to apoptosis, autophagy, cell adhesion/migration, cell 
cycle arrest, heat shock protein, oxidative stress, proteolysis and signalling pathway/ 
signal transduction were chosen for RT-PCR validation (Table 5.1). Newly isolated 
RNA was used for RT-PCR validation, which was performed using TaqMan
®
 gene 
expression assay.  
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Table 5.1: Selected genes for validation of microarray analysis using RT-PCR 
 
Category of gene Gene symbol Gene full name TaqMan
®
 gene 
expression 
assay number 
Apoptosis BMF Bcl2 modifying factor Hs00372937_m1 
IGFBP3 Insulin-like growth factor 
binding protein 3 
Hs00181211_m1 
PLEKHF1 Pleckstrin homology 
domain containing, 
family F member 1 
Hs00759096_s1 
PPARG Peroxisome proliferator-
activated receptor 
gamma 
Hs01115513_m1 
Autophagy SQSTM1 Sequestosome 1 Hs00177654_m1 
Cell 
adhesion/migration 
IGFBP5 Insulin-like growth factor 
binding protein 5 
Hs01052296_m1 
Cell cycle arrest MLF1 Myeloid leukaemia 
factor 1 
Hs00223695_m1 
Heat shock protein HSPD1 Heat shock 60kDa 
protein 1 (chaperonin) 
Hs01036753_g1 
Oxidative stress ANG Angiogenin, 
ribonuclease, RNase A 
family, 5 
Hs04195574_sH 
CYP1A1 Cytochrome P450, 
family 1, subfamily A, 
polypeptide 1 
Hs01054797_g1 
CYP1B1 Cytochrome P450, 
family 1, subfamily B, 
polypeptide 1 
Hs02382916_s 
GPX2 Glutathione peroxidase 2 Hs01591589_m1 
MGST1 Microsomal glutathione 
S-transferase 1 
Hs00220393_m1 
Proteolysis SERPINA3 Serpin peptidase 
inhibitor, clade A (alpha-
1 antiproteinase, 
antitrypsin), member 3 
Hs00153674_m1 
SERPINA5 Serpin peptidase 
inhibitor, clade A (alpha-
1 antiproteinase, 
antitrypsin), member 5 
Hs00167244_m1 
SPINT1 Serine peptidase 
inhibitor, Kunitz type 1 
Hs00173678_m1 
Signalling 
pathway/signal 
transduction 
P2RY6 Pyrimidinergic receptor 
P2Y, G-protein coupled, 
6 
Hs00602548_m1 
TFG TRK-fused gene Hs02832013_g1 
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5.3.1 Reverse transcription of RNA to cDNA  
Reverse transcription was performed using high capacity RNA-to-cDNA™ kit 
according to the manufacturer’s instruction (Applied Biosystems, USA). One 
microgram of the total RNA was used for each 20 µL reaction. Reagents for reverse 
transcription were mixed as follows:  
2X RT buffer 10 µL 
20X RT enzyme mix 1 µL 
RNA + nuclease-free water 9 µL 
 
Reaction was initiated by incubation in PTC-100
™
 programmable thermal controller 
(MJ Research
™
, Inc., USA) programmed at 37 °C for 60 min, followed by 95 °C for 5 
min and hold at 4 °C. Synthesized cDNA for RT-PCR application was stored at -20 °C. 
5.3.2 RT-PCR TaqMan
®
 assay 
The reaction mixtures were mixed as follows: 
2X TaqMan
® 
gene expression master mix 10 µL 
20X TaqMan
®
 gene expression assay 1 µL 
cDNA template (10 ng) + nuclease-free water 9 µL 
 
Amplification was performed at 50 °C for 2 min and 95 °C for 10 min followed by 40 
cycles at 95 °C for 15 sec and 60 °C for 1 min per cycle using StepOnePlus™ RT-PCR 
system (Applied Biosystems, USA). The comparative Ct method was used to determine 
the relative expression between control and treated sample, using beta actin as a 
normalization control.  
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5.4 Measurement of cytochrome P450 activities 
Combination of CYP1A1 and CYP1B1 enzyme activities in the control and LAAO-
treated MCF-7 cells were measured using P450-Glo
™ 
CYP1A1 assay kit according to 
the manufacturer’s instruction (Promega, USA). In brief, MCF-7 cells at the seeding 
density of 1,000 cells per well were seeded onto white-walled 96-well cell culture plate. 
After overnight seeding at 37 °C, cells were treated with OH-LAAO at its IC50 value 
(0.04 µg/mL) for 72 h. Spent medium was replaced with 50 µL of the fresh medium 
containing 100 µM Luciferin-CEE substrate. Cells were incubated for another 3 h at 
37 °C, 5% CO2. Subsequently, an equal volume of reconstituted Luciferin detection 
reagent (50 µL) was added into each well and mixed. The plate was allowed to 
equilibrate at room temperature for 20 min and the luminescence of each sample was 
measured with glomax-multi detection system (Promega, USA). 
5.5 Measurement of intracellular reactive oxygen species (ROS) activity  
Intracellular ROS activity, a parameter to measure intracellular H2O2 level was 
determined using OxiSelect™ intracellular ROS assay kit according to the 
manufacturer’s guidelines (Cell Biolabs, USA). An oxidation sensitive 2’, 7’-
dichlorodihydrofluorescin diacetate (DCFH-DA) method was used in this assay. In brief, 
DCFH-DA is diffused into the cells and deacetylated by cellular esterases to non-
fluorescent 2’, 7’-dichlorodihydrofluorescin (DCFH), which will be rapidly oxidized to 
a highly fluorescent 2’, 7’-dichlorodihydrofluorescein (DCF) by ROS (H2O2) generated 
in the treatment. 
Human breast tumourigenic (MCF-7) cells at the seeding density of 25,000 cells per 
well were seeded onto black-walled 96-well cell culture plate. After overnight 
incubation at 37 °C, medium was removed and the cells were gently washed with PBS. 
Cells were then treated with 100 µL of 1X DCFH-DA solution (diluted in serum-free 
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medium) for 1 h at 37 °C. Medium containing DCFH-DA was discarded and the cells 
were gently washed with PBS. Subsequently, cells were treated with 0.03 µg/mL and 
0.05 µg/mL of OH-LAAO for 24 h. Following treatment, cells were washed with PBS 
and 100 µL of 1X cell lysis buffer (diluted in the medium) was added into each well to 
lyse the cells. Contents of the wells were gently mixed for 5 min in the dark. The 
fluorescent intensity of each sample was measured with glomax-multi detection system 
(Promega, USA) at 460 nm excitation/515-585 nm emission.  
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RESULTS 
5.6 Isolation of RNA 
Total RNA for microarray and RT-PCR analyses were isolated using TRIzol
® 
reagent 
and followed by clean-up with RNeasy
® 
mini columns. The isolated RNA was highly 
purified (OD ratio of A260/A280 and A260/A230 ranged from 1.8 to 2.0, as determined 
by Nanodrop; Table 5.2) as well as of high quality as judged by formaldehyde agarose 
gel electrophoresis (Figure 5.1).  
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Table 5.2: Purity and concentration of the isolated RNA for microarray and RT-PCR 
analyses 
 
RNA Sample 
OD Ratio Concentration 
(µg/mL) A260/A280 A260/A230 
Microarray    
Control sample 1 1.85 2.00 289.00 
Treated sample 1 1.91 1.93 325.00 
Control sample 2 1.90 1.84 277.00 
Treated sample 2 1.94 1.90 302.9 
Control sample 3 2.00 1.91 313.2 
Treated sample 3 1.84 1.93 298.3 
RT-PCR    
Control sample 1 2.02 1.86 258.40 
Treated sample 1 2.02 1.87 267.10 
Control sample 2 1.98 1.85 252.90 
Treated sample 2 1.87 2.02 257.00 
Control sample 3 1.80 1.92 205.80 
Treated sample 3 1.88 1.90 268.80 
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Figure 5.1: Electrophoresis of the isolated RNA on 1.2% denaturing formaldehyde agarose gel. 
Total RNA isolated from MCF-7 cells were separated on 1.2% denaturing formaldehyde 
agarose gel electrophoresis at a constant voltage of 80 V for 20 - 30 min using 1X MOPS 
running buffer. Two distinct bands (28 S and 18 S) for all the RNA samples were clearly seen 
on the gel images. (A) Formaldehyde agarose gel electrophoresis of total RNA isolated for 
microarray analysis. Lane 1: control sample 1; Lane 2: control sample 2; Lane 3: control sample 
3; Lane 4: treated sample 1; Lane 5: treated sample 2; Lane 6: treated sample 3. (B) 
Formaldehyde agarose gel electrophoresis of total RNA isolated for RT-PCR analysis. Lane 1: 
control sample 1; Lane 2: control sample 2; Lane 3: control sample 3; Lane 4: treated sample 1; 
Lane 5: treated sample 2; Lane 6: treated sample 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
28 S 
28 S 
18 S 
18 S 
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5.7 Gene expression analysis of MCF-7 cells treated with LAAO 
5.7.1 Alterations of gene expression profile of MCF-7 cells using microarray 
analysis 
Gene expression analysis was carried out using HumanRef-8 v3.0 Expression 
BeadChip
®
 which contains more than 22,000 transcript probes in each gene chip. 
Changes of 1.5-fold or greater in gene expression (P-value < 0.05) were considered as 
significant. A total of 178 genes showed significant difference in expression following 
OH-LAAO treatment. Of these 178 genes, 84 (47.2%) were down-regulated, and 94 
(52.8%) were up-regulated. Table 5.3 shows the 178 genes and the fold changes as a 
result of OH-LAAO treatment. The 178 genes were classified into 27 categories 
according to their main biological functions: angiogenesis (3 genes), apoptosis (4 genes), 
autophagy (1 gene), carbohydrate metabolism (1 gene), cell adhesion or migration (9 
genes), cell cycle arrest (2 genes), cellular organization (8 genes), detoxification (4 
genes), DNA replication and cell cycle (4 genes), growth factor activity (1 gene), heat 
shock protein (1 gene), heme metabolism (2 genes), hormonal activity (2 genes), 
immune response (7 genes), inflammatory response (4 genes), ion or molecule transport 
(16 genes), lipid metabolism (5 genes), nervous system (9 genes), nucleic acid 
metabolism (1 gene), osteomuscular system (4 genes), oxidative stress (4 genes), 
oxidoreductase activity (4 genes), protein synthesis, modification and transport (9 
genes), proteolysis (9 genes), signalling pathway or signal transduction (16 genes), 
steroid metabolism (3 genes), and others (45 genes).  
Genes that are related to cytotoxic action of OH-LAAO include 27 genes found in the 
following categories: apoptosis, autophagy, cell cycle arrest, DNA replication and cell 
cycle, heat shock protein, oxidative stress, proteolysis and signalling pathway or signal 
transduction.  
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Among these genes, the following genes which have been reported as pro-apoptotic 
regulator were grouped under categories of apoptosis, heat shock protein and signalling 
pathway or signal transduction: Bcl-2 modifying factor, insulin-like growth factor 
binding protein 3, pleckstrin homology domain containing (family F), peroxisome 
proliferator-activated receptor gamma, heat shock 60 kDa protein 1, caveolin 1 
(caveolae protein), and pirin. Of these 7 pro-apoptotic genes, 6 were up-regulated and 1 
down-regulated.  
Genes that may be involved in cell death were grouped under categories of cell cycle 
arrest (myeloid leukaemia factor 1, up-regulated, it suppresses cell cycle; cyclin-
dependent kinase inhibitor 2B, which functions to arrest cell cycle progress, down-
regulated), DNA replication and cell cycle (betacellulin, and RET proto-oncogene, 
positively regulate cell cycle, were down-regulated; kruppel-like factor 10 that 
suppresses cell cycle, was up-regulated; dual specificity phosphatise 5, negative 
regulation of cellular proliferation, was down-regulated) and proteolysis (5 protease 
genes were up-regulated and 4 protease inhibitor genes were down-regulated).  
All the four genes that may be involved in oxidative stress were up-regulated: 
cytochrome P450 (families A and B), glutathione peroxidise 2, and microsomal 
glutathione S-transferease. Particularly noteworthy is the 6- to 34-fold up-regulation of 
the two cytochrome P450 family 1 genes, CYP1A1 and CYP1B1, respectively.  
It is also interesting to note that gene sequestosome 1 that is involved in autophagy was 
also up-regulated as a result of OH-LAAO treatment (Table 5.4). 
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Table 5.3: Functional clustering of 178 genes exhibiting 1.5-fold or greater changes in expression in MCF-7 cells following king cobra venom L-amino 
acid oxidase treatment 
 
Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Angiogenesis 
ANG (Angiogenin, 
ribonuclease, RNase A 
family, 5) 
2.5 EPHA2 (Ephrin receptor A2) -1.6 
VEGFA (Vascular 
endothelial growth factor A) 
1.5 
Apoptosis 
BMF (Bcl2 modifying factor) 1.7 
IGFBP3 (Insulin-like growth 
factor binding protein 3) 
2.2 
PLEKHF1 (Pleckstrin 
homology domain containing, 
family F member 1) 
1.9 
PPARG (Peroxisome 
proliferator-activated receptor 
gamma) 
2.5 
    
Autophagy 
SQSTM1 (Sequestosome 1) 
 
1.5 
    
Carbohydrate 
metabolism 
PDK4 (Pyruvate 
dehydrogenase kinase, 
isozyme 4) 
1.5 
    
Cell 
adhesion/migration 
CELSR2 (Cadherin, EGF 
LAG seven-pass G-type 
receptor 2 (flamingo 
homolog, Drosophila) 
-1.8 CLDN9 (Claudin 9) -1.6 CLSTN2 (Calsyntenin 2) 1.6 
IGFBP5 (Insulin-like growth 
factor binding protein 5) 
-1.9 ITGB4 (Integrin, beta 4) -1.5 JUB (Jub, ajuba homolog) -1.5 
LAMA3 (Laminin, alpha 3) 
 
 
2.6 TGM2 (Transglutaminase 2) -1.7 THBS1 (Thrombospondin 1) -1.6 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Cell cycle arrest  
CDKN2B (Cyclin-dependent 
kinase inhibitor 2B (p15, 
inhibits CDK4) 
-1.6 
MLF1 (Myeloid leukaemia 
factor 1) 
1.6 
  
Cellular organization 
GSN (Gelsolin) -1.7 KRT6A (Keratin 6A) -4.1 KRT8 (Keratin 8) -1.5 
KRT80 (Keratin 80) -1.5 KRT81 (Keratin 81) -2.3 KRT86 (Keratin 86) -2.3 
SPTBN1 (Spectrin, beta, non-
erythrocytic 1) 
1.5 TUBB6 (Tubulin, beta 6) -1.6 
  
Detoxification 
ALDH1A3 (Aldehyde 
dehydrogenase 1 family, 
member A3) 
2.8 
ALDH3A1 (Aldehyde 
dehydrogenase 3 family, 
member A1) 
7.5 AOX1 (Aldehyde oxidase 1) -1.5 
UGT1A6 (UDP 
glucuronosyltransferase 1 
family, polypeptide A6) 
3.2 
    
DNA replication and 
cell cycle 
BTC (Betacellulin) -1.5 
DUSP5 (Dual specificity 
phosphatase 5) 
-1.9 
KLF10 (Kruppel-like factor 
10) 
 
1.5 
RET (Ret proto-oncogene) -1.8   
  
Growth factor 
activity 
GDF15 (Growth 
differentiation factor 15) 
 
1.6 
  
  
Heat shock protein 
HSPD1 (Heat shock 60kDa 
protein 1 (chaperonin) 
1.5   
  
Heme metabolism  FECH (Ferrochelatase) 1.6 
HMOX1 (Heme oxygenase 
(decycling) 1) 
1.7   
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Hormonal activity 
DIO2 (Deiodinase, 
iodothyronine, type II) 
-2.2 
TFF3 (Trefoil factor 3, 
intestinal) 
-1.7 
  
Immune response 
C20orf114 (Chromosome 20 
open reading frame 114) 
3.8 IL4R (Interleukin 4 receptor) -1.5 
IRF1 (Interferon regulatory 
factor 1) 
1.6 
LGALS3BP (Lectin, 
galactoside-binding, soluble, 
3 binding protein) 
1.5 
PTGER4 (Prostaglandin E 
receptor 4 (subtype EP4) 
2.2 
S100A14 (S100 calcium 
binding protein A14) 
-2.4 
SUSD2 (Sushi domain 
containing 2) 
-1.6     
Inflammatory 
response 
ANXA1 (Annexin A1) -2.8 
S100A13 (S100 calcium 
binding protein A13) 
-1.7 
S100A8 (S100 calcium 
binding protein A8) 
-2.1 
S100A9 (S100 calcium 
binding protein A9) 
-1.6     
Ion or molecule 
transport 
ABCG1 (ATP-binding 
cassette, sub-family G 
(WHITE), member 1) 
-1.5 
ABCG2 (ATP-binding 
cassette, sub-family G 
(WHITE), member 2) 
1.6 
CLIC3 (Chloride intracellular 
channel 3) 
-1.9 
KCNK2 (Potassium channel, 
subfamily K, member 2) 
1.7 LCN2 (Lipocalin 2) 1.7 MCOLN2 (Mucolipin 2) 1.5 
OSTalpha (Organic solute 
transporter alpha) 
1.5 
S100A16 (S100 calcium 
binding protein A16) 
-2.0 
S100A6 (S100 calcium 
binding protein A6) 
-1.5 
SLC25A29 (Solute carrier 
family 25) 
-1.5 
SLC3A2 (Solute carrier 
family 3) 
2.0 
SLC44A1 (Solute carrier 
family 44, member 1) 
1.6 
SLC7A11  
(solute carrier family 7 
(anionic amino acid 
transporter light chain) 
1.8 
SLC7A5  
(solute carrier family 7 
(amino acid transporter light 
chain, L system), member 5) 
2.5 
SLCO2A1 (Solute carrier 
organic anion transporter 
family, member 2A1) 
-1.8 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Ion or molecule 
transport 
STRA6 (Stimulated by 
retinoic acid gene 6 homolog) 
1.9     
Lipid metabolism 
ACOT11 (Acyl-CoA 
thioesterase 11) 
1.7 
ACOX2 (Acyl-CoA oxidase 
2, branched chain) 
-1.7 
DEGS2 (Degenerative 
spermatocyte homolog 2, 
lipid desaturase) 
-1.7 
SCD (Stearoyl-CoA 
desaturase (delta-9-
desaturase) 
-1.8 
SREBF1 (Sterol regulatory 
element binding transcription 
factor 1) 
-1.6 
  
Nervous system 
AHNAK (AHNAK 
nucleoprotein) 
-1.6 
FAM5B (Family with 
sequence similarity 5, 
member B) 
-1.5 
GABBR2 (Gamma-
aminobutyric acid (GABA) B 
receptor, 2) 
-1.6 
GLDN (Gliomedin) 2.6 
GM2A (GM2 ganglioside 
activator) 1.5 
NAB2 (NGFI-A binding 
protein 2 (EGR1 binding 
protein 2) 
-1.7 
NAV2 (Neuron navigator 2) -2.9 
NEDD9 (Neural precursor 
cell expressed, 
developmentally down-
regulated 9) 
1.9 
PCP4 (Purkinje cell protein 
4) 
-1.6 
Nucleic acid 
metabolism 
PRPS1 (Phosphoribosyl 
pyrophosphate synthetase 1) 
1.7 
    
Osteomuscular 
system 
 
BMP1 (Bone morphogenetic 
protein 1) 
-1.6 MGP (Matrix Gla protein) -3.6 
PNKD (Paroxysmal 
nonkinesigenic dyskinesia) 
-1.7 
TMSB4X (Thymosin beta 4, 
X-linked) 
 
 
-1.6 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Others 
AGR2 (Anterior gradient 
homolog 2) 
-1.9 
ANKRD29 (Ankyrin repeat 
domain 29) 
2.3 
ASS1 (Argininosuccinate 
synthase 1) 
-1.7 
C15orf48 (Chromosome 15 
open reading frame 48) 
-2.1 C1orf112 (Chromosome 1 
open reading frame 112) 
1.6 
C1QTNF6 (C1q and tumor 
necrosis factor related protein 
6) 
-1.5 
C20orf186 (Chromosome 20 
open reading frame 186) 
1.7 
C9orf61 (Chromosome 9 
open reading frame 61) 
-1.6 
CCDC83 (Coiled-coil domain 
containing 83) 
-1.9 
EPS8L1 (EPS8-like 1) -1.6 
FAM105A (Family with 
sequence similarity 105, 
member A) 
1.7 
FAM123A (Family with 
sequence similarity 123A) 
2.2 
FAM174B (Family with 
sequence similarity 174, 
member B) 
2.0 
FTHL11 (Ferritin, heavy 
polypeptide-like 11) 
1.7 
FTHL12 (Ferritin, heavy 
polypeptide-like 12) 
1.5 
FTHL2 (Ferritin, heavy 
polypeptide-like 2) 
1.6 
FTHL3P (Ferritin, heavy 
polypeptide 1 pseudogene 3) 
1.7 
H19 (H19, imprinted 
maternally expressed 
transcript) 
-2.8 
HS3ST3A1 (Heparan sulfate 
(glucosamine) 3-O-
sulfotransferase 3A1) 
-1.7 
IER5L (Immediate early 
response 5-like) 
-1.5 LACTB (Lactamase, beta) 1.6 
LMCD1 (LIM and cysteine-
rich domains 1) 
2.1 
LRIG3 (Leucine-rich repeats 
and immunoglobulin-like 
domains 3) 
1.5 
LYPD1 (LY6/PLAUR 
domain containing 1) 
 
-1.4 
MEST (Mesoderm specific 
transcript homolog) 
 
1.6 
MSMB (Microseminoprotein, 
beta) 
-1.5 
MYEOV (Myeloma 
overexpressed) 
-1.9 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Others 
NBPF1 (Neuroblastoma 
breakpoint family, member 1) 
 
2.1 OXTR (Oxytocin receptor) -1.5 PLAC1 (Placenta-specific 1) -1.7 
PPL (Periplakin) -1.5 
RAI14 (Retinoic acid induced 
14) 
1.7 
RHOBTB3 (Rho-related BTB 
domain containing 3) 
-1.5 
SAT1 (Spermidine/spermine 
N1-acetyltransferase 1) 
1.5 
SCUBE2 (Signal peptide, 
CUB domain, EGF-like 2) 
1.8 SELL (Selectin L) 2.5 
SERTAD4 (SERTA domain 
containing 4) 
-1.5 
SH3BGRL2 (SH3 domain 
binding glutamic acid-rich 
protein like 2) 
1.5 
SPOCK1 (Sparc/osteonectin, 
cwcv and kazal-like domains 
proteoglycan) 
-2.1 
TFPI (Tissue factor pathway 
inhibitor (lipoprotein-
associated coagulation 
inhibitor) 
1.7 
TLE6 (Transducin-like 
enhancer of split 6 (E(sp1) 
homolog, Drosophila) 
1.5 
TMTC3 (Transmembrane and 
tetratricopeptide repeat 
containing 3) 
1.5 
TSKU (Tsukushin) 3.0 
VTCN1 (V-set domain 
containing T cell activation 
inhibitor 1) 
2.1 
ZNF365 (Zinc finger protein 
365) 
-1.8 
Oxidative stress 
CYP1A1 (Cytochrome P450, 
family 1, subfamily A, 
polypeptide 1) 
33.9 
CYP1B1 (Cytochrome P450, 
family 1, subfamily B, 
polypeptide 1) 
6.1 
GPX2 (Glutathione 
peroxidase 2 
(gastrointestinal) 
2.2 
MGST1 (Microsomal 
glutathione S-transferase 1) 
1.5     
Oxidoreductase 
activity 
DHRS3 
(Dehydrogenase/reductase 
(SDR family 3) 
2.7 
LOXL1 (Lysyl oxidase-like 
1) 
-1.6 
NQO1 (NAD(P)H 
dehydrogenase, quinone 1) 
2.0 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Oxidoreductase 
activity 
TXNRD1 (thioredoxin 
reductase 1) 
2.5     
Protein synthesis, 
modification and 
transport 
ELF5 (E74-like factor 5 (ets 
domain transcription factor) 
2.0 
FHL2 (Four and a half LIM 
domains 2) 
-1.5 
PARP4 (Poly (ADP-ribose) 
polymerase family, member 
4) 
 
1.7 
RAB31 (RAB31, member 
RAS oncogene family) 
-1.5 
RNASE4 (Ribonuclease, 
RNase A family, 4) 
1.7 
ST3GAL1 (ST3 beta-
galactoside alpha-2,3-
sialyltransferase 1) 
1.7 
TIPARP (TCDD-inducible 
poly(ADP-ribose) 
polymerase) 
2.3 UPK3B (Uroplakin 3B) 1.7 
XPOT (Exportin, tRNA 
(nuclear export receptor for 
tRNAs) 
1.5 
Proteolysis 
ADAM19 (ADAM 
metallopeptidase domain 19) 
1.7 
APH1B (Anterior pharynx 
defective 1 homolog B) 
1.5 LXN (Latexin) 2.2 
OTUB2 (OTU domain, 
ubiquitin aldehyde binding 2) 
1.5 
SCPEP1 (Serine 
carboxypeptidase 1) 
1.5 
SERPINA1 (Serpin peptidase 
inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), 
member 1) 
-1.7 
SERPINA3 (Serpin peptidase 
inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), 
member 3) 
-1.9 
SERPINA5 (Serpin peptidase 
inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), 
member 5) 
-1.6 
SPINT1 (Serine peptidase 
inhibitor, Kunitz type 1) 
-1.6 
Signalling 
pathway/signal 
transduction 
 
AHRR (Aryl-hydrocarbon 
receptor repressor) 
1.5 
ARHGDIB (Rho GDP 
dissociation inhibitor (GDI) 
beta) 
 
 
-1.8 CALML5(Calmodulin-like 5) -2.3 
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Category of gene Gene name 
Fold 
change 
Gene name 
Fold 
change 
Gene name 
Fold 
change 
Signalling 
pathway/signal 
transduction 
 
CAV1 (Caveolin 1, caveolae 
protein, 22kDa) 
-1.8 
DKK1 (Dickkopf homolog 1 
(Xenopus laevis) 
-1.5 
FLRT3 (Fibronectin leucine 
rich transmembrane protein 
3) 
1.9 
GPER (G protein-coupled 
estrogen receptor 1) 
-1.5 
GPR126 (G protein-coupled 
receptor 126) 
-1.7 
P2RY6 (Pyrimidinergic 
receptor P2Y, G-protein  
coupled, 6) 
1.7 
PANX2 (Pannexin 2) 1.8 
PIR (Pirin, iron-binding 
nuclear protein) 
1.5 
PMEPA1 (Prostate 
transmembrane protein, 
androgen induced 1) 
-1.7 
RAP1GAP (RAP1 GTPase 
activating protein) 1.5 
S100A10 (S100 calcium 
binding protein A10) 
-1.5 
SIPA1L2 (Signal-induced 
proliferation-associated 1 like 
2) 
1.5 
TFG (TRK-fused gene) 
1.7 
 
    
Steroid metabolism 
AKR1C2 (Aldo-keto 
reductase family 1, member 
C2 (dihydrodiol 
dehydrogenase 2; bile acid 
binding protein; 3-alpha 
hydroxysteroid 
dehydrogenase, type III) 
2.7 
AKR1C3 (Aldo-keto 
reductase family 1, member 
C3 (3-alpha hydroxysteroid 
dehydrogenase, type II) 
3.2 
UGT2B7 (UDP 
glucuronosyltransferase 2 
family, polypeptide B7) 
2.3 
Genes with significantly changes in expression are classified into 27 categories according to their main biological function. Fold change values that are negative 
indicate down-regulation, while positive values indicate up-regulation, i.e, increase in expression in relative to the control cells. Data were obtained from triplicate 
analyses (n = 3). 
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Table 5.4: Summary of 27 genes involved in the cytotoxic action of king cobra venom L-amino acid oxidase 
Gene name/ Category of gene Function 
Fold change 
 
Apoptosis   
BMF (Bcl2 modifying factor) Bind to Bcl2 proteins and function as an apoptotic activator 1.7 
IGFBP3 (Insulin-like growth factor binding protein 3) Positive regulation of apoptotic process 2.2 
PLEKHF1 (Pleckstrin homology domain containing, family F 
member 1) 
Induce apoptosis via lysosomal-mitochondrial pathway 1.9 
PPARG (Peroxisome proliferator-activated receptor gamma) 
 
Activation of cysteine-type endopeptidase activity involved in 
apoptosis 
2.5 
   
Autophagy   
SQSTM1 (Sequestosome 1) Facilitate protein degradation by autophagy 1.5 
   
Cell cycle arrest   
CDKN2B (Cyclin-dependent kinase inhibitor 2B (p15, inhibits 
CDK4) 
Cell growth regulator that inhibits cell cycle G1 progression -1.6 
MLF1 (Myeloid leukaemia factor 1) 
 
Suppress CDKN1B/p27Kip1 progression and induces cell cycle 
arrest 
1.6 
   
DNA replication and cell cycle   
BTC (Betacellulin) Promotes cell proliferation -1.5 
DUSP5 (Dual specificity phosphatase 5) Negative regulation of cellular proliferation and differentiation -1.9 
KLF10 (Kruppel-like factor 10) Acts as transcriptional repressor and inhibits growth of cancer 
cells 
1.5 
RET (RET proto-oncogene) Positive regulations of cell cycle  -1.8 
   
Heat shock protein   
HSPD1 (Heat shock 60kDa protein 1 (chaperonin) Involve in caspase-3 maturation 1.5 
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Table 5.4, continued   
Gene name/ Category of gene Function 
Fold change 
 
Oxidative stress   
CYP1A1 (Cytochrome P450, family 1, subfamily A, 
polypeptide 1) 
Enhances the oxidative stress by producing ROS 33.9 
CYP1B1 (Cytochrome P450, family 1, subfamily B, 
polypeptide 1) 
Enhances the oxidative stress by producing ROS 6.1 
GPX2 (Glutathione peroxidase 2 (gastrointestinal) Response to oxidative stress 2.2 
MGST1 (Microsomal glutathione S-transferase 1) Response to oxidative stress 1.5 
   
Proteolysis   
ADAM19 (ADAM metallopeptidase domain 19) Involves in membrane protein ectodomain proteolysis 1.7 
APH1B (Anterior pharynx defective 1 homolog B) Functions in membrane protein intracellular domain proteolysis 1.5 
LXN (Latexin) Acts as protease 2.2 
OTUB2 (OTU domain, ubiquitin aldehyde binding 2) Involves in proteolysis 1.5 
SCPEP1 (Serine carboxypeptidase 1) Involves in proteolysis 1.5 
SERPINA1 (Serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 1) 
Acts as protease inhibitor -1.7 
SERPINA3 (Serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 3) 
Negative regulation of proteolysis -1.9 
SERPINA5 (Serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 5) 
Inhibits protease activity -1.6 
SPINT1 (Serine peptidase inhibitor, Kunitz type 1) Protease inhibitors -1.6 
   
Signalling pathway/signal transduction   
CAV1 (Caveolin 1, caveolae protein, 22kDa) Involve in apoptotic signaling pathway -1.8 
PIR (Pirin, iron-binding nuclear protein) Modulation of NFκB pathway 1.5 
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5.7.2 Verification of microarray gene expression data using RT-PCR 
A total of 18 genes with altered expression from the various biological function groups 
were subjected to RT-PCR for validation, using TaqMan
®
 gene expression assay. The 
selected genes were ANG (angiogenin, ribonuclease, RNase A family, 5), BMF (Bcl2 
modifying factor), CYP1A1 (cytochrome P450, family 1, subfamily A, polypeptide 1), 
CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1), GPX2 (glutathione 
peroxidase 2), HSPD1 (heat shock 60 kDa protein 1), IGFBP3 (insulin-like growth 
factor binding protein 3), IGFBP5 (insulin-like growth factor binding protein 5), 
MGST1 (microsomal glutathione S-transferase 1), MLF1 (myeloid leukaemia factor 1), 
P2RY6 (pyrimidinergic receptor P2Y, G-protein coupled, 6), PLEKHF1 (pleckstrin 
homology domain containing, family F member 1), PPARG (peroxisome proliferator-
activated receptor gamma), SERPINA3 (serpin peptidase inhibitor, clade A Alpha-1 
antiproteinase, antitrypsin, member 3), SERPINA5 (serpin peptidase inhibitor, clade A 
alpha-1 antiproteinase, antitrypsin, member 5), SPINT1 (serine peptidase inhibitor, 
Kunitz type 1), SQSTM1 (sequestosome 1) and TFG (TRK-fused gene). 
The relative expression of each gene was obtained by comparative Ct method after 
normalizing against the beta actin as internal control. Figure 5.2 shows the expression 
patterns of the selected 18 genes using RT-PCR, as compared to that determined by 
microarray analysis. The highest expression of genes was CYP1A1, with the fold-
change of 29.0 and 33.9 as determined by RT-PCR and microarray, respectively. The 
results show that the expression patterns and the fold-change determined by the two 
approaches are in agreement and comparable to each other, thereby validating the 
microarray analysis. 
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Figure 5.2: Expression patterns of the selected 18 genes determined by microarray and RT-PCR. RT-PCR was performed in triplicate and the results 
were expressed as fold-change ± S.D.  
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5.8 Intracellular reactive oxygen species (ROS) activity induced by king cobra 
venom L-amino acid oxidase 
To further investigate the involvement of H2O2 or ROS in the cytotoxic action of OH-
LAAO, intracellular ROS level in LAAO- and vehicle-treated MCF-7 cells were 
determined. MCF-7 cells pre-loaded with DCFH-DA were treated with two different 
concentrations of OH-LAAO: IC20 (0.03 µg/mL) and IC50 (0.05 µg/mL) for 24 h. The 
fold-change of the ROS activity in LAAO-treated cells was determined in relative to the 
control (PBS-treated) cells. As shown in Figure 5.3, OH-LAAO treatment significantly 
increased the intracellular ROS activity in the MCF-7 cells: the intracellular ROS 
activity in the cells treated with 0.03 µg/mL and 0.05 µg/mL of OH-LAAO increased by 
2.7- and 4.2-fold, respectively.  
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Figure 5.3: Intracellular reactive oxygen species (ROS) activity in MCF-7 cells treated with 
king cobra venom L-amino acid oxidase. The MCF-7 cells pre-loaded with DCFH-DA were 
treated with IC20 (0.03 µg/mL) and IC50 (0.05 µg/mL) of OH-LAAO for 24 h. The fluorescent 
intensity of each sample was measured at the excitation wavelength of 460 nm and emission 
wavelength of 515 - 585 nm. Results were expressed as fold-change in relative to the control. 
Error bars indicate the S.D of three independent experiments. Statistical analysis was performed 
using one-way ANOVA, followed by Tukey’s post hoc multiple comparison test. * P < 0.05 in 
the LAAO-treated versus control cells. 
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5.9 Enzyme activities of CYP1A1 and CYP1B1 in king cobra venom LAAO-
treated cells 
Total activities of CYP1A1 and CYP1B1 in king cobra venom LAAO-treated cells were 
determined using P450-Glo
™ 
CYP1A1 assay kit. The luminescence of each sample was 
measured after 72 h treatment with 0.04 µg/mL (IC50) of OH-LAAO. As shown in 
Figure 5.4, the combination of CYP1A1 and CYP1B1 enzyme activities in LAAO-
treated cells were 2.3-fold greater than that in the vehicle-treated cells (P < 0.05).  
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Figure 5.4: Total CYP1A1 and CYP1B1 activities in MCF-7 cells treated with king cobra 
venom L-amino acid oxidase. Cells were treated with 0.04 µg/mL of OH-LAAO for 72 h. The 
enzymes activities were determined using P450-Glo
™ 
CYP1A1 assay kit (n = 3). The fold-
change of the control is 1 and the error bar indicates the S.D. * P < 0.05 in the LAAO-treated 
versus control cells. 
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DISCUSSION 
Snake venom LAAOs have been shown to induce apoptosis in various cancer cells (Ahn 
et al., 1997; Braga et al., 2008; Alves et al., 2011; Samel et al., 2006, see also chapter 
4). Zhang and Cui (2007) reported that ACTX-6, a LAAO isolated from Agkistrodon 
acutus venom, could increase the activities of caspase-3, -8 and -9 in ACTX-6 treated 
cells, suggesting that both pathways of apoptosis are involved. In chapter 4, we also 
demonstrated that caspase-8 and -9 activities were significantly increased in LAAO-
treated MCF-7 cells, indicating that OH-LAAO also mediates its cytotoxicity via both 
intrinsic and extrinsic apoptosis pathways.  
It has been established that the apoptosis is the result of LAAO-induced oxidative stress 
(Tan and Fung, 2009). Under normal physiological conditions, cells maintain redox 
homeostasis through generation and elimination of reactive oxygen/nitrogen species. 
The presence of high levels of exogenous H2O2 liberated by LAAO could result in 
oxidative stress to the cell, which may disrupt the redox homeostasis, causing apoptosis 
(Kannan and Jain, 2000; Trachootham et al., 2008). What then are the molecular events 
triggered by the oxidative stress that lead to activation of apoptosis?  
In the present study, the OH-LAAO induced alterations in gene expression in MCF-7 
cells was investigated by oligonucleotide microarray approach, to provide deeper 
understandings of the molecular events leading to cell deaths induced by the enzyme. 
Microarray analysis showed that the oxidative stress induced by H2O2 liberated during 
the enzymatic reaction of OH-LAAO resulted in the alterations of expression of 178 
genes, out of which at least 27 genes are involved in apoptosis and cell death (Table 
5.4). Half (14 out of 27) of these gene expression alterations were also validated by RT-
PCR (Comparing Table 5.4 and Figure 5.2). The 27 genes with altered expressions are 
as follows: 
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 Four genes related to the activation of apoptosis, including Bcl-2 modifying 
factor (BMF), insulin-like growth factor binding protein 3 (IGFBP3), pleckstrin 
homology domain containing family F (PLEKHF1) and peroxisome proliferator-
activated receptor gamma (PPARG) were up-regulated. The involvement of 
BMF and PLEKHF1 also suggest the involvement of mitochondria-mediated 
pathway. 
 Heat shock 60 kDa protein 1 (HSPD1), which is involved in caspase-3 
maturation, was up-regulated and indicative of activation of apoptosis. 
 Caveolin 1 (CAV1) and pirin (PIR) genes are involved in apoptotic signalling 
pathway and modulation of NFκB pathway, respectively. Down-regulation of 
CAV1 is indicative of negative regulation of apoptosis, while up-regulation of 
PIR is indicative of involvement of NFκB pathway in apoptosis. 
 Cyclin-dependent kinase inhibitor 2B (CDKN2B) and myeloid leukaemia factor 
1 (MLF1), the two genes that are involved in cell cycle arrest, was down- and 
up-regulated, respectively. The former (CDKN2B) was cell growth regulator 
that inhibits cell cycle G1 progression, while the later functions in induction of 
cell cycle arrest. The down-regulation of CDKN2B gene promotes cell 
proliferation. The up-regulation of MLF1 gene that is involved in cell cycle 
arrest was reflective of cell death event. 
 Four genes that are involved in DNA replication and cell cycle: betacellulin 
(BTC), dual specificity phosphatase 5 (DUSP5) and RET proto-oncogene (RET) 
were down-regulated. Betacellulin and RET proto-oncogene promote cell 
proliferation and act as positive regulation of cell cycle, whereas DUSP5 is 
negative regulation of cell proliferation. On the other hand, KLF10 (kruppel-like 
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factor 10) that acts as transcriptional repressor and inhibits growth of cancer cell 
was up-regulated. 
 Nine genes that are involved in proteolysis (see Table 5.4). The five genes that 
are involved in proteolysis were all up-regulated, whereas the other four genes 
that are coded for protease inhibitor or negative regulation of proteolysis were 
all down-regulated. Together, these suggest that there was an overall increase in 
proteolysis, which is reflective of cell death event. 
 Four genes that are involved in oxidative stress, including cytochrome P450, 
family 1, subfamily A, polypeptide 1 (CYP1A1), cytochrome P450, family 1, 
subfamily B, polypeptide 1 (CYP1B1), glutathione peroxidase 2 (GPX2), and 
microsomal glutathione S-transferase 1 (MGSTI). All these genes were up-
regulated. In particular, CYP1A1 and CYP1B1 both were very substantially up-
regulated (33.9- and 6.1-folds, respectively). While the up-regulation of both 
GPX2 and MGSTI, the two genes involved in responses to oxidative stress are 
expected, the very substantial up-regulation of the two cytochrome P450 enzyme 
genes are interesting as they will presumably further enhance the LAAO-
induced oxidative stress by producing more ROS.  
 Sequestosome 1 (SQSTM1) gene, which is involved in autophagy, is known to 
be up-regulated by oxidative stress. The up-regulation of this gene contributes to 
apoptosis and cell death induced by OH-LAAO. 
It is interesting to note that none of the caspase related genes (CASP3, CASP7, CASP8 
and CASP9) were found to be differentially expressed, even though enzymatic assays 
did demonstrate clearly the increase in these activities (Chapter 4, Section 4.9.1 & 
4.11.1). Presumably, the relevant gene expression alterations may be too low to be 
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detected in the present study design. The other possibility is by the time the RNAs were 
collected for microarray assay (72 h after OH-LAAO treatment), expression of caspase 
might have dropped to the normal values. 
It is also interesting to note that the expressions of cytochrome P450 genes (CYP1A1 
and CYP1B1) were increased very substantially following OH-LAAO treatment. In 
particular, expression of CYP1A1 gene increased 33.9-fold. These results of microarray 
analysis were also validated by RT-PCR, whereby expression of CYP1A1 gene was 
increased by 29-fold, and also by increase in CYP1A1 and CYP1B1 enzyme activities 
in MCF-7 cells, though only by 2.3-fold. This difference is expected as microarray and 
RT-PCR measured changes at transcription levels, whereas enzymatic activities 
measured changes at translation levels.   
Cytochrome P450s are known to induce oxidative stress by producing excessive ROS 
(Dostalek et al., 2008), which can results in an imbalance of the redox homeostasis 
within the cells (Ramadass et al., 2003). Thus, the substantial activation of the ROS 
generating cytochrome P450 may contributes to the potent cytotoxic action of OH-
LAAO, further enhancing the oxidative stress.   
Measurement of intracellular ROS concentrations demonstrated that indeed there was a 
significant increased in the ROS in LAAO-treated MCF-7 cells. Similar observations 
have been reported by Sun et al. (2003). 
What then are the causes of the extensive alterations of gene expression, in particular 
those related to apoptotic events and cell death? The alterations of gene expression may 
be due directly to the modulation effects of H2O2 or other ROS generated during the 
enzymatic reaction, as these are known to serve as second messengers for various 
physiological stimuli (Kannan and Jain, 2000; Verzola et al., 2004). However, it is 
unlikely that the ROS could serve as second messengers for so many processes or 
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pathways that led to alterations of expression of hundreds of genes. Rather, it is more 
likely that the alterations of gene expression observed were largely caused by oxidative 
modifications of signalling proteins, such as transcriptional factors (Trachootham et al., 
2008). These modifications further modulate the activity of the signalling proteins in 
redox-sensitive signal transduction pathways as well as in transcriptional regulatory 
networks. This probably explains why, while most pro-apoptotic genes were up-
regulated, some others were down-regulated. Nevertheless, the overall results of the 
gene expression alterations appear to favour apoptotic cell death, with involvement of 
proteolysis, autophagy and regulation of cell cycle.  
In conclusion, the direct cytotoxic effect of H2O2 liberated by enzymatic action of the 
OH-LAAO, as well as the oxidative modifications of signalling molecules may be the 
primary events leading eventually to apoptosis and cell death. The very substantial up-
regulation of the expression of the cytochrome P450 genes, which may lead to further 
excessive ROS production, certainly plays a key role in apoptosis activation, even 
though the molecular events that lead to the up-regulation of the genes remain to be 
elucidated. 
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CHAPTER 6 
ALTERATIONS OF PROTEOME OF MCF-7 CELLS INDUCED BY KING 
COBRA (Ophiophagus hannah) VENOM L-AMINO ACID OXIDASE 
TREATMENT 
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INTRODUCTION 
Proteomics is a study of structure, function and expression of proteins in a complex 
biological sample. In combination with high resolution protein separation (2D 
electrophoresis) and mass spectrometry (MS) analyses, proteomics has become a 
popular approach for the study of proteome profiling, comparative protein expression 
analysis, localization and identification of protein post-translational modifications, and 
protein-protein interactions (Chandramouli and Qian, 2009). Protein expression analysis 
could provide useful information on cellular processes in response to the external 
stimuli (treatment conditions). It should be noted that much of the regulation of 
physiological processes occurs post-transcriptionally. Thus, measurement of mRNA 
levels (gene expression) alone is insufficient to give a complete picture of cellular 
activity in response to the external stimuli and therefore some other approaches such as 
proteomic study may be necessary in coupling with gene expression analysis. This 
chapter describes the investigation of the alterations of protein expression profile of 
MCF-7 cells as a result of OH-LAAO treatment, using 2D electrophoresis proteomic 
approach. The differentially expressed proteins were then classified into few different 
groups based on their biological functions.  
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METHODS 
6.1 Preparation of protein samples  
6.1.1 Preparation of cell lysate 
Protein samples for two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
and western blot analysis were prepared as follows: MCF-7 cells were seeded onto cell 
culture flask and incubated overnight in 37 °C humidified incubator for the cells to 
attach. Cells were treated with 0.04 µg/mL (IC50 value) of OH-LAAO for 72 h. After 
treatment, cells were harvested by trypsin-EDTA and washed twice with PBS. Cell 
pellet was re-suspended in lysis buffer [containing urea (7 M), thiourea (2 M), CHAPS 
(4% w/v), IPG buffer (2% v/v), DTT (40 mM), and protease inhibitor mix]. The mixture 
was allowed to stand on ice for 30 min and vortexed rigorously every 10 min. After 
centrifugation at 10,000 x g for 30 min at 4 °C, the supernatant was recovered and 
stored at -80 °C.   
6.1.2 Protein precipitation and solubilization 
Proteins were precipitated using 2-D clean-up kit according to the manufacturer’s 
guideline (GE Healthcare, Sweden). In brief, 100 μL of the protein sample was mixed 
with 300 μL of the precipitant and the mixture was incubated on ice for 15 min. Co-
precipitant (300 µL) was then added into the mixture, mixed and centrifuged at 12,000 
× g for 5 min. Supernatant was discarded. Forty microlitres of the co-precipitant was 
layered on top of the pellet and kept on ice for 5 min. After centrifugation for another 5 
min, the supernatant was discarded. Milli-Q
®
 water (25 µL) was then pipetted on top of 
the pellet and vortexed. Subsequently, pre-chilled wash buffer (1 mL) and additive (5 
µL) were added and vortexed until the pellet is fully dispersed. The mixture was 
incubated at -20 °C for 30 min and vortexed rigorously every 10 min. After spin down 
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at 12,000 × g for 5 min, supernatant was discarded. Protein pellet was air-dried for 5 
min and solubilised in 30 µL of thiourea rehydration buffer [containing urea (7 M), 
thiourea (2 M), CHAPS (2% w/v), IPG buffer (0.5% v/v), 0.002% v/v of 1% orange G 
stock solution, and DTT (18 mM)].  
6.1.3 Protein concentration determination 
Protein concentration was determined using 2-D quant kit according to the 
manufacturer’s protocol (GE Healthcare, Sweden) with slight modifications as 
described in general methods (Chapter 2, Section 2.9.2).  
6.2 Two dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
6.2.1 Sample loading and rehydration of immobilized pH gradient (IPG) strip 
For isoelectric focusing (IEF), 150 µg of the protein samples were dissolved in the 
thiourea rehydration buffer to a final volume of 250 µL. Total volume of the mixture 
(250 µL) was pipetted onto the slot of the re-swelling tray. Subsequently, the dried gel 
side of the IPG strip (13 cm, linear pH 3 - 10 gradient) was placed onto the slot that 
contained the protein sample. To prevent evaporation and urea crystallization, 2 mL of 
the cover fluid was overlaid on top of the strip. Strip rehydration was performed at room 
temperature for 16 - 18 h.  
6.2.2 First dimensional isoelectric focusing 
Rehydrated strips were transferred onto the channels of the manifold with gel side faced 
up. Pre-wetted paper wicks were placed at the acidic and basic ends of each strip. 
Subsequently, the electrode was placed on top of the paper wicks and the cams were 
swivelled into closed position. All the channels of the manifold were flooded with the 
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cover fluid. The Ettan IPGphor3 Isoelectric Focusing System (GE Healthcare, 
Amersham Biosciences, Sweden) was programmed with the parameters as follows: 
Step Ramping mode Voltage (V) Time (h:min) kVh 
Step 1  Step and hold 500 1:30 0.5 
Step 2  Gradient 1000 1:00 0.8 
Step 3  Gradient 8000 2:30 11.3 
Step 4 Step and Hold 8000 1:15 4.4 
 
6.2.3 Preparation of 12.5% resolving gel 
Resolving gel (12.5%) was prepared according to the method of Laemmli (1970). 
Compositions of resolving gel are listed below: 
Milli-Q
®
  water 31.8 mL 
Acrylamide/Bis-acrylamide (30% stock) 41.7 mL 
10% (w/v) SDS 1.0 mL 
1.5 M Tris-HCl, pH 8.8 25.0 mL 
10% (w/v) ammonium persulfate 0.5 mL 
TEMED  33.0 µL  
 
Solutions or reagents were mixed and poured into the gel cassette to a level which is 
sufficient for the rehydrated IPG strip to be inserted later. The gel was overlaid with 
water and gel cassette was allowed to stand at room temperature for 30 min for it to 
polymerize.  
6.2.4 Equilibration of immobilized pH gradient (IPG) strip 
After IEF, IPG strip was equilibrated with 5 mL of the SDS equilibration buffer I [6 M 
urea, 50 mM Tris-HCl (pH 8.8), 30% (v/v) glycerol, 2% (w/v) SDS, 0.002% (w/v) 
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orange G, and 50 mg (w/v) DTT] for 15 min at room temperature with agitation. 
Subsequently, SDS equilibration buffer I was replaced with 5 mL of the SDS 
equilibration buffer II [6 M urea, 50 mM Tris-HCl (pH 8.8), 30% (v/v) glycerol, 2% 
(w/v) SDS, 0.002% (w/v) orange G, and 125 mg (w/v) IAA] and the IPG strip was 
equilibrated for another 15 min at room temperature with shaking. The IPG strip was 
rinsed with 1X SDS electrophoresis running buffer [25 mM Tris-HCl (pH 8.3), 192 mM 
glycine, and 0.1% (w/v) SDS]. 
6.2.5 Second dimensional sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Second dimensional SDS-PAGE was performed using SE 600 Ruby electrophoresis 
tank (GE Healthcare, Amersham Biosciences, Sweden). The IPG strip was transferred 
onto the surface of the 12.5% resolving gel. Two millilitres of the sealing solution 
[contained 0.5% (w/v) agarose and 0.002% (w/v) Orange G] was poured into the gel 
cassette to seal the IPG strip with the resolving gel. Upper chamber of the tank was 
filled with 2X SDS electrophoresis running buffer while the lower chamber was filled 
with 1X SDS electrophoresis running buffer. The running parameter was programmed 
as follows: 
Step Current (mA/gel) Voltage (V) Duration (h:min) 
1 15 80 0:20 
2 40 200 6:00 
 
Electrophoresis was stopped when the front dye reached half centimetre to the bottom 
of the gel. 
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6.2.6 Protein staining  
Silver staining was performed using Pierce
®
 silver stain for mass spectrometry kit 
according to the manufacturer’s protocol (Thermo Scientific Pierce, USA). Briefly, gel 
was washed twice with milli-Q
®
 water for 5 min each and fixed overnight in the fixing 
solution (60% water, 30% ethanol, and 10% acetic acid) at room temperature with 
agitation. After overnight fixation, gel was washed with 10% ethanol, followed by milli-
Q
®
 water for 5 min each wash. Gel was then incubated in the sensitizer working 
solution for 1 min, and washed with two changes of milli-Q
®
 water for 1 min each wash. 
Subsequently, gel was incubated in the silver stain [containing 1% (v/v) silver stain 
enhancer] for 5 min and washed with two changes of milli-Q
®
 water for 20 sec each 
wash. Developer working solution was then added onto the gel and the spot intensity 
was monitored for about 7 min. Once the desired intensity is reached, the developer 
working solution was replaced with the stop solution (5% acetic acid in milli-Q
®
 water) 
and incubated for another 10 min with agitation.  
6.2.7 Image acquisition and analysis 
Image acquisition was performed using ImageScanner™ III (LabScan6.0, Swiss 
Institute of Bioinformatics). Differences in the protein expression were identified by 
ImageMaster™ 2D Platinum 7.0 software (GE Healthcare, Amersham Biosciences, 
Sweden). The images of the samples of the control and LAAO-treated groups were 
analysed by creating a match sets followed by classes. Gel image from each group with 
high resolution was assigned as the image master. Three landmark points were defined 
on the gel images and the spots matching procedure was performed manually to correct 
the mismatching spots generated by the software. Protein spots that displaying at least 
1.5-fold difference in expression (ANOVA P-value < 0.05) were excised manually from 
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the gels and subjected to in-gel trypsin digestion and subsequent MALDI-TOF/TOF 
identification. 
6.3 Protein identification 
6.3.1 In-gel trypsin digestion 
Differentially regulated protein spots were excised manually from the 2-D gels, and 
destained with 50 mM sodium thiosulphate containing 15 mM potassium ferricyanide. 
After destaining, gel plugs were washed 3 times with 500 µL of 50% acetonitrile 
containing 100 mM NH4HCO3 for 20 min each wash, and subsequently dehydrated by 
incubating in 50 µL of 100% acetonitrile for 15 min with shaking and dried completely 
using speed vacuum for 15 min. Trypsin digestion was performed by overnight 
incubation with 25 µL of 50 mM NH4HCO3 containing 150 ng of trypsin at 37 °C. After 
trypsin digestion, 50 µL of 50% acetonitrile was added into the sample and incubated 
for a further 15 min at room temperature with shaking. The supernatant was collected. 
Peptides remaining in the gel plugs were extracted again by adding 50 µL of 100% 
acetonitrile and followed by incubation at room temperature for 15 min. The 
supernatant was collected and pooled into the previous tube. Finally, peptides were 
dried completely using speed vacuum and stored at -20 °C for further analysis.  
6.3.2 Samples cleaned-up 
Peptides were reconstituted with 10 µL of 0.1% (v/v) formic acid prior to desalting. The 
C18ZipTip
®
 was rinsed with 10 µL of the wetting solution [50% (v/v) acetonitrile in 
H2O] and equilibrated with 0.1% (v/v) formic acid. Ten microlitres of the reconstituted 
peptide proteins were aspirated into the pre-equilibrated C18ZipTip
®
 and dispensed. 
This step was repeated for 10 times. C18ZipTip
®
 was washed three times with the 
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washing solution [0.1% (v/v) formic acid]. Subsequently, peptides were eluted with 4 
µL of the 50% acetonitrile containing 0.1% (v/v) formic acid.  
6.3.3 MALDI-TOF/TOF mass spectrometry analysis 
The peptide proteins were mixed with an equal volume of α-cyano-4-hydroxycinnamic 
acid matrix [(10 mg/mL in 50% (v/v) acetonitrile containing 0.1% (v/v) trifluoroacetic 
acid]. Two microlitres of the peptide mixtures were spotted on Opti-TOF™ LC/MALDI 
INSERT (123 x 81 mm) (Applied Biosystems Inc., CA, USA). The MALDI-TOF/TOF 
was performed using MDS SCIEX 4800 Plus MALDI TOF/TOF™ analyser (Applied 
Biosystems Inc., CA, USA). Each sample was first analysed with MALDI-TOF mass 
spectrometry to generate the peptide mass fingerprinting (PMF) data [Scanning range: 
900 - 4000 mass-to-charge ratio (m/z)]. The five most abundant peptides that exceeded 
the set threshold were then selected for further fragmentation (MALDI-TOF/TOF) 
analysis to generate the full scan mass spectrum. 
6.3.4 Database searching 
All acquired spectra from samples were processed using Data Explorer™ 4.0 software 
(Applied Biosystems Inc., CA, USA). The data was searched against SwissProt 
database (Date of database searched: December 2012) using MASCOT searching 
engine version 2.2 (Matrix Science Inc., MA, USA). Protein score obtained by 
MASCOT was based on the MOWSE scoring algorithm. The MASCOT search analysis 
settings were as follows:   
Taxonomy: Homo sapiens 
Protease for digestion: trypsin 
Fixed modification: carbamidomethyl 
Variable modification: oxidation 
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MS/MS fragment tolerance: ± 0.2 Da 
Precursor tolerance: 75 ppm 
Peptide charge: + 1; monoisotopic 
6.4 Western blot analysis 
6.4.1 Cell lysate proteins preparation and quantitation 
Cell lysate proteins for western blot analysis were prepared as described previously in 
this chapter (Section 6.1.1). Protein concentration was determined using 2-D quant kit 
according to the manufacturer’s protocol as described in general methods (Chapter 2, 
Section 2.9.2). 
6.4.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was performed as 
described in general methods (Chapter 2, Section 2.10). Briefly, cell lysate containing 
20 µg of the proteins were mixed with the sample incubation buffer at an equal ratio and 
heated at 70 - 80 °C for 5 - 10 min. The samples were then separated on 12.5% SDS-
PAGE at 90 V for about 2 h.   
6.4.3 Western blotting  
Following SDS-PAGE, proteins were transferred onto iBlot™ Polyvinylidene fluoride 
(PVDF) membrane using iBlot™ dry blotting system, iBlot™ gel transfer device 
(Invitrogen™, Grand Island, USA) at 20 V for 8 min. Gel sandwich was arranged in the 
following order from the bottom iBlot™ copper anode to the top copper cathode: 
PVDF membrane         SDS-PAGE gel         pre-wet filter paper       
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The PVDF membrane was removed from the blotting device and blocked with blocking 
solution (5% BSA in TBS-T) for 1 h with agitation at room temperature, followed by 
overnight hybridization at 4 °C with primary antibody in 2% BSA blocking solution. 
After 3 times washing with TBS-T, membrane was further incubated at room 
temperature for 1 h in 2% BSA blocking solution containing HRP-anti mouse secondary 
antibody. The membrane was washed with TBS-T and the reactive bands were 
developed using 1-step 3,3',5,5'-tetramethylbenzidine (TMB)-blotting solution for 3 - 5 
min. Summary of antibody dilutions are listed in Table 6.1. 
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Table 6.1: Antibodies for western blotting analysis  
Antibody Source Supplier Dilution 
Monoclonal anti-Hsc 70 Mouse Abcam
®
 1:10,000 
Monoclonal anti-Grp 75 Mouse Abcam
®
 1:1,000 
Monoclonal anti-beta actin Mouse Abcam
®
 1:2,000 
Anti-mouse IgG- HRP conjugate Goat Thermo Scientific Pierce 1:1,000 
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6.4.4 Stripping of PVDF membrane  
For repeated hybridization with antibody against beta-actin as a loading control, 
membrane was stripped in the stripping buffer [0.4 M Glycine, 2% (v/v) Tween-20, and 
0.2% (w/v) SDS, pH 2.2] at room temperature for 10 - 20 min. After stripping, 
membrane was washed twice with TBS-T and blocked with 5% BSA blocking solution 
for 1 h before re-hybridize with the loading control.  
6.5 Statistical analysis 
Differences in the protein expression were analysed by ImageMaster™ 2D Platinum 7.0 
software and ANOVA P-values were applied (GE Healthcare, Sweden). Changes of 
1.5-fold or greater in protein expression (P < 0.05) were considered as significant. 
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RESULTS 
6.6 Proteomic analysis of MCF-7 cells treated with L-amino acid oxidase 
The MCF-7 cells were treated with 0.04 µg/mL of OH-LAAO or vehicle for 72 h. Total 
cell lysate proteins of 150 µg were separated by 2D-PAGE. First dimensional isoelectric 
focusing (IEF) was performed on a linear IPG (pH 3 - 10) strips. The second 
dimensional SDS-PAGE was performed on 12.5% polyacrylamide resolving gels. Gels 
were visualized by silver staining. The 2D gel images (n = 3) were analysed by 
ImageMaster™ 2D Platinum 7.0 software. The representative gel images are shown in 
Figure 6.1. A total of 823 well-defined protein spots were detected but of these, only 21 
protein spots were (as indicated by numbered circles) excised for protein identification 
by mass spectrometry. These protein spots appeared in all replicates and exhibiting 1.5-
fold or greater (P < 0.05) change in expression. 
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Figure 6.1: 2D gel images of MCF-7 cell lysate proteins with and without OH-LAAO treatment. Representative 2D gel images stained with silver stain. MCF-7 cells 
were treated with PBS (vehicle, left) or OH-LAAO (0.04 µg/mL, right) for 72 h. The 21 differentially expressed protein spots excised for mass spectrometry 
analyses are indicated by circles with numeral. 
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6.7 Identification of the differentially expressed proteins by MALDI-TOF/TOF                    
The 21 differentially expressed proteins in the 2D gels stained by silver stain were 
identified by MALDI-TOF/TOF, as shown in Table 6.2. Of the 21 proteins, 10 (47.6%) 
were up-regulated and 11 (52.4%) were down-regulated. The identified proteins were 
further classified according to their biological functions according to SwissProt and 
Gene Ontology Databases (Table 6.2). 
6.7.1 Regulation of proteins involved in metabolism 
Only two proteins that are involved in metabolism were differentially expressed: 
cytosolic 10-formyltetrahydrofolate dehydrogenase (up-regulated), and UDP-glucose 4-
epimerase (down-regulated). .  
6.7.2 Regulation of proteins involved in mRNA processing and translation 
Four proteins were found to be differentially expressed in the LAAO-treated MCF-7 
cells. Of these, 3 proteins were down-regulated (neuroguidin, poly(rC)-binding protein 
1, and heterogeneous nuclear ribonucleoprotein H). The up-regulated protein was 40S 
ribosomal protein SA.  
6.7.3 Regulation of proteins involved in nucleotide and amino acid biosynthesis 
Two down-regulated (ribose-phosphate pyrophosphokinase 1, and mitochondrial 
ornithine aminotransferase) and one up-regulated (nucleoside diphosphate kinase B) 
proteins were identified in LAAO-treated cells.  
 
 
179 
 
6.7.4 Regulation of proteins involved in oxido-reduction 
Three proteins involved in oxido-reduction were differentially expressed following 
LAAO-treatment: NADPH-cytochrome P450 reductase, and mitochondrial 
monofunctional C1-tetrahydrofolate synthase were up-regulated; while D-3-
phosphoglycerate dehydrogenase was down-regulated.  
6.7.5 Regulation of proteins involved in protein ubiquitination and proteolysis 
A protein that is involved in ubiquitination was up-regulated (E3 ubiquitin-protein 
ligase UBR5), whereas another protein that acts as protease inhibitor or negative 
regulator of proteolysis was down-regulated (alpha-1-antichymotrypsin). Indicating that, 
OH-LAAO treatment promotes proteolysis. 
6.7.6 Regulation of stress-related proteins 
Heat shock cognate 71 kDa protein, and stress-70 protein were all found to be up-
regulated in the treated cells 
6.7.7 Regulation of proteins involved in structural integrity 
Three proteins involved in structural integrity were found to be differentially expressed 
in the LAAO-treated cells. The up-regulated proteins were lamin-B1, and keratin type II 
cytoskeletal 8. The down-regulated protein was actin cytoplasmic 1. 
6.7.8 Regulation of proteins involved in other functions 
The differentially expressed proteins that were grouped under this category are solute 
carrier family 25 member 52, and growth/differentiation factor 8. Both were down-
regulated.  
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Table 6.2: Differentially expressed proteins identified by MALDI-TOF/TOF mass spectrometry 
Spot no UniProtKB/Swiss-Prot 
(Accession number) 
Protein description Fold-change Protein scores Sequence coverage 
(%) 
 
Metabolism     
     
4 O75891 Cytosolic 10-formyltetrahydrofolate 
dehydrogenase 
3.3 49 9 
16 Q14376 UDP-glucose 4-epimerase -1.8 64 13 
      
mRNA processing and translation     
     
6 Q8NEJ9 Neuroguidin -1.8 35 9 
7 Q15365 Poly(rC)-binding protein 1 -1.5 137 22 
12 P31943 Heterogeneous nuclear ribonucleoprotein H -1.6 313 20 
21 P08865 40S ribosomal protein SA 2.0 195 19 
      
Nucleotide and amino acid biosynthesis     
     
1 P22392 Nucleoside diphosphate kinase B 1.6 70 15 
2 P60891 Ribose-phosphate pyrophosphokinase 1 -1.6 108 18 
17 P04181 Ornithine aminotransferase, mitochondrial -1.7 84 18 
 
Protein ubiquitination and proteolysis 
    
     
8 O95071 E3 ubiquitin-protein ligase UBR5 3.2 42 10 
19 P01011 Alpha-1-antichymotrypsin (SERPINA3) -2.6 70 15 
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Table 6.2, Continued     
Spot no UniProtKB/Swiss-Prot 
(Accession number) 
Protein description Fold-change Protein scores Sequence coverage 
(%) 
     
Oxido-reduction     
     
5 P16435 NADPH-cytochrome P450 reductase 1.5 64 12 
11 Q6UB35 monofunctional C1-tetrahydrofolate 
synthase, mitochondrial 
2.3 58 10 
13 O43175 D-3-phosphoglycerate dehydrogenase -1.5 104 17 
      
Stress-related protein     
     
14 P11142 Heat shock cognate 71 kDa (Hsc70) 1.9 100 21 
15 P38646 Stress-70 protein, mitochondrial (Grp75) 6.6 508 35 
      
Structural integrity     
     
9 P60709 Actin, cytoplasmic 1 -1.5 79 18 
18 P20700 Lamin-B1 1.6 95 17 
20 P05787 Keratin, type II cytoskeletal 8 2.0 76 16 
      
Others     
     
3 Q3SY17 Solute carrier family 25 member 52 -2.2 52 9 
10 O14793 Growth/differentiation factor 8 -2.6 43 9 
      
A positive fold-change indicates up-regulated, while a negative fold-change indicates down-regulated in protein expression in relative to the control 
cells. Protein scores > 55 are significant (P < 0.05). Data was obtained from triplicate analyses (n = 3) (Date of database searched: December 2012). 
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6.8 Validation of differential expression of proteins by western blot analysis 
Western blot analyses were performed to validate the observed alterations in protein 
expression by 2D gel proteomic analysis. The heat shock cognate 71 kDa (Hsc70) and 
stress-70 proteins (Grp75) were selected for western blot validation, using beta-actin as 
a loading control. Equal amounts (20 µg) of cell lysate proteins extracted from MCF-7 
cells treated with 0.04 µg/mL of OH-LAAO or PBS (vehicle) were used in the western 
blot analysis. As shown in Figure 6.2, both proteins examined were up-regulated in the 
LAAO-treated cells compared with the vehicle-treated cells. The results were consistent 
with the observations in the 2D gel proteomic analysis.  
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Figure 6.2: Western blot analysis of Hsc70 and Grp75 in LAAO-treated MCF-7 cells. The 
expression level of (A) Hsc70 and (B) Grp75 in the LAAO-treated cells was compared to the 
control. Beta-actin was used as an equal loading control. Molecular weights are indicated on the 
right. The images are representative of three independent experiments. 
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    DISCUSSION 
The present study investigated the alterations of protein expression profile of MCF-7 
cells as a result of OH-LAAO treatment, using 2D electrophoresis proteomic approach. 
The results show that a total of 21 proteins were expressed differentially as a result of 
the treatment. Based on their biological functions, the differentially expressed proteins 
can be divided into different groups (Table 6.2). As the main purpose of the study is to 
investigate the molecular events that occur during the OH-LAAO treatment of the 
cancer cells, only those proteins that are related to cell death were considered in greater 
detail: 
6.9 Modulation of proteins involved in stress response 
King cobra venom LAAO (OH-LAAO) has been shown to induce intracellular 
oxidative stress through the production of H2O2 during the enzymatic reaction (Chapter 
5). Synthesis of stress proteins is a ubiquitous characteristic for cells in response to 
various environment insults including oxidative stress (Gomer et al., 1991). Increased 
expressions of stress proteins confer cellular resistance against oxidative stress 
condition.  
The increased in the expression of heat shock cognate 71 kDa (Hsc70) and 
mitochondria stress-70 protein (Grp75) further confirm the role of oxidative stress in 
LAAO-mediated cell death. The increased in the expression of these two proteins were 
also validated by Western blot analysis. 
The Hsc70, and Grp75 function to regulate cell survival and confer cytoprotection from 
oxidative stress (Wang et al., 2013) through the modulation of the activity of ROS 
scavenger such as glutathione peroxidase (Guo et al., 2007; Williamson et al., 2008). It 
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is interesting to note that microarray analysis also demonstrates an increased in 
expression of glutathione peroxidase 2 (GPX2) (Chapter 5).  
The observed increased expression of the stress-related proteins that functions to 
counteract cellular stress is in agreement with the suggestion that the primary event 
leading to cell death as a result of the OH-LAAO treatment is due to oxidative stress 
induced by H2O2. However, since the amount of enzyme used in the study (0.04 µg/mL) 
is so low, the net amount of H2O2 released by the enzymatic action must be rather 
limited, yet the enzyme exhibits extremely potent cytotoxic activity. We have earlier 
(Chapter 4) suggested that the potent cytotoxic effect induced by OH-LAAO may be 
due to its ability to bind to cancer cells, and thereby releasing high local levels of H2O2 
in the cancer cells. Nevertheless, there is also the possibility of involvement of other 
molecular mechanisms that can trigger excessive production of cellular ROS. Such 
mechanism may involve cellular oxido-reductases that regulate the balance between 
cellular oxidant and reductant levels, as discussed below. 
6.10 Modulation of proteins involved in oxido-reduction 
The differentially expressed proteins that are involved in oxido-reduction (NADPH-
cytochrome P450 reductase, monofunctional C1-tetrahydrofolate synthase, and D-3-
phosphoglycerate dehydrogenase) are the enzymatic components of ROS production 
system during endoplasmic reticulum stress response (Bhandary et al., 2012). The 
observed increased expression of cytochrome P450 reductase (CPR) is particularly 
interesting, as this will facilitate the transfer of electrons from NADPH to cytochrome 
P450 isoenzymes (Döhr et al., 2001), and as a result increases the production of ROS 
during the reaction cycle and hence, contribute further to cellular oxidative stress 
(Fleming, 2001). It is interesting to note that microarray and RT-PCR analysis also 
demonstrated very substantial up-regulation of expression of the two cytochrome P450 
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genes (CYP1A1 and CYP1B1), and that the enzyme activities of CYP1A1 and CYP1B1 
were both significantly increased in the LAAO-treated MCF-7 cells (Chapter 5).  
6.11 Modulation of proteins involved in ubiquitination and proteolysis 
The E3 ubiquitin-protein ligase confers specificity to the ubiquitination process and 
directs the conjugation of ubiquitin (a polypeptide co-factor) to specific target proteins. 
The ubiquitinated proteins lead to the recognition by the 26S proteasome that degrades 
ubiquitinated proteins into small peptides (Lecker et al., 2006). Numerous studies have 
demonstrated that the ubiquitination-mediated degradation plays an important role in 
controlling the levels of various cellular proteins including many molecules that 
regulate cell death machinery, such as p53, caspases, and Bcl-2 family members. 
Ubiquitination-degradation of ring finger-containing members of the IAP (inhibitor of 
apoptosis) family proteins is required for apoptosis to occur, indicating that apoptosis 
proceeds through death pathways as well as ubiquitin-proteasome pathway (Yang and 
Yu, 2003).  
Thus, the up-regulation of E3 ubiquitin-protein ligase UBR5 and down-regulation of 
alpha-1-antichymotrypsin (SERPINA3), a serine-protease inhibitor, suggest that there 
was likely to be an overall increase in ubiquitination-mediated degradation and 
proteolysis, which contributed to cell death. It is noteworthy that the down-regulation of 
expression of SERPINA3 is in agreement with the results of alteration of SERPNA3 
gene in microarray analysis (Chapter 5).  
6.12 Modulation of proteins involved in cell proliferation and apoptosis 
The three proteins; keratin type II cytoskeletal 8 (grouped under structural integrity), 
cytosolic 10-formyltetrahydrofolate dehydrogenase (group under metabolism), and 40S 
ribosomal protein SA (grouped under mRNA processing and translation) are all 
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involved in the regulation of apoptosis. Studies have suggested that keratin type II 
cytoskeletal 8 (K8) was involved in modulating of cellular responses to pro-apoptotic 
stimuli by desensitising the cells to pro-apoptotic signalling mediated by tumour 
necrosis factor-α (TNF-α) or by Fas ligand, by binding to their receptors (Owens and 
Lane, 2003). Cytosolic 10-formyltetrahydrofolate dehydrogenase has been shown to 
induce G1 cell cycle arrest and p53-dependent apoptosis (Hoeferlin et al., 2011). The 
40S ribosomal protein SA (67-kDa laminin receptor), functions as a cancer-specific 
death receptor induced apoptosis via cGMP-mediated pathway (Kumazoe et al., 2013). 
The up-regulation of these proteins all confirmed that OH-LAAO induces apoptosis, as 
was discussed in the earlier chapters (Chapter 4 and 5).   
6.13 Conclusions: what can we learn about mechanism of LAAO-induced 
apoptosis from proteomic studies? 
In Chapter 5, the present study reports the investigation of the alterations of gene 
expression that occurred as a result of OH-LAAO treatment, using microarray analysis. 
The results showed that the oxidative stress induced by H2O2 liberated during the 
enzymatic reaction of OH-LAAO resulted in the alterations of expression of 178 genes, 
out of which at least 27 genes are involved in apoptosis and cell death. Of particular 
interest was the substantial up-regulation of the ROS generating cytochrome P450 genes 
which may further contribute to the cytotoxic action of the H2O2 generated by the 
enzymatic actions of OH-LAAO.  
In the present proteomic studies, 21 proteins were found to be differentially expressed 
as a result of OH-LAAO treatment. However, only a few of the altered proteins are 
related to the genes that were found to be expressed differentially in microarray analysis, 
including alpha-1-antichymotrypsin (SERPINA3, gene expression down-regulated 1.9-
fold, protein expression down-regulated 2.6-fold) and cytochrome P450 reductase. 
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Apart from that, an increased in the expression of Hsc70 and Grp75 proteins were also 
partly associated with the up-regulation of glutathione peroxidase 2 (GPX2) gene. The 
lack of congruence between the results of gene expression studies (microarray studies) 
and protein expression studies (proteomic studies), however, are expected. While the 
former investigated the alterations at transcriptional level, the proteomic studies 
investigated the alterations at translational level. Also, even though samplings of lysate 
proteins (for proteomic studies) and RNA (for microarray studies) were both done after 
72 h OH-LAAO treatment, the proteome was more a reflection of the transcriptome of 
the cells existed sometime earlier before the harvest of the cellular RNA. It is 
reasonable to expect the cell’s transcriptome to change as time progress, as the H2O2 
and ROS generated as a result of OH-LAAO treatment continue to cause oxidative 
damages to the cellular proteins. Another complicating factor is the dose of OH-LAAO 
used in the two studies differs. 
What then can we learn about the mechanism of LAAO-induced apoptosis from 
proteomic studies? From the results of gene expression (microarray) studies, it is 
postulated that the alterations of gene expression observed were largely caused by non-
specific oxidative modifications of signalling proteins, such as transcriptional factors, 
which  further modulate the activity of the signalling proteins in redox-sensitive signal 
transduction pathways as well as in transcriptional regulatory networks. Results from 
the proteomic studies support this postulate: A total of 21 proteins involved in 
different/unrelated pathway and cellular functions were differently expressed, indicating 
that it is likely due to the result of non-specific oxidative modifications of signalling 
proteins caused by the cellular ROS generated. 
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CHAPTER 7 
CONCLUSION AND FUTURE STUDIES 
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CONCLUSION 
 King cobra venom LAAO (OH-LAAO) is a very potent antibacterial agent. It 
was effective in inhibiting the two Gram-positive bacteria (S. aureus and S. 
epidermidis) and was moderately effective against the Gram-negative bacteria 
(P. aeruginosa, K. pneumonia, and E. coli) tested. On a molar basis, the 
antibacterial activity of OH-LAAO against all bacteria tested was far more 
potent than most of the commonly used antibiotics examined. Bacterial binding 
affinity of the enzyme plays an important role in its antibacterial activity. 
 King cobra venom LAAO is an extremely potent and selective cytotoxic agent 
against tumorigenic cells. Its cytotoxicity was far more potent than that of 
doxorubicin, a commonly used anti-cancer chemotherapeutic agent. The 
cytotoxic action of the enzyme is exerted through induction of apoptosis, and is 
associated with the increase in caspase-3/7 activities, positive staining of 
annexin V to cell membrane and formation of DNA fragmentation in the 
LAAO-treated cells. Its apoptosis induction activity is via both intrinsic and 
extrinsic pathways as indicated by increase in caspase-9 and -8 activities as well 
as increased cytochrome c levels in both cytosolic and mitochondria fractions in 
the LAAO-treated cells.  
 Gene expression and proteomic profiling of the LAAO-treated MCF cells 
suggested that the primary events leading eventually to apoptosis and cell death 
were largely caused by non-specific oxidative modifications of signalling 
proteins, such as transcriptional factors, which further modulate the activity of 
the signalling proteins in redox-sensitive signal transduction pathways as well as 
in transcriptional regulatory networks. In addition, the very substantial up-
regulation of the expression of the cytochrome P450 genes, which may lead to 
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further excessive ROS production, certainly plays a key role in the apoptosis 
activation.  
 The effectiveness of the enzyme in suppressing the growth of solid tumours in 
vivo without causing much significant toxic effects supports its potential as an 
anti-cancer agent. 
FUTURE STUDIES 
 Therapeutic application of the enzyme as an antibacterial agent will always have 
its limitations due to its relatively high production cost (either purified from 
venom or via cloning). The design of new antibacterial drugs or new therapeutic 
approaches which mimic the mode of antibacterial action of OH-LAAO could be 
a promising alternative.  
 The high molecular weight of the OH-LAAO (130 kDa) may hinder its 
penetration into the solid tumour; thereby limiting its effectiveness as anti-
cancer agent. Further development in delivery system is required. In addition, 
the enzyme is probably more effective against cancer cell suspensions such as 
leukaemia and ascites, than in solid tumours. Alternatively, the enzyme could be 
cloned and transfected to tumour cells to induce cell death in situ.  
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Appendix I 
Ethical clearance for laboratory animal  
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Appendix II 
Buffer and reagent preparation 
A. Preparation of Bradford reagent 
Coomassie brilliant blue G-250 (100 mg) was first dissolved in 50 mL of 95% ethanol. 
One hundred millilitres of 85% phosphoric acid was then added. The reagent mixture 
was top-up with milli-Q
®
 water to a final volume of 1L and filtered using the filter 
paper.  
B. Preparation of nutrient agar plates 
Dehydrated nutrient agar (28 g) was dissolved in 1 L of the autoclaved milli-Q
®
 water 
and sterilized by autoclaving at 121 °C for 15 minutes. The agar solution was cooled to 
50 °C and subsequently poured onto the Petri dish to a level until it completely covered 
the dish surface. The agar plates were allowed to solidify at room temperature and 
stored at 4 °C. 
C. Preparation of nutrient broth  
Dehydrated nutrient broth (13 g) was dissolved in 1 L of the autoclaved milli-Q
®
 water. 
The broth was autoclaved and stored at 4 °C until used. 
D. Preparation of Mueller-Hinton broth 
Dehydrated Mueller-Hinton broth (21 g) was dissolved in 1 L of the autoclaved milli-
Q
®
 water. After autoclave and overnight chill at 4 °C, The broth was supplemented with 
the divalent cations of Mg
2+
 (10 mg/L) and Ca
2+
 (20 mg/L) as recommended by 
National Committee for Clinical Laboratory Standards, (NCCLS) (2000). The cations 
adjusted Mueller-Hinton broth was stored at 4 °C.  
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E. Preparation of antibiotics stock solutions 
Antibiotics stock solutions were calculated by using the formula below: 
 
All the antibiotics were dissolved/diluted in their appropriate solvent/diluents as 
indicated below: 
 
Antibiotic Solvent Diluent 
Cefotaxime Water Water 
 
Kanamycin Water Water 
 
Tetracycline Ethanol Water 
 
Vancomycin Water Water 
 
Penicillin Water Water 
 
Antibiotics solutions were filtered using 0.2 µm membrane filter, aliquoted into the 2 
mL vials and stored at -20 °C.  
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Appendix III 
Heat map for differentially expressed genes in MCF-7 cells following L-amino acid 
oxidase treatment. 
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The heat map illustrates the expression level of 178 genes in relative to the corresponding 
vehicle (PBS) treated cells. Cells were treated with 0.015 µg/mL of LAAO or PBS for 72 h. 
Microarray analysis was conducted using HumanRef-8 v3.0 Expression BeadChips. The colour 
scale ranged from saturated green for -5.0-fold and below (decreased expression) to saturated 
red for 5.0-fold and above (increased expression). Each gene is represented by a single row. (A) 
Represent genes number 1 to 60. (B) Represent genes number 61 to 120. (3) Represent genes 
number 121 to 178. 
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Appendix IV 
List of publications in ISI-indexed journals 
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